Sentence,class,file
Available from: http://www.rand.org/ content/dam/rand/pubs/white_papers/2005/WP137.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Available from:http://personcentredcare.health.org.uk/sites/default/files/resources/what_is_co-production.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Available from:http://www.nationalvoices.org.uk/publications/our-publications/narrative-person-centred-coordinated-care 4.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Available from: http://cdn.basw.co.uk/upload/basw_102418-7.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Available from:http://www.scie.org.uk/care-act-2014/assessment-and-eligibility/strengths-based-approach/what-is-a-strengths-based-approach.asp 7.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Available from: http://www.health.org.uk/publication/helping-measure-person-centred-care 8.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Availablefrom:https://www.kingsfund.org.uk/blog/2012/11/developing-integrated-care-scale-and-pace-time-make-it-happen 9.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
Available from: https://handyapproachtocare.com/ 15.,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/bmjqir.u214461.w5681.PMC5483530.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/f1/bmjqir.u214071.w5561.PMC5483531.pdf
http://issuu.com/goshcc/docs/15_05_annual_reports_hospital_repor/174?e=1 [last accessed 23/06/16] 3.,Non-OADS,/arxiv_data1/oa_pdf/d7/f1/bmjqir.u214071.w5561.PMC5483531.pdf
http://www.gosh.nhs.uk/about-us/ our-priorities/quality-improvement [last accessed 23/06/16] 4.,Non-OADS,/arxiv_data1/oa_pdf/d7/f1/bmjqir.u214071.w5561.PMC5483531.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/e4/bmjqir.u211147.w6661.PMC5483532.pdf
Science Daily website http://www.sciencedaily.com/  releases/2012/09/120929140236.htm.,Non-OADS,/arxiv_data1/oa_pdf/e6/76/jgc-14-04-223.PMC5483590.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Att ribution- NonCommercial-NoDerivatives licence (http://creativecommons.org/ licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/3b/S2059866116000030a.PMC5483894.pdf
"Supplementary Material To view supplementary material for this article, please visit https://doi.org/ 10.1017/cts.2016.3 References 1.Notice of Revised NIH De ﬁnition of “Clinical Trial ”[Internet] [cited March 23, 2016].",Non-OADS,/arxiv_data1/oa_pdf/34/3b/S2059866116000030a.PMC5483894.pdf
( https://grants.nih.gov/grants/guide/notice- ﬁles/NOT- OD-15-015.html ).,Non-OADS,/arxiv_data1/oa_pdf/34/3b/S2059866116000030a.PMC5483894.pdf
( https://obssr.od.nih.gov/training/web-based- learning/good-clinical-practice-for-social-and-behavioral-research-elearn- ing-course/ ).Table 3.,Non-OADS,/arxiv_data1/oa_pdf/34/3b/S2059866116000030a.PMC5483894.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/53/S2059866116000091a.PMC5483939.pdf
"Supplementary Material To view supplementary material for this article, please visit https://doi.org/10.1017/cts.2016.9 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d5/53/S2059866116000091a.PMC5483939.pdf
( https://doi.org/10.1002/1097-0142 (19940201)73:3 <643::AID-CNCR2820730323 >3.0.CO;2-5 ) 8.,Non-OADS,/arxiv_data1/oa_pdf/d5/53/S2059866116000091a.PMC5483939.pdf
( https://doi.org/10.4137/CIN.S17292 ) 30.,Non-OADS,/arxiv_data1/oa_pdf/d5/53/S2059866116000091a.PMC5483939.pdf
http://www.acgme.org/About-Us/ Publications-and-Resources/Graduate-Medical-Education-Data-Resource-Book.,Non-OADS,/arxiv_data1/oa_pdf/3b/ba/acm-92-976.PMC5483979.pdf
http://www.cdc.gov/nchs/data/ndi/ndi_users_guide.pdf.,OADS,/arxiv_data1/oa_pdf/3b/ba/acm-92-976.PMC5483979.pdf
"20 2015 ACGME Symposium on Physician  Well-Being, November 29–December 1, 2016. http://www.acgme.org/What-We-Do/Initiatives/Physician-Well-Being/2016-ACGME-Symposium-on-Physician-Well-Being.",Non-OADS,/arxiv_data1/oa_pdf/3b/ba/acm-92-976.PMC5483979.pdf
"Chicago, IL: Accreditation Council for Graduate Medical Education;  November 4, 2016. http://www.acgme.",Non-OADS,/arxiv_data1/oa_pdf/3b/ba/acm-92-976.PMC5483979.pdf
aFor more information about PROMIS: http://www.nihpromis.org/about/abouthome.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
bFor more information about CG-CAHPS: https://www.ahrq.gov/cahps/surveys-guidance/cg/index.html.,OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
cFor more information about HCAHPS: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment- Instruments/HospitalQualityInits/HospitalHCAHPS.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
http://www.qualityforum.org/Publications/2014/01/MAP_Pre- Rulemaking_Report__2014_ Recommendations_on_Measures_for_More_than_20_Federal_Programs.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
http://www.qualityforum.org/QPS/ QPST ool.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
https://www.qualitymeasures.ahrq.gov/.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
https://www.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
"December 18, 2014. http://khn.org/news/medicare-cuts- payments-to-721-hospitals-with-highest- rates-of-infections-injuries/.",Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
"July 27, 2016. http://khn.org/ news/many-well-known-hospitals-fail-to- score-5-stars-in-medicares-new-ratings/.",Non-OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
https://www.cdc.gov/nhsn/about-nhsn/index.html.,OADS,/arxiv_data1/oa_pdf/b6/cb/acm-92-943.PMC5483980.pdf
"Supplemental Digital Content 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
"The number of monthly visits of sampled patients who used PHC facilities from January 2011 to June 2013 in the 2study arms are shown in Supplemental Digital Content 3, http://links.lww.com/QAI/B22.",Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
"Available at:http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf.Accessed July 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://www.who.int/nmh/events/2013/revised_draft_ncd_action_plan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://apps.who.int/iris/ bitstream/10665/44009/1/9789241597418_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://www.who.int/nmh/countries/zaf_en.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://beta2.statssa.gov.za/publications/P0302/P03022014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: https://www.idealclinic.org.za/docs/guidelines/PC%20101%20Guideline%20v2_%202013%2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://ideas.repec.org/c/boc/bocode/s432001.html.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
Available at: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/02/qai-75-472.PMC5483981.pdf
"Response Progress Report, the nationwide average prevalence of HIV-1 infection among MSM population reached 7.7% (http://unaids.org.cn/en/index/index.asp).5In 2014, the proportion of MSM among newly identi ﬁed HIV cases reached 25.8%.5Meanwhile, epidemiological studies on the MSM population of China have shown that most MSMengage in high-risk behaviors, such as multiple sexual partners and unprotected anal intercourse, 6–8which might increase opportunities for HIV-1 dual infection.",Non-OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
"(see Supplemental Digital Con tent, Methods, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
"454 Pyrosequencing and Data Cleaning Strategy Ampli ﬁed PCR products were pooled, and subsequently, a second PCR was performed with primers (Table S2, http://links.lww.com/QAI/B13) containing adaptors for 454 pyrose- quencing and a multiplex identi ﬁer (MID) sequence to identify each sample (for details on MID sequences, see Table S3,http://links.lww.com/QAI/B13).",Non-OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
"Subtype reference sequences were downloaded from the Los Alamos HIV sequences database (http://www.hiv.lanl.gov), and con-sensus sequences and subtype reference sequences were aligned using HIV Align (http://www.hiv.lanl.gov/content/ sequence/VIRALIGN/viralign.html).",OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
Phylogenetic trees weregenerated using the neighbor-joining method based on Kimura 2-parameter model with 1000 bootstrap replicates using MEGA 5.04 (http://www.megasoftware.net/).,OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
Differences between sequences were visualized with the Highlighter tool (http://www.hiv.lanl.gov/content/sequence/ HIGHLIGHT/HIGHLIGHT_XYPLOT/highlighter.html).,OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
"Other clinical data and demographic characteristics are summarized in Table S4 (see Supplemental Digital Content, http://links.lww.com/QAI/B13) according to dual-infectionstatus.",Non-OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
"Both Intersubtype and Intrasubtype Dual Infections Could Be Detected Among ThisMSM Cohort According to the phylogenetic tree, the genetic dis- tance value (Table S5, http://links.lww.com/QAI/B13), andhighlighter analysis, 9 intersubtype and 9 intrasubtype dual infections were identi ﬁed among the 64 participants.",OADS,/arxiv_data1/oa_pdf/71/a8/qai-75-480.PMC5483982.pdf
"METHODS Search Strategy and Inclusion Criteria Our study protocol is described elsewhere (modi ﬁcations in Supplemental Digital Content, Table 1, http://links.lww.com/ QAI/B20).30Brieﬂy, we searched 5 databases (Ovid MEDLINE, Ovid EMBASE, Cumulative Index of Nursing and AlliedHealth Literature, Scopus, and W eb of Science) for potentially relevant studies published in English up to June 28, 2016 (Supplemental Digital Content , Table 2, http://links.lww.com/ QAI/B20 for MEDLINE search strategy).",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"Secondary out-comes included site (proximal versus distal colon, colon versus rectum) and stage of diagnosis, treatment modalities and outcomes, including standardized mortality ratio (SMR) [orequivalents, includ ing hazard ratio (HR) ] of all-cause or CRC- speciﬁc mortality among those with HIV relative to a referent HIV uninfected population (Supplemental Digital Content,Table 3, http://links.lww.com/QAI /B20).",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"Data extracted included publication details, study design andmethods, study sample/participant characteristics, and re- ported outcome measure(s), including variables used to standardize SIR/SMR estimates (Supplemental Digital Con-tent, Table 4, http://links.lww.com/QAI/B20).",OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"Reporting was done in accordance with PRISMA Guidelines 37(Supplemental Digital Content, Table 5, http://links.lww.com/QAI/B20).We did not contact corresponding authors for additionalstudy details if not reported in the full-text article.",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"Included articlesreported data from the United States (n = 17), 17–19,38 –513 from Italy,15,52,532 each from Australia6,13and Taiwan,55,56 and single articles reporting data from Canada,50Brazil,51the United Kingdom,20France,52Germany,54and Denmark.1 Four articles38,39,43,55included in the review were excludedfrom quantitative synthesis because of overlapping reports from the same study population (Supplemental DigitalContent, Table 6, http://links.lww.com/QAI/B20).",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"In analyses that pooled results from publications reporting CRC cancer andcolon cancer separately, we observed no summary effect riskspeciﬁc to CRC (SIR 1.04; 95% CI: 0.85 to 1.27), whereas a lower risk of colon cancer was observed among people with HIV relative to an uninfected comparator population (SIR 0.63;95% CI: 0.52 to 0.75) (Supplemental Digital Content, Figure 1, http://links.lww.com/QAI/B20).",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"By contrast, pooled results from 3 studies reporting 21 cases for women found a higher rateof CRC among women with HIV 20,41,56(SIR 3.53; 95% CI: 1.57 to 7.96) (Supplemental Digital Content, Figure 2, http://links.lww.com/ QAI/B20).",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"No such ch ange was observed in the 4 studies indepen dently reporting men20,41,54,56(SIR 1.41; 95% CI: 0.31 to 6.37) (Supplemental Digital Content, Figure 3, http://links.lww.co m/QAI/B20).",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
"Asymmetry was observed in the funnel plot of studies of CRC/colon SIR, a ﬁnding which may re ﬂect the inclusion of a small number of heterogeneous studies with null effects, (Supplemental Digital Content, Figure 4, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/qai-75-439.PMC5483984.pdf
Available from:  http://bios.conabio.,Non-OADS,/arxiv_data1/oa_pdf/41/58/ejh-61-2-2782.PMC5484011.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Bhatia A, Kumar Y, Kathpalia AS.",Non-OADS,/arxiv_data1/oa_pdf/fc/a0/jclinpath-2016-203868.PMC5484024.pdf
http://www.nrdo.gov.sg (accessed 10 Apr 2016).,OADS,/arxiv_data1/oa_pdf/fc/a0/jclinpath-2016-203868.PMC5484024.pdf
http://www.who.int/tb/publications/global_report/ en/ (accessed 10 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/jclinpath-2016-203868.PMC5484024.pdf
https://shs.wustl.edu/ MedicalAndHealthCare/Documents/Countries%20with%20a%20High% 20Prevalence%20of%20Tuberculosis.pdf (accessed 10 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/jclinpath-2016-203868.PMC5484024.pdf
http://data.worldbank.org/indicator/SH.TBS.INCD?page=3 (accessed 10 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/fc/a0/jclinpath-2016-203868.PMC5484024.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ ▸http://dx.doi.org/10.1136/jech-2016-208632 ▸http://dx.doi.org/10.1136/jech-2016-208773REFERENCES 1 Peckham S, Lowery D, Spencer S. Are ﬂuoride levels in drinking water associated with hypothyroidism prevalence in England?",Non-OADS,/arxiv_data1/oa_pdf/29/8a/jech-2016-208649.PMC5484025.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Meyer I.,Non-OADS,/arxiv_data1/oa_pdf/f0/7b/jech-2016-207943.PMC5484026.pdf
"To view  please visit the journal online (http://dx.doi.org/10.1136/jech-2016-208012) 1Child and Adolescent Public  Health Epidemiology Unit, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden 2Unit of Occupational Medicine,  Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden 3Centre for Social Research on  Alcohol and Drugs, Stockholm University, Stockholm, Sweden 4Health Care Services, Centre for  Epidemiology and Community Medicine, Stockholm County Council, Stockholm, Sweden Correspondence to Emelie Thern, Child and Adolescent Public Health Epidemiology Unit, Department of Public Health Sciences, Karolinska Institutet, Tomtebodavägen 18A, Widerströmska huset, Stockholm 171 77, Sweden; emelie.thern@ki.se Received 29 June 2016 Revised 23 November 2016Accepted 29 December 2016Published Online First 13 January 2017Mental health 344 Thern E, et al.",Non-OADS,/arxiv_data1/oa_pdf/21/52/jech-2016-208012.PMC5484029.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 International Labour Organization.,Non-OADS,/arxiv_data1/oa_pdf/21/52/jech-2016-208012.PMC5484029.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Hurt LS, Ronsmans C, Thomas SL.",Non-OADS,/arxiv_data1/oa_pdf/3a/cd/jech-2016-207857.PMC5484032.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Myers JP, vom Saal FS, Akingbemi BT, et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
"http://www.monsanto.com/products/documents/glyphosate-background-materials/agronomic%20bene ﬁts%20of%20glyphosate %20in%20europe.pdf, 2010:1 –82.",Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
2016. https://www.echa.europa.eu/documents/ 10162/13626/clh_report_glyphosate_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
2015. http://www.epa.,OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
2009. http://www.regulations.gov/#!,Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
2016. https://www.epa.gov/sites/production/ ﬁles/ 2016-09/documents/glyphosate_issue_paper_evaluation_of_carcincogenic_potential.pdf (accessed 24 Jan 2017).,OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
2015. http://monographs.iarc.fr/ENG/Monographs/vol112/mono112-09.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
2016. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
"2016. http://www.bfr.bund.de/en/frequently_asked_questions_on_the_assessment_ of_the_health_risk_of_glyphosate-127871.html 51 Beronius A, Hanberg A, Zilliacus J, et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/80/jech-2016-208463.PMC5484035.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jclinpath-2016-204089).,Non-OADS,/arxiv_data1/oa_pdf/45/35/jclinpath-2016-204089.PMC5484037.pdf
Cancer Cytopathol 2016. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/45/35/jclinpath-2016-204089.PMC5484037.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Montravers P, Dupont H, Gauzit R, et al.",Non-OADS,/arxiv_data1/oa_pdf/45/7b/jclinpath-2016-203936.PMC5484093.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/cb/main.PMC5484176.pdf
The  Total  Sanitation  Campaign http://dx.doi.org/10.1016/j.ijheh.2017.05.004 1438-4639/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/cb/main.PMC5484176.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/cb/main.PMC5484176.pdf
Medicine (2017) 96:25(e6727)Received: 24 March 2016 / Received in ﬁnal form: 2 April 2017 / Accepted: 5 April 2017 http://dx.doi.org/10.1097/MD.0000000000006727Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c2/9d/medi-96-e6727.PMC5484180.pdf
"[12]Each of the variables were given a score from 0 to 4 except for the operation, which was calculated based on theduration of operation and type of dressing, where 1 hour =2 points (Supplemental ﬁle 1, http://links.lww.com/MD/B697).",OADS,/arxiv_data1/oa_pdf/c2/9d/medi-96-e6727.PMC5484180.pdf
Medicine (2017) 96:25(e6929)Received: 28 September 2016 / Received in ﬁnal form: 16 April 2017 / Accepted: 21 April 2017 http://dx.doi.org/10.1097/MD.0000000000006929Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b3/1e/medi-96-e6929.PMC5484181.pdf
Available at http://www.gao.gov/products/GAO-13-525.,OADS,/arxiv_data1/oa_pdf/b3/1e/medi-96-e6929.PMC5484181.pdf
Available at: https://www.ama-assn.org/practice-management/understanding-medicare-payment-reform-macra.,Non-OADS,/arxiv_data1/oa_pdf/b3/1e/medi-96-e6929.PMC5484181.pdf
Medicine (2017) 96:25(e6938)Received: 14 November 2016 / Received in ﬁnal form: 1 April 2017 / Accepted: 23 April 2017 http://dx.doi.org/10.1097/MD.0000000000006938Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5c/1b/medi-96-e6938.PMC5484182.pdf
"DEGs and pathway enrichment analyses As shown in Figure 2, a total of 224 DEGs including 77 downregulated and 147 upregulated genes (supplementaryTable 1, http://links.lww.com/MD/B743) were identi ﬁed in HCC tissues compared to in cirrhosis tissues, using jlogFC j≥1 andPvalue<.05 as threshold values.",OADS,/arxiv_data1/oa_pdf/5c/1b/medi-96-e6938.PMC5484182.pdf
"4; supplementary Table 2, http://links.lww.com/MD/B744).",Non-OADS,/arxiv_data1/oa_pdf/5c/1b/medi-96-e6938.PMC5484182.pdf
Medicine (2017) 96:25(e6939)Received: 30 December 2016 / Received in ﬁnal form: 18 April 2017 / Accepted: 27 April 2017 http://dx.doi.org/10.1097/MD.0000000000006939Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0c/0a/medi-96-e6939.PMC5484183.pdf
Medicine (2017) 96:25(e6960)Received: 28 March 2017 / Received in ﬁnal form: 16 April 2017 / Accepted: 24 April 2017 http://dx.doi.org/10.1097/MD.0000000000006960Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8a/4a/medi-96-e6960.PMC5484184.pdf
Medicine (2017) 96:25(e6988)Received: 4 February 2017 / Received in ﬁnal form: 29 April 2017 / Accepted: 1 May 2017 http://dx.doi.org/10.1097/MD.0000000000006988Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0a/6c/medi-96-e6988.PMC5484185.pdf
Medicine (2017) 96:25(e7009)Received: 7 March 2017 / Received in ﬁnal form: 25 April 2017 / Accepted: 26 April 2017 http://dx.doi.org/10.1097/MD.0000000000007009Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8d/b6/medi-96-e7009.PMC5484186.pdf
Medicine (2017) 96:25(e7012)Received: 16 February 2017 / Received in ﬁnal form: 23 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000007012Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
"Samples, sequencing, and quality control High-throughput sequencing of lncRNAs and mRNAs was performed for total RNA obtained from 1 normal oral mucosa, 1 OLP, and 1 human papillomavirus-related OSCC tissue sampleby Genenergy Bio-Technology Corporation (Shanghai, China;http://www.genenergy.cn/).",OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
Low-quality reads wereremoved using Trim Galore (version 0.3.5) and read quality was assessed using FastQC (http://www.bioinformatics.babraham.,OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
"Data mapping Clean RNA-seq reads were mapped using TopHat (version 2.0.8, http://tophat.cbcb.umd.edu/) against the human genome ( Homo sapiens GRCh37), which was downloaded from ftp://ftp.",OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
All anno- tated coding sequences (transcripts) were obtained using Homo_sapiens.GRCh37.74.gtf in the Ensembl database (http://www.ensembl.org/).,OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
"Functional enrichment analysis of DEGs The Gene Ontology (GO) (http://www.geneontology.org) project provides high-quality electronic and manual annotations forgenes, gene products, and sequences.",OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
The genome-wide maps of enhancer elements wereobtained from http://hgdownload.soe.ucsc.edu/goldenPath/hg19/ database/vistaEnhancers.txt.gz.,OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
"Potential trans-target genes of lncRNAs were screened using RNAplex (http://www.bioinf.uni-leipzig.de/Software/RNAplex/) to identify possible hybridization sites for short, highly stableRNA –RNA interactions.",OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
"The networks of OPL versus normal, OSCC versus normal, and OSCC versus OPL are shown in Supplementary Figures 1-3, http://links.lww.com/MD/B728.",OADS,/arxiv_data1/oa_pdf/2c/02/medi-96-e7012.PMC5484187.pdf
Medicine (2017) 96:25(e7036)Received: 10 October 2016 / Received in ﬁnal form: 8 April 2017 / Accepted: 9 May 2017 http://dx.doi.org/10.1097/MD.0000000000007036Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/22/72/medi-96-e7036.PMC5484188.pdf
Medicine (2017) 96:25(e7054)Received: 17 December 2016 / Received in ﬁnal form: 25 April 2017 / Accepted: 26 April 2017 http://dx.doi.org/10.1097/MD.0000000000007054Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"”, http://links.lww.com/MD/B749).",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"2, Supplemental Content, which demonstrates the way to probethe inferior border of C1 “pedicle ”., http://links.lww.com/MD/ B749).",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"3, Supplemental Content, which demonstrates the way to probe the medial border of C1 “pedicle ”, http://links.lww.com/MD/B749) Additionally, the borders of C1 vertebral pedicle were “located ”(see Video1, Supplemental Video1, which records the way to locate the borders of C1 “pedicle ”, http://links.lww.com/MD/B750).",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"The cortical bone of C1 was grinded off with the help of high-speed burr, and subsequently, a pilot hole was made with a battery-powered drill under “direct vision ”in an anterior-posterior (AP) direction, at 5 –10°angle cranially (see Video2, Supplemental Video2, which records the way to make a pilot hole of C1 “pedicle ”http://links.lww.com/ MD/B751).",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"4, Supplemental Content, which demonstrates the way to probe the medial border of C2 pedicle., http://links.lww.com/MD/B749).The entry point was at the point of intersection at a distance of 4mm from the medial border of the vertebral pedicle and 5mm from the superior border of the vertebral lamina, in a convergentdirection at an angle of 15 –20°and at an angle of 20 –25° cranially (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
http://links.lww.com/MD/B752).,Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"5, Supplemental Content, which demonstrates the way to mould the graft bone, http://links.lww.com/MD/B749) with the cancellous bone side down, after axial vertebral platedecorticated with high-speed burr (see Fig 6, Supplemental Content, which demonstrates the preparation process of fdecorti- cating the cortex, http://links.lww.com/MD/B749) and ﬁxedwith a titanium cable (Medtronic Sofamor Danek) (see Fig.",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"7, Supple- mental Content, which shows the positions of screws and graft, http://links.lww.com/MD/B749).",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
"Another lateral and anterior-posterior view under image intensi ﬁer are seen to ensure the position of screws and graft, (see Fig 8, Supplemental Content, which shows the position of screws and cable., http://links.lww.com/MD/B749) and reconstruct the end point of the suboccipitalgroup on the spinous process of C2.",Non-OADS,/arxiv_data1/oa_pdf/ba/1f/medi-96-e7054.PMC5484189.pdf
Medicine (2017) 96:25(e7058)Received: 1 December 2016 / Received in ﬁnal form: 9 May 2017 / Accepted: 11 May 2017 http://dx.doi.org/10.1097/MD.0000000000007058Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cd/35/medi-96-e7058.PMC5484190.pdf
Medicine (2017) 96:25(e7090)Received: 23 December 2016 / Received in ﬁnal form: 9 April 2017 / Accepted: 29 April 2017 http://dx.doi.org/10.1097/MD.0000000000007090Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ca/a3/medi-96-e7090.PMC5484192.pdf
Medicine (2017) 96:25(e7100)Received: 13 January 2017 / Received in ﬁnal form: 27 April 2017 / Accepted: 30 April 2017 http://dx.doi.org/10.1097/MD.0000000000007100Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f3/d2/medi-96-e7100.PMC5484193.pdf
Medicine (2017) 96:25(e7130)Received: 17 April 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 17 May 2017 http://dx.doi.org/10.1097/MD.0000000000007130Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/08/medi-96-e7130.PMC5484194.pdf
Medicine (2017) 96:25(e7133)Received: 6 April 2016 / Received in ﬁnal form: 20 May 2017 / Accepted: 22 May 2017 http://dx.doi.org/10.1097/MD.0000000000007133Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0c/d7/medi-96-e7133.PMC5484195.pdf
Medicine (2017) 96:25(e7145)Received: 21 November 2016 / Received in ﬁnal form: 22 May 2017 / Accepted: 25 May 2017 http://dx.doi.org/10.1097/MD.0000000000007145Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7f/b3/medi-96-e7145.PMC5484196.pdf
Medicine (2017) 96:25(e7148)Received: 7 March 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007148Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f1/38/medi-96-e7148.PMC5484197.pdf
Medicine (2017) 96:25(e7149)Received: 24 November 2016 / Received in ﬁnal form: 8 April 2017 / Accepted: 22 May 2017 http://dx.doi.org/10.1097/MD.0000000000007149Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9a/34/medi-96-e7149.PMC5484198.pdf
Medicine (2017) 96:25(e7150)Received: 1 December 2016 / Received in ﬁnal form: 18 April 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007150Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/97/a3/medi-96-e7150.PMC5484199.pdf
http://www.crd.york.ac.uk/pros pero).,Non-OADS,/arxiv_data1/oa_pdf/97/a3/medi-96-e7150.PMC5484199.pdf
Medicine (2017) 96:25(e7156)Received: 1 February 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 20 May 2017 http://dx.doi.org/10.1097/MD.0000000000007156Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cd/38/medi-96-e7156.PMC5484200.pdf
"CRAs were distinguishedfrom benign lesions including hyperplastic or in ﬂammatory polyps (Supplementary Table 1, http://links.lww.com/MD/ B739).",Non-OADS,/arxiv_data1/oa_pdf/cd/38/medi-96-e7156.PMC5484200.pdf
Medicine (2017) 96:25(e7175)Received: 19 April 2017 / Received in ﬁnal form: 20 May 2017 / Accepted: 22 May 2017 http://dx.doi.org/10.1097/MD.0000000000007175Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/17/5c/medi-96-e7175.PMC5484205.pdf
Medicine (2017) 96:25(e7178)Received: 8 October 2016 / Received in ﬁnal form: 18 May 2017 / Accepted: 22 May 2017 http://dx.doi.org/10.1097/MD.0000000000007178Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/74/db/medi-96-e7178.PMC5484206.pdf
Medicine (2017) 96:25(e7181)Received: 2 February 2017 / Received in ﬁnal form: 24 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007181Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d9/32/medi-96-e7181.PMC5484207.pdf
"S1A, http://links.lww.com/MD/B747).",Non-OADS,/arxiv_data1/oa_pdf/d9/32/medi-96-e7181.PMC5484207.pdf
"S1B, http://links.lww.com/MD/B747) or in AGC patientsirrespective of the primary tumor location (lower third, P=.287; upper two-thirds, P=.151).",Non-OADS,/arxiv_data1/oa_pdf/d9/32/medi-96-e7181.PMC5484207.pdf
"S1C and S1D, http://links.lww.com/MD/B747).",Non-OADS,/arxiv_data1/oa_pdf/d9/32/medi-96-e7181.PMC5484207.pdf
"S2, http://links.lww.com/MD/B747).",Non-OADS,/arxiv_data1/oa_pdf/d9/32/medi-96-e7181.PMC5484207.pdf
"S3A, http://links.lww.com/ MD/B747), which would be derived from small sample numbers.",Non-OADS,/arxiv_data1/oa_pdf/d9/32/medi-96-e7181.PMC5484207.pdf
Medicine (2017) 96:25(e7184)Received: 16 January 2017 / Received in ﬁnal form: 24 May 2017 / Accepted: 25 May 2017 http://dx.doi.org/10.1097/MD.0000000000007184Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5c/77/medi-96-e7184.PMC5484208.pdf
Medicine (2017) 96:25(e7190)Received: 13 April 2017 / Received in ﬁnal form: 5 May 2017 / Accepted: 10 May 2017 http://dx.doi.org/10.1097/MD.0000000000007190Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/93/95/medi-96-e7190.PMC5484209.pdf
"Quality assessment For RCTs, the risk of bias was evaluated by 2 reviewers on the basis of the Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (http://handbook.cochrane.org/).",OADS,/arxiv_data1/oa_pdf/93/95/medi-96-e7190.PMC5484209.pdf
Available at: http://www.cochrane-hand book.org.,Non-OADS,/arxiv_data1/oa_pdf/93/95/medi-96-e7190.PMC5484209.pdf
Available at: http://handbook.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/93/95/medi-96-e7190.PMC5484209.pdf
Medicine (2017) 96:25(e7192)Received: 21 March 2017 / Received in ﬁnal form: 19 May 2017 / Accepted: 24 May 2017 http://dx.doi.org/10.1097/MD.0000000000007192Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/64/66/medi-96-e7192.PMC5484210.pdf
Medicine (2017) 96:25(e7194)Received: 13 March 2017 / Received in ﬁnal form: 18 May 2017 / Accepted: 21 May 2017 http://dx.doi.org/10.1097/MD.0000000000007194Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4e/f4/medi-96-e7194.PMC5484211.pdf
Available at: http://www.cdc.gov/oralhealth/ infectioncontrol/faq/bloodborne_exposures.htm.,Non-OADS,/arxiv_data1/oa_pdf/4e/f4/medi-96-e7194.PMC5484211.pdf
Medicine (2017) 96:25(e7195)Received: 7 April 2017 / Received in ﬁnal form: 18 May 2017 / Accepted: 20 May 2017 http://dx.doi.org/10.1097/MD.0000000000007195Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/66/63/medi-96-e7195.PMC5484212.pdf
"CH.C., Santiago, Chile; and Department of Anaesthesiology and General Intensive Care, Medical Universi- ty of Vienna, Vienna, Austria; Supplemetary table S1, http://links.lww.com/MD/B754) were included in the study.",Non-OADS,/arxiv_data1/oa_pdf/66/63/medi-96-e7195.PMC5484212.pdf
"The oropharyngeal and tracheoesophageal cuffs of the EzT were in ﬂated successively with 80 and 5 to 10mL, respectively, as recommended by the manufacturer (supplementary ﬁgure S1, http://links.lww.com/MD/B754).",Non-OADS,/arxiv_data1/oa_pdf/66/63/medi-96-e7195.PMC5484212.pdf
Medicine (2017) 96:25(e7197)Received: 19 September 2016 / Received in ﬁnal form: 23 March 2017 / Accepted: 19 May 2017 http://dx.doi.org/10.1097/MD.0000000000007197Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c8/3a/medi-96-e7197.PMC5484214.pdf
Medicine (2017) 96:25(e7198)Received: 30 October 2016 / Received in ﬁnal form: 9 May 2017 / Accepted: 21 May 2017 http://dx.doi.org/10.1097/MD.0000000000007198Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c0/83/medi-96-e7198.PMC5484215.pdf
Medicine (2017) 96:25(e7205)Received: 11 August 2016 / Received in ﬁnal form: 16 May 2017 / Accepted: 17 May 2017 http://dx.doi.org/10.1097/MD.0000000000007205Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/47/f1/medi-96-e7205.PMC5484216.pdf
"D 0<0.6 and r2<0.3 in the block (supplement Figure 1, http://links.lww.com/MD/B755).",Non-OADS,/arxiv_data1/oa_pdf/47/f1/medi-96-e7205.PMC5484216.pdf
Medicine (2017) 96:25(e7206)Received: 20 January 2017 / Received in ﬁnal form: 12 May 2017 / Accepted: 15 May 2017 http://dx.doi.org/10.1097/MD.0000000000007206Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/e3/medi-96-e7206.PMC5484217.pdf
Medicine (2017) 96:25(e7208)Received: 23 January 2017 / Received in ﬁnal form: 18 April 2017 / Accepted: 15 May 2017 http://dx.doi.org/10.1097/MD.0000000000007208Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/07/89/medi-96-e7208.PMC5484218.pdf
Medicine (2017) 96:25(e7216)Received: 12 February 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 18 May 2017 http://dx.doi.org/10.1097/MD.0000000000007216Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/52/bd/medi-96-e7216.PMC5484220.pdf
Medicine (2017) 96:25(e7217)Received: 5 March 2017 / Received in ﬁnal form: 8 May 2017 / Accepted: 22 May 2017 http://dx.doi.org/10.1097/MD.0000000000007217Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8d/34/medi-96-e7217.PMC5484221.pdf
Medicine (2017) 96:25(e7220)Received: 30 October 2016 / Received in ﬁnal form: 18 May 2017 / Accepted: 26 May 2017 http://dx.doi.org/10.1097/MD.0000000000007220Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b2/f1/medi-96-e7220.PMC5484222.pdf
Medicine (2017) 96:25(e7221)Received: 20 November 2016 / Received in ﬁnal form: 27 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007221Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/08/54/medi-96-e7221.PMC5484223.pdf
Medicine (2017) 96:25(e7224)Received: 21 February 2017 / Received in ﬁnal form: 23 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007224Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3f/88/medi-96-e7224.PMC5484224.pdf
"Evolution-based sequence information included the Sorting Intolerant From Tolerant (SIFT, http://sift.jcvi.org/) based on the degree of conservation of amino acid residues in sequence alignments derived from closely related sequences, collected through PSI-BLAST and the Grantham scorethat attempts to predict the distance between 2 amino acids, in an evolutionary sense.",OADS,/arxiv_data1/oa_pdf/3f/88/medi-96-e7224.PMC5484224.pdf
"[28]Polymorphism Phenotyping v2 (PolyPhen- 2, http://genetics.bwh.harvard.edu/pph2/) was used to predict thepossible impact of an amino acid substitution on the structure and function of a human protein using straightforward physical and comparative considerations.",OADS,/arxiv_data1/oa_pdf/3f/88/medi-96-e7224.PMC5484224.pdf
Medicine (2017) 96:25(e7225)Received: 24 February 2017 / Received in ﬁnal form: 24 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007225Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d7/68/medi-96-e7225.PMC5484225.pdf
Medicine (2017) 96:25(e7227)Received: 8 August 2016 / Received in ﬁnal form: 26 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007227Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/medi-96-e7227.PMC5484226.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/medi-96-e7227.PMC5484226.pdf
Medicine (2017) 96:25(e7228)Received: 19 February 2017 / Received in ﬁnal form: 28 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007228Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/medi-96-e7228.PMC5484227.pdf
Medicine (2017) 96:25(e7236)Received: 6 February 2017 / Received in ﬁnal form: 26 May 2017 / Accepted: 29 May 2017 http://dx.doi.org/10.1097/MD.0000000000007236Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f0/20/medi-96-e7236.PMC5484229.pdf
Medicine (2017) 96:25(e7237)Received: 9 January 2017 / Received in ﬁnal form: 27 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007237Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b5/64/medi-96-e7237.PMC5484230.pdf
Medicine (2017) 96:25(e7238)Received: 18 January 2017 / Received in ﬁnal form: 23 May 2017 / Accepted: 29 May 2017 http://dx.doi.org/10.1097/MD.0000000000007238Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0b/84/medi-96-e7238.PMC5484231.pdf
Medicine (2017) 96:25(e7239)Received: 31 January 2017 / Received in ﬁnal form: 25 May 2017 / Accepted: 26 May 2017 http://dx.doi.org/10.1097/MD.0000000000007239Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0b/9f/medi-96-e7239.PMC5484232.pdf
Medicine (2017) 96:25(e7240)Received: 31 December 2016 / Received in ﬁnal form: 26 April 2017 / Accepted: 26 May 2017 http://dx.doi.org/10.1097/MD.0000000000007240Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/df/db/medi-96-e7240.PMC5484233.pdf
"The targeted regions (shown inSupplemental Table S1, http://links.lww.com/MD/B757) were captured according to the standard procedures using a custom- ized NimbleGen capture array (Roche-NimbleGen Inc. Madison,WI) and then sequenced on the Illumina Hiseq2000 platform (Illumina Inc, San Diego, CA).",OADS,/arxiv_data1/oa_pdf/df/db/medi-96-e7240.PMC5484233.pdf
"The raw reads were aligned to the human reference genome (hg19) using Burrows-Wheeler Align-ment tool v0.7.1 (http://maq.sourceforge.net), producing binary sequence alignment/map ﬁles containing various mapping information.",OADS,/arxiv_data1/oa_pdf/df/db/medi-96-e7240.PMC5484233.pdf
The duplicate reads were then removed usingPicard v1.137 (https://github.com/broadinstitute/picard/releases)and realigned using Genome Analysis Toolkit v3.4 –46.,OADS,/arxiv_data1/oa_pdf/df/db/medi-96-e7240.PMC5484233.pdf
Variants were called using SNPTools and annotated using the ANNOVAR software package (http://www.openbioinformatics.org/annovar/).,OADS,/arxiv_data1/oa_pdf/df/db/medi-96-e7240.PMC5484233.pdf
Medicine (2017) 96:25(e7244)Received: 21 January 2017 / Received in ﬁnal form: 26 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007244Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5e/b9/medi-96-e7244.PMC5484234.pdf
Medicine (2017) 96:25(e7253)Received: 7 April 2017 / Received in ﬁnal form: 18 May 2017 / Accepted: 29 May 2017http://dx.doi.org/10.1097/MD.0000000000007253Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/27/f7/medi-96-e7253.PMC5484235.pdf
We have also searched thereferences of relevant review articles and of all the obtained case- control studies individually to discover possible eligible studies (Supplementary Digital Content http://links.lww.com/MD/B758).,Non-OADS,/arxiv_data1/oa_pdf/27/f7/medi-96-e7253.PMC5484235.pdf
Medicine (2017) 96:25(e7260)Received: 6 February 2017 / Received in ﬁnal form: 23 May 2017 / Accepted: 27 May 2017 http://dx.doi.org/10.1097/MD.0000000000007260Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/83/43/medi-96-e7260.PMC5484237.pdf
Medicine (2017) 96:25(e7265)Received: 13 February 2017 / Received in ﬁnal form: 25 May 2017 / Accepted: 26 May 2017 http://dx.doi.org/10.1097/MD.0000000000007265Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/eb/80/medi-96-e7265.PMC5484239.pdf
Medicine (2017) 96:25(e7268)Received: 5 March 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 25 May 2017 http://dx.doi.org/10.1097/MD.0000000000007268Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/57/28/medi-96-e7268.PMC5484240.pdf
Medicine (2017) 96:25(e7269)Received: 8 March 2017 / Received in ﬁnal form: 8 May 2017 / Accepted: 28 May 2017 http://dx.doi.org/10.1097/MD.0000000000007269Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/99/09/medi-96-e7269.PMC5484241.pdf
Medicine (2017) 96:25(e7270)Received: 22 February 2017 / Received in ﬁnal form: 5 May 2017 / Accepted: 2 June 2017 http://dx.doi.org/10.1097/MD.0000000000007270Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fd/f6/medi-96-e7270.PMC5484242.pdf
Medicine (2017) 96:25(e7277)Received: 2 March 2017 / Received in ﬁnal form: 26 May 2017 / Accepted: 5 June 2017 http://dx.doi.org/10.1097/MD.0000000000007277Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e1/10/medi-96-e7277.PMC5484246.pdf
http://seer.cancer.gov/statfacts/html/mulmy.html.,Non-OADS,/arxiv_data1/oa_pdf/e1/10/medi-96-e7277.PMC5484246.pdf
Medicine (2017) 96:25(e7279)Received: 7 December 2016 / Received in ﬁnal form: 26 May 2017 / Accepted: 5 June 2017 http://dx.doi.org/10.1097/MD.0000000000007279Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f5/ca/medi-96-e7279.PMC5484247.pdf
"Search strategy and selection criteria The manuscripts in Chinese were collected from CNKI (http:// www.cnki.com/), CQVI P (http://www.cqvip.com/), and Wan fang.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/medi-96-e7279.PMC5484247.pdf
"The following studies were excluded: participants suffering from any related diseases, or taking medication known to affectthyroid structure or function; participants were special popula- tions (such as pregnant women, infants, or smokers) or workers in a speci ﬁc occupation; UIC data taken form historical data instead of through a survey sample; and the number of “No”or “unclear ”answers exceeded 5 out of the 14 questions in the QUADAS quality assessment tool (http://links.lww.com/MD/B760).",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/medi-96-e7279.PMC5484247.pdf
Medicine (2017) 96:25(e7282)Received: 6 February 2017 / Received in ﬁnal form: 1 June 2017 / Accepted: 2 June 2017 http://dx.doi.org/10.1097/MD.0000000000007282Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5a/d4/medi-96-e7282.PMC5484248.pdf
Medicine (2017) 96:25(e7283)Received: 9 December 2016 / Received in ﬁnal form: 29 March 2017 / Accepted: 3 June 2017 http://dx.doi.org/10.1097/MD.0000000000007283Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3f/4d/medi-96-e7283.PMC5484249.pdf
Medicine (2017) 96:25(e7284)Received: 21 November 2016 / Received in ﬁnal form: 1 June 2017 / Accepted: 4 June 2017 http://dx.doi.org/10.1097/MD.0000000000007284Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/18/aa/medi-96-e7284.PMC5484250.pdf
"Foreach patient, the main diagnosis was recorded and all other conditions that coexisted at hospital admission or that developed during hospital stay were considered to be secondary conditions.The main diagnosis and secondary conditions listed in the discharge notes were grouped into 13 categories, matching the ICD-9 classi ﬁcation with some modi ﬁcations (see Supplementary ﬁle S1, http://links.lww.com/MD/B763).",Non-OADS,/arxiv_data1/oa_pdf/18/aa/medi-96-e7284.PMC5484250.pdf
"Main diagnosis Survived, n =6386 Died, n =882 OR [95% CI] P 1D e ﬁciency and other anemia 324 (5.1) 11 (1.3) 0.8 [0.4 –1.48] .42 2 Heart failure 772 (12.1) 85 (9.6) 2.5 [1.76 –3.51] <.001 3 Chronic obstructive pulmonary disease and allied conditions313 (4.9) 22 (2.5) 1.6 [0.96 –2.63] .07 4 Cerebrovascular disease 730 (11.4) 66 (7.5) 2 [1.42 –2.94] .001 5 Malignant neoplasms 204 (3.2) 123 (14.1) 13.6 [9.63 –19.22] <.001 6 Acute coronary syndrome 555 (8.7) 29 (3.3) 1.2 [0.75 –1.86] .48 7 Cardiac dysrhythmias 411 (6.4) 10 (1.1) 0.6 [0.28 –1.08] .08 8 Pneumonia 722 (11.3) 206 (23.4) 6.4 [4.75 –8.74] <.001 9 Acute and chronic renal failure 318 (5.0) 59 (6.7) 4.2 [2.86 –6.14] <.001 10 Sepsis and septicemia 168 (2.6) 128 (14.5) 17.2 [12.13 –24.40] <.001 11 Septic shock 6 (0.1) 56 (6.4) 210.6 [87.2 –508.8] <.001 12 Venous thrombosis and embolism 154 (2.4) 8 (0.9) 1.2 [0.55 –2.50] .68 13 Urinary tract infections 400 (6.3) 21 (2.4) 1.2 [0.71 –1.98] .52 14 Other 1309 (20.5) 58 (6.6) See Supplementary ﬁle S1, http://links.lww.com/MD/B763 for diagnosis/medical conditions included in each group.",Non-OADS,/arxiv_data1/oa_pdf/18/aa/medi-96-e7284.PMC5484250.pdf
"The calculator for predicting in-hospital mortality is available in the Supplementary ﬁle (S2), http://links.lww.com/ MD/B764.",Non-OADS,/arxiv_data1/oa_pdf/18/aa/medi-96-e7284.PMC5484250.pdf
Medicine (2017) 96:25(e7286)Received: 16 February 2017 / Received in ﬁnal form: 16 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007286Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3c/94/medi-96-e7286.PMC5484251.pdf
"All the T1-weighted were processed and analyzed automati- cally with the tools of the FSL software package (FMRIB Software Library, http://fmrib.ox.ac.uk/fsl/fslwiki/).",OADS,/arxiv_data1/oa_pdf/3c/94/medi-96-e7286.PMC5484251.pdf
Medicine (2017) 96:25(e7294)Received: 12 April 2017 / Received in ﬁnal form: 1 June 2017 / Accepted: 5 June 2017 http://dx.doi.org/10.1097/MD.0000000000007294Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f2/e3/medi-96-e7294.PMC5484253.pdf
Medicine (2017) 96:25(e7298)Received: 17 January 2017 / Received in ﬁnal form: 2 June 2017 / Accepted: 6 June 2017 http://dx.doi.org/10.1097/MD.0000000000007298Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b1/c9/medi-96-e7298.PMC5484254.pdf
Medicine (2017) 96:25(e7300)Received: 22 December 2016 / Received in ﬁnal form: 5 June 2017 / Accepted: 6 June 2017 http://dx.doi.org/10.1097/MD.0000000000007300Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8a/dc/medi-96-e7300.PMC5484255.pdf
Medicine (2017) 96:25(e7326)Received: 15 September 2016 / Received in ﬁnal form: 3 March 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007326Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/02/73/medi-96-e7326.PMC5484258.pdf
Medicine (2017) 96:25(e7327)Received: 16 January 2017 / Received in ﬁnal form: 17 May 2017 / Accepted: 30 May 2017 http://dx.doi.org/10.1097/MD.0000000000007327Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4a/7d/medi-96-e7327.PMC5484259.pdf
Medicine (2017) 96:25(e7369)Received: 7 April 2017 / Received in ﬁnal form: 2 June 2017 / Accepted: 6 June 2017 http://dx.doi.org/10.1097/MD.0000000000007369Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9c/56/medi-96-e7369.PMC5484263.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.009-010.edtDOI:  http://dx.doi.org/10.1590/2177-6709.22.2.009-010.edt 1 Adjunct professor, Universidade Federal do Pará (UFPA), School of Dentistry, Belém, Pará, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/90/c5/2176-9451-dpjo-22-02-00009.PMC5484265.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.021-026.oin Submitted : February 06, 2017 - Revised and accepted : February 13, 2017 » The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.Contact address : Alberto Consolaro E-mail: consolaro@uol.com.brPremaxilla: an independent bone that can base  therapeutics for middle third growth!",Non-OADS,/arxiv_data1/oa_pdf/9a/55/2176-9451-dpjo-22-02-00021.PMC5484266.pdf
DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.021-026.oinorthodontic  insight A descrição inicial da pré-maxila teve a participação de Goethe.,Non-OADS,/arxiv_data1/oa_pdf/9a/55/2176-9451-dpjo-22-02-00021.PMC5484266.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.030-034.int  Submitted: January 17, 2017 - Revised and accepted : February 07, 2017interview I have been blessed to have had the opportunity of knowing Paul A. Gange for a long time and becoming a good friend of his.",Non-OADS,/arxiv_data1/oa_pdf/98/89/2176-9451-dpjo-22-02-00030.PMC5484267.pdf
DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.030-034.int Paul Gange Conheço Paul A. Gange há um bom tempo e nos tornamos bons amigos.,Non-OADS,/arxiv_data1/oa_pdf/98/89/2176-9451-dpjo-22-02-00030.PMC5484267.pdf
"4 Assistant Professor, Graduate University of Advanced Technology, Mechanical  Engineering Department , Kerman, Iran.DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.045-054.oar How to cite this article : Nakhaei S, Habib Agahi R, Aminian A, Rezaeiza - deh M. Discoloration and force degradation of orthodontic elastomeric ligatures.",Non-OADS,/arxiv_data1/oa_pdf/e0/5a/2176-9451-dpjo-22-02-00045.PMC5484269.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.045-054.oar » The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.",Non-OADS,/arxiv_data1/oa_pdf/e0/5a/2176-9451-dpjo-22-02-00045.PMC5484269.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.055-060.oar Submitted : February 29, 2016 - Revised and accepted : October 14, 2016 » The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/2176-9451-dpjo-22-02-00055.PMC5484270.pdf
"Contact address : Fábio Lourenço Romano Avenida do Café s/n, Monte Alegre, CEP: 14.040-904  Ribeirão Preto/SP, Brasil – E-mail: fabioromano@forp.usp.brDOI:   http://dx.doi.org/10.1590/2177-6709.22.2.055-060.oar Objetivo:  o objetivo deste estudo foi avaliar in vitro  a influência do laser de CO2 sobre a resistência ao cisalhamento da colagem  (RCC) no esmalte dentário, usando diferentes tipos de braquetes cerâmicos.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/2176-9451-dpjo-22-02-00055.PMC5484270.pdf
"Submitted : May 18, 2016 - Revised and accepted : October 09, 2016 » The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.DOI:   http://dx.doi.org/10.1590/2177-6709.22.2.061-068.oar How to cite this article : Pereira JS, Jacob HB, Locks A, Brunetto M, Ri - beiro GLU.",Non-OADS,/arxiv_data1/oa_pdf/67/aa/2176-9451-dpjo-22-02-00061.PMC5484271.pdf
DOI: http://dx.doi.org/10.1590/2177-6709.22.2.061-068.oar » Patients displayed in this article previously approved the use of their facial and in - traoral photographs.,Non-OADS,/arxiv_data1/oa_pdf/67/aa/2176-9451-dpjo-22-02-00061.PMC5484271.pdf
"» The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.069-076.oar How to cite this article : Krishnan S, Pandian S, Rajagopal R. Six-month  bracket failure rate with a flowable composite: A split-mouth randomized con - trolled trial.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/2176-9451-dpjo-22-02-00069.PMC5484272.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.069-072.oar Submitted : July 19, 2016 - Revised and accepted : September 27, 2016 Contact address : Sindhuja Krishnan Department of Orthodontics and Dentofacial Orthopaedics, Madha Dental  College, MGR University, Chennai, Tamilnadu, India E-mail: reachsindhuja@yahoo.comIntrodução:  o uso de resinas compostas fluidas como agentes de cimentação em Ortodontia tem merecido grande atenção, em função  de sua adequada capacidade adesiva, facilidade de uso clínico e número reduzido de etapas de colagem.",Non-OADS,/arxiv_data1/oa_pdf/8a/ad/2176-9451-dpjo-22-02-00069.PMC5484272.pdf
"Submitted : August 09, 2016 - Revised and accepted : November 01, 2016DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.077-086.oar How to cite this article : Sena LMF, Damasceno e Araújo LAL, Farias ACR,  Pereira HSG.",Non-OADS,/arxiv_data1/oa_pdf/88/00/2176-9451-dpjo-22-02-00077.PMC5484273.pdf
DOI: http://dx.doi.org/10.1590/2177-6709.22.2.077-086.oar » Patients displayed in this article previously approved the use of their facial and in - traoral photographs.,Non-OADS,/arxiv_data1/oa_pdf/88/00/2176-9451-dpjo-22-02-00077.PMC5484273.pdf
"Submitted : September 21, 2016 - Revised and accepted : November 17, 2016 » The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.087-094.oar How to cite this article : Siécola GS, Capelozza Filho L, Lorenzoni DC, Jan - son G, Henriques JFC.",Non-OADS,/arxiv_data1/oa_pdf/b8/83/2176-9451-dpjo-22-02-00087.PMC5484274.pdf
DOI: http://dx.doi.org/10.1590/2177-6709.22.2.087-094.oar » Patients displayed in this article previously approved the use of their facial and in - traoral photographs.,Non-OADS,/arxiv_data1/oa_pdf/b8/83/2176-9451-dpjo-22-02-00087.PMC5484274.pdf
"Araújo Pinho, 62, 7º andar - Universidade Federal da Bahia, Faculdade de Odon - tologia , Salvador / BA, Brasil – CEP: 40.110-150 - E-mail: awmachado@gmail.com » The authors report no commercial, proprietary or financial interest in the products  or companies described in this article.DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.095-105.oar How to cite this article : Menezes EBC, Bittencourt MAV, Machado AW.",OADS,/arxiv_data1/oa_pdf/d5/bd/2176-9451-dpjo-22-02-00095.PMC5484275.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.095-105.oar Submitted : September 28, 2016 - Revised and accepted : November 11, 2016 » Patients displayed in this article previously approved the use of their facial and in - traoral photographs.Objetivo:  o objetivo do presente estudo foi avaliar a percepção da estética do sorriso, entre ortodontistas e leigos, em re - lação a diferentes posições verticais de incisivos centrais superiores, em análises de  face completa e do sorriso aproximado.",Non-OADS,/arxiv_data1/oa_pdf/d5/bd/2176-9451-dpjo-22-02-00095.PMC5484275.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.106-117.bbo » The author reports no commercial, proprietary or financial interest in the products  or companies described in this article.",Non-OADS,/arxiv_data1/oa_pdf/41/17/2176-9451-dpjo-22-02-00106.PMC5484276.pdf
"DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.106-117.bbo INTRODUCTION Tooth agenesis is part of orthodontic routine, being  found among 4-5% of the overall population, without  including third molars.",Non-OADS,/arxiv_data1/oa_pdf/41/17/2176-9451-dpjo-22-02-00106.PMC5484276.pdf
Overbite.DOI:  http://dx.doi.org/10.1590/2177-6709.22.2.118-125.sar How to cite this article : Martins RP.,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/2176-9451-dpjo-22-02-00118.PMC5484277.pdf
"DOI: http://dx.doi.org/10.1590/2177-6709.22.2.118-125.sar Submitted : January 26, 2017  Revised and accepted : March 03, 2017 » The author reports no commercial, proprietary or financial interest in the products  or companies described in this article.",Non-OADS,/arxiv_data1/oa_pdf/9a/1b/2176-9451-dpjo-22-02-00118.PMC5484277.pdf
"[8]Inadditi on,recent adva nces inthesynthesis ofglycom imetics, which can modify aspecif ic atom orchem ical moiety inaregio- and stereoselect ive mann er,haveopened new avenues forstructure-b ased studies ofmolecu larrecogni tion event s.[9]The characteri zation ofthe assoc iated binding energy isalso ofparamount interest forthe desig n.[a]Dr.L.Unione,Dr.A.Ard/C181,Dr.T.Diercks, Prof. Dr.J.Jim/C216nez-Barbero Molecular Recog nition and Host–Pa thogen Interac tions CICbioG UNE, Bizkaia Techno logy Park, Building 801A,48170 Derio (Spain ) E-mail :jjbarbero@cicb iogune.es [b]M.Alcal /C181,B.Echeverria ,Dr.S.Serna ,Dr.N.Reichar dt Glycot echnolog yLaborator y,CICbiomaG UNE Paseo Miram /C243n,20014Donosti a-San Seba stian (Spain) E-mail :nreichar dt@cic biomagu ne.es [c]Dr.A.Franc onetti Depar tment ofOrganic Chemistry ,Faculty ofChemistr y Universi tyofSevill e,Profesor Garc /C237aGonz/C181lez1,41012 Sevilla (Spain) [d]Prof. Dr.F.J.CaÇada Depar tment ofChem icaland Physical Biolog y,CIB-C SIC Ramiro deMaeztu 9,28040 Mad rid(Spain) [e]Dr.N.Reichard t CIBER-BB N,Paseo Mira m/C243n,20009 Donos tia-San Sebasti /C181n(Spain) [f]Prof. Dr.J.Jim/C216nez-Barbero Basque Founda tion forScience, MariaDiaz deHaro 13 48009 Bilbao (Spain) [g]Prof. Dr.J.Jim/C216nez-Barbero Depar tment ofOrganic Chemistry II,Faculty ofScience and Techno logy Universi tyoftheBasqu eCountry,48940Leioa, Bizkaia(Spain) Supportin ginformat ionforthisarticle canbefound under : http://dx.doi.or g/10.10 02/chem.20 1605573.",Non-OADS,/arxiv_data1/oa_pdf/6c/e3/CHEM-23-3957.PMC5484281.pdf
https://doi.org/10.1111/ina.12355,Non-OADS,/arxiv_data1/oa_pdf/45/c5/INA-27-746.PMC5484285.pdf
Available from URL: http://www.stats.govt.nz 13 Statistics New Zealand.,OADS,/arxiv_data1/oa_pdf/24/fa/AJAG-36-114.PMC5484290.pdf
"Available from URL: http://www.stats.govt.nz 17 Wu Z, Penning M. Immigration and loneliness in later life.",Non-OADS,/arxiv_data1/oa_pdf/24/fa/AJAG-36-114.PMC5484290.pdf
"Available from URL: http://www.webcitation.org/5tTRTc9yJ 34 Moher D, Liberati A, Tetzlaff J, Altman DG.",OADS,/arxiv_data1/oa_pdf/24/fa/AJAG-36-114.PMC5484290.pdf
Available from URL: http://dspace.ubvu.vu.nl/bitstream/handle/1 871/18954/1999% 20dJG%20vT%20Loneliness%20manual.pdf?sequence=2 41 Ministry of Social Development.,Non-OADS,/arxiv_data1/oa_pdf/24/fa/AJAG-36-114.PMC5484290.pdf
"Available from URL: http://www.ucp.pt/site/resources/documents/ICS/GNC/ArtigosGNC/AlexandreCastroCaldas/26_CuRu87.pdf 45 Bemelmans R, Gelderblom GJ, Jonker P, de Witte L. Socially assis- tive robots in elderly care: A systematic review into effects and effec-tiveness.",OADS,/arxiv_data1/oa_pdf/24/fa/AJAG-36-114.PMC5484290.pdf
"Available from: http://apps.who.int/classifications/icd10/browse/2015/enAccessed December 08, 2016.",OADS,/arxiv_data1/oa_pdf/57/90/JGS-65-995.PMC5484292.pdf
"Available from: http://www.datadictionary.nhs.uk/web_site_content/supporting_information/clinical_coding/opcs_classification_ of_interventions_and_procedures.asp Accessed December 08, 2016.",Non-OADS,/arxiv_data1/oa_pdf/57/90/JGS-65-995.PMC5484292.pdf
"Available at http://www.hscic.gov.uk/catalogue/PUB0194620 Accessed June 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/57/90/JGS-65-995.PMC5484292.pdf
"National Hospital Cost Data Collection, Australian Public Hospitals Cost Report2013 ‐2014 Round 18 [https://www.ihpa.gov.au/publica- tions/australian ‐public ‐hospitals ‐cost‐report ‐2013 ‐2014 ‐round ‐18].",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/PON-26-849.PMC5484300.pdf
https://doi.org/10.1002/ pon.4239BOYAGES ET AL .,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/PON-26-849.PMC5484300.pdf
Available at: http://www.who.int/pbd/deafness/estimates/en/.,Non-OADS,/arxiv_data1/oa_pdf/ee/07/LARY-127-1689.PMC5484303.pdf
"Available from http://www.marinespecies.org at VLIZ; accesse d April 8, 2016 [2].",Non-OADS,/arxiv_data1/oa_pdf/50/24/MED-37-702.PMC5484305.pdf
"MolluscaBase (2015); accessed at http://www.molluscabase.org on April 8, 2016 [3].",Non-OADS,/arxiv_data1/oa_pdf/50/24/MED-37-702.PMC5484305.pdf
"Australian Museum Sea Slug Forum, Sydney; available at http://www.seaslugforum.net.",Non-OADS,/arxiv_data1/oa_pdf/50/24/MED-37-702.PMC5484305.pdf
All the NCI data that we report below (if available) were obtained on the public NCI website at https://dtp.cancer.gov/databases_tools/data_search.htm.,OADS,/arxiv_data1/oa_pdf/50/24/MED-37-702.PMC5484305.pdf
"The clinical trial site, https://clinicaltrials.gov, does not mention any ongoing trial with aplyronine A.",Non-OADS,/arxiv_data1/oa_pdf/50/24/MED-37-702.PMC5484305.pdf
"The European MetaHit project (FP7, http://www.metahit.eu/) proposed that the microbial communities could be classiﬁed into three main enterotypes characterised by the predominant bacterial pop- ulation: Bacteroides (enterotype 1), Prevotella (enterotype 2) and Ruminococcus (enterotype 3) [58].",Non-OADS,/arxiv_data1/oa_pdf/57/db/MNFR-61-na.PMC5484307.pdf
The ﬁrst initiative to this end is the creation of a dedicated Action called “FA1403- POSITIVe” (https://www6.inra.fr/cost-positive) within the framework of the European Cooperation in Science and Technology (COST).,Non-OADS,/arxiv_data1/oa_pdf/57/db/MNFR-61-na.PMC5484307.pdf
"Furthermore, despite the knowledge accumulated on the metabolism of plant bioactives in humans, and while most plant biosynthetic pathways of these compounds are accessi- ble on-line at KEGG (http://www.genome.jp/kegg/pathway.",Non-OADS,/arxiv_data1/oa_pdf/57/db/MNFR-61-na.PMC5484307.pdf
"html) or MetaCyc (http://metacyc.org/) databases, their metabolic pathways in humans or mammals have not yet been published in online databases.",OADS,/arxiv_data1/oa_pdf/57/db/MNFR-61-na.PMC5484307.pdf
"Up to now, caffeine is the only plant food bioactive for which the metabolism in humans is described in the KEGG database (http://www.genome.jp/ kegg/pathway/map/map00232.html).",Non-OADS,/arxiv_data1/oa_pdf/57/db/MNFR-61-na.PMC5484307.pdf
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/docs/1st_annual_update_nystate_ roadmap.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
http://www.leap-froggroup.org/ratings-reports/reports-hospital-performance.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
http://transform.childbirthconnection.org/reports/listeningtomothers/.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
http://transform.childbirthconnection.org/wp-content/uploads/2013/06/LTM-III_Pregnancy-and-Birth.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
https://effectivehealthcare.ahrq.gov/ehc/products/343/763/CQG-Public-Reporting_Protocol_20110817.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
https://www.cdc.gov/prams/.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
https://www.nichd.nih.gov/health/topics/high-risk/conditioninfo/ pages/risk.aspx.,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
https://doi.org/10.1111/birt.12273,Non-OADS,/arxiv_data1/oa_pdf/82/54/BIRT-44-120.PMC5484308.pdf
"Parsippany, NJ: Daiichi Sankyo, Inc;2014.http://www.accessdata.fda.gov/drugsatfda_docs/label/ 2006/021176s014lbl.pdf.AccessedApril2016.",Non-OADS,/arxiv_data1/oa_pdf/57/cf/JCPH-57-747.PMC5484310.pdf
[http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/94/22/BJO-124-1080.PMC5484313.pdf
[http://monographs.iarc.fr/ENG/ Monographs/vol100E/mono100E.pdf].,Non-OADS,/arxiv_data1/oa_pdf/94/22/BJO-124-1080.PMC5484313.pdf
[http://data.euro.who.int/dmdb/].,OADS,/arxiv_data1/oa_pdf/94/22/BJO-124-1080.PMC5484313.pdf
"GLOBOCAN 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.",Non-OADS,/arxiv_data1/oa_pdf/a8/4f/CNCR-123-2303.PMC5484320.pdf
http://www.theguardian.com/society/ 2013/mar/08/jeremy-hunt-nhs-mediocrity-mid-staffs.,Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
Publi- cation date: 17 December 2015 http://www.rcgp.org.uk/news/2015/december/cqc-chief-inspector-steve- ﬁeld- has-lost-con ﬁdence-of-gps.asp Department of Health.,Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
Secondary The New NHS 1997. http://www.gov.uk/government/pub- lications/the-new-nhs.,Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
Available at: http://www.legislation.gov.uk/ukpga/2003/43/contents (Accessed: 1 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
Available at: http://www.legislation.gov.uk/uksi/2009/462/schedule/4/made (Accessed: 1 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
Secondary NHS England asks NICE to suspend safe stafﬁng programme 2015. http://www.nice.org.uk/news/ article/nhs-england-asks-nice-to-suspend-safe-staf ﬁng- programmePublic Accounts committee report into the CQC.,Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
"2015. http://www.parliament.uk/ business/committees/com- mittees-a-z/commons-select/public-accounts-committee/inquiries/parliam ent-2015/care-qua lity-commission- 15-16/ Waterman RW, Meier J.",Non-OADS,/arxiv_data1/oa_pdf/4b/45/HPM-32-e185.PMC5484322.pdf
Available at: http://cafe.foundation/v2/pdf_tech/Noise.Technologies/NASA.2007.Prop.Noise.Feri.1A.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/a8/AOR-41-573.PMC5484328.pdf
"[*]Dr.T.N.Gieshoff, Dr.U.Chakraborty ,M.Villa, Prof. Dr.A.Jacobi vonWangelin Institute ofOrganic Chemist ry,University ofRegensburg Universit /C228tsstrasse 31,93040 Regen sburg (Germany) E-mail :axel.jacobi@u r.de Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016125 48.",Non-OADS,/arxiv_data1/oa_pdf/6a/88/ANIE-56-3585.PMC5484329.pdf
"Donner T echnologies, http://www.donner-tech.com/whats_wrong_with_ld.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1f/61/ELSC-17-605.PMC5484330.pdf
We are also grateful to the College of Radiographers Industrial Partnership Scheme (http://www.sor.org/about-us/awards/corips-research-grants) for funding the study.,Non-OADS,/arxiv_data1/oa_pdf/8c/e2/ECC-26-na.PMC5484333.pdf
https://doi.org/10.1111/ecc.12580,Non-OADS,/arxiv_data1/oa_pdf/8c/e2/ECC-26-na.PMC5484333.pdf
ACKNOWLEDGMENT We thank Dr. Stephen Cauley (Massachusetts General Hospital) for sharing the interface of their online imagereconstruction (part of the package that can be requested at: https://www.nmr.mgh.harvard.edu/software/c2p/sms) for use in our SMS ASL sequence.,Non-OADS,/arxiv_data1/oa_pdf/96/e3/MRM-78-121.PMC5484334.pdf
https://doi.org/10.1111/dom.12878808 TSUJIMOTO ET AL.,OADS,/arxiv_data1/oa_pdf/92/b1/DOM-19-800.PMC5484336.pdf
2012 [cited 2016 January 9]; Available from: http://globocan.iarc.fr/Pages/ fact_sheets_cancer.aspx.,OADS,/arxiv_data1/oa_pdf/00/35/JSO-115-647.PMC5484338.pdf
2010 [cited 2015 October 29]; Available from: http://www.cdc.gov/genomics/gtesting/ACCE/index.htm.,OADS,/arxiv_data1/oa_pdf/00/35/JSO-115-647.PMC5484338.pdf
2010 [cited 2016 September 27]; Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=89513 66.,OADS,/arxiv_data1/oa_pdf/00/35/JSO-115-647.PMC5484338.pdf
https://doi.org/10.1002/jso.24561662| HYAMS ET AL.,OADS,/arxiv_data1/oa_pdf/00/35/JSO-115-647.PMC5484338.pdf
Statistical analyses Statistical analyses were performed using R(The R Project for Statistical Computing; https://www.r-project.org) version 3.0 or higher.,OADS,/arxiv_data1/oa_pdf/f6/6b/AOS-95-e270.PMC5484346.pdf
http://www.fda.gov/downloads/Drugs/ …/Guidances/ ucm071624.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/f9/DOM-19-858.PMC5484356.pdf
https://doi.org/10.1111/dom.12892HARRIS ET AL.,OADS,/arxiv_data1/oa_pdf/9a/f9/DOM-19-858.PMC5484356.pdf
To view this mini commentary visit https://dx.doi.org/10.1111/1471-0528.14381.,Non-OADS,/arxiv_data1/oa_pdf/38/6f/BJO-124-1153.PMC5484358.pdf
"Països Catalans 16, 43007 Tarragona, SpainE-mail: aechavarren@iciq.eshttp://www.iciq.org/research/research_group/prof-antonio-m-echavarren/ [b]Departament de Química Orgànica i Analítica, Universitat Rovira i Virgili C/ Marcel ·lí Domingo s/n, 43007 Tarragona, Spain ORCID(s) from the author(s) for this article is/are available on the WWW under http://dx.doi.org/10.1002/ejoc.201601129.",Non-OADS,/arxiv_data1/oa_pdf/d5/08/EJOC-2017-14.PMC5484365.pdf
To view this mini commentary visit http://dx.doi.org/10.1111/1471-0528.14215.,Non-OADS,/arxiv_data1/oa_pdf/0e/92/BJO-124-1225.PMC5484371.pdf
2014 [http://data.euro.who.int/hfadb/linecharts/linechart.php?w=1920&h=1080].,OADS,/arxiv_data1/oa_pdf/0e/92/BJO-124-1225.PMC5484371.pdf
"Available from http://www.danielsoper.com/statcalc Spinrad, T. L. & Stifter, C. A.",OADS,/arxiv_data1/oa_pdf/79/bb/ICD-26-na.PMC5484378.pdf
"SHORT PAPER On the generalization of attitude accessibility after repeated attitude expression Mathilde Descheemaeker*, Adriaan Spruyt †, Russell H. Fazio ‡&D i r kH e r m a n s * * Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium †Faculty of Psychology and Educational Sciences, Ghent University, Ghent, Belgium ‡Department of Psychology, Ohio State University, Columbus, Ohio, USA Correspondence Mathilde Descheemaeker, Faculty ofPsychology and Educational Sciences, KU Leuven, Tiensestraat 102 box 3712, 3000 Leuven, Belgium.E-mail: mathilde.descheemaeker@ppw.kuleuven.be Received: 7 June 2015 Accepted: 16 March 2016 http://dx.doi.org/10.1002/ejsp.2206 Keywords: attitude accessibility, repeated evaluation, generalizationAbstract The more accessible an attitude is, the stronger is its in ﬂuence on information processing and behavior.",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1037/0022-3514.62.6.893 Bassili, J. N., & Fletcher, J. F. (1991).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1086/269265 Clark, J., Wegener, D. T., & Fabrigar, L. (2008).",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1348/0144666041501688 Descheemaeker, M., Spruyt, A. , & Hermans, D. (2014).",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0095302 Downing, J. W., Judd, C. M., & Brauer, M. (1992).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1080/0269993004200024 Fazio, R. H. (2007).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1521/soco.2007.25.5.603 F a z i o ,R .H .",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1037/0033-2909.132.5.778 Greenhouse, S. W., & Geisser, S. (1959).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1016/ S0022-1031(03)00038-6 Houston, D. A., & Fazio, R. H. (1989).",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1037//0022-3514.60.2.193 Kokkinaki, F., & Lunt, P. (1997).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.org/10.1111/j.2044-8309.1997.,Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/ 10.1177/0146167295211007 Monahan, J. L., Rhodes, N., & Ro skos-Ewoldsen, D. R. (2009).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1177/0093650208326466 Powell, M. C., & Fazio, R. H. (1984).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1037//0022-3514.63.2.198 Sanbonmatsu, D. M., Posavac, S., Vanous, S., Ho, E., & Fazio, R. H. (2007).",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1016/j.jesp.2006.04.008 Smith, E. R., & Zárate, M. A.",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1016/j.cognition.2011.08.017 Spruyt, A., De Houwer, J., & Hermans, D. (2009).",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1016/j.jml.2009.03.004 Spruyt, A., De Houwer, J., Hermans, D., & Eelen, P. (2007).",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1016/j.jesp.2006.06.009 White, K. M., Hogg, M. A., & Terry, D. J.",OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
"http://dx.doi.org/10.1207/ 153248302753674604 Wicker, A. W. (1969).",Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/cb/EJSP-47-97.PMC5484379.pdf
Available at: http://www.deutsches-ivf-register.de/perch/resources/ downloads/jre32015eshreicmartadamson.pdf [Accessed 15 Sept 2016]).,Non-OADS,/arxiv_data1/oa_pdf/26/05/BIOE-31-409.PMC5484380.pdf
Available at: http://www.bruno-latour.,Non-OADS,/arxiv_data1/oa_pdf/26/05/BIOE-31-409.PMC5484380.pdf
Available at: http://www.dfg.de/download/pdf/dfg_im_ profil/reden_stellungnahmen/2006/stammzel lforschung_deutschland_ lang_0610.pdf [Accessed 15 Sept 2016]: 131.,Non-OADS,/arxiv_data1/oa_pdf/26/05/BIOE-31-409.PMC5484380.pdf
AchievingWorld-ClassCancerOutcomes: TakingtheStrategyForward ; 2016. https://www.england.nhs .uk/2016/05/cancer-strategy/ [accessed 19 November 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
NationalBowel CancerAuditReport ; 2015. http://www.hscic.gov.uk/bowel [accessed 15 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
Colorectal Cancer:DiagnosisandManagement ; 2011. http://www.nice .org.uk/guidance/cg131/resources/colorectal-cancer- diagnosis-and-management-35109505330117 [accessed 15 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
http://content.digital .nhs.uk/hes [accessed 24 January 2017].,Non-OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
DeathsRegisteredinEngland andWales ; 2015.https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ deaths/bulletins/deathsregistrationsummarytables/2015 [accessed 15 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
https://www.sheffield.ac.uk/polopoly_fs/1&middot; 282375!/file/IMD2007.pdf [accessed 15 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
InternationalStatistical ClassificationofDiseasesandRelatedHealthProblems(10thRevision); 2011. http://www.who.int/classifications/icd/ ICD10Volume2_en_2010.pdf [accessed 15 September 2016].,OADS,/arxiv_data1/oa_pdf/4c/38/BJS-104-918.PMC5484381.pdf
"TotalSynthesis ofViniferifuran, Resv eratrol-Piceatannol Hybrid, Anigopreissin AandAnalogues –Investigation ofDemethylation Strategies DucDuy VoaandMikael Elofssona,* aDepar tment ofChemis try,Ume/C229Univer sity,SE901 87,Ume/C229,Sweden E-mail :Mikael.Elof sson@u mu.se Receiv ed:October 4,2016;Publishe donline :Decembe r8,2016 Support inginformation forthisarticle canbefound under:http://dx.doi.org/1 0.1002/a dsc.201601089 .",Non-OADS,/arxiv_data1/oa_pdf/10/2f/ADSC-358-4085.PMC5484382.pdf
"Author, London; 2015. http://csdmruk.cegedim.com/our- data/our-data.shtml (accessed 13 Septebmer 2016).",Non-OADS,/arxiv_data1/oa_pdf/4a/bd/PDS-26-615.PMC5484386.pdf
"Indiana University School of Medicine, India- napolis, IN; 2016. http://medicine.iupui.edu/clinpharm/ddis/clinical-table/(accessed 29 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/4a/bd/PDS-26-615.PMC5484386.pdf
"Food and Drug Administration, Silver Spring, MD; 30 June 2015. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ ucm080499.htm (accessed 14 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/4a/bd/PDS-26-615.PMC5484386.pdf
"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance: London, July2016 .http://www.encepp.eu/encepp_stud-ies/indexRegister.shtml (accessed 14 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/4a/bd/PDS-26-615.PMC5484386.pdf
Keywords Photogrammetry; Coal mining; Underground; Rib characterization This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/8b/nihms863562.PMC5484423.pdf
"https://doi.org/10.1177/2050313X17716050 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17716050 journals.sagepub.com/home/sco Introduction Medical standards for the determination of death by neu- rological criteria were first published by the American Academy of Neurology (AAN) in 1995.",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/10.1177_2050313X17716050.PMC5484424.pdf
"https://doi.org/10.1177/2333794X17714378Global Pediatric Health Volume 4: 1 –7  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17714378 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Acute bronchiolitis (AB), which is the most common  acute lower respiratory system disease in infants, is often caused by a viral infection.",Non-OADS,/arxiv_data1/oa_pdf/8e/23/10.1177_2333794X17714378.PMC5484425.pdf
http://www.who.int/immunization/research/meetings_workshops/rsv_vaccine_development/en/.,Non-OADS,/arxiv_data1/oa_pdf/8e/23/10.1177_2333794X17714378.PMC5484425.pdf
http://www.who.int/immunization/research/meetings_workshops/rsv_vaccine_development/en/.,Non-OADS,/arxiv_data1/oa_pdf/8e/23/10.1177_2333794X17714378.PMC5484425.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/50/16/10.1177_2325967117712236.PMC5484426.pdf
"Vienna, Austria: R Foundation for Statistical Computing; 2014. http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/50/16/10.1177_2325967117712236.PMC5484426.pdf
2013. http://www.nfhs.org/ParticipationStatics/ ParticipationStatics.aspx/.,Non-OADS,/arxiv_data1/oa_pdf/50/16/10.1177_2325967117712236.PMC5484426.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/27/5c/10.1177_2325967117712235.PMC5484427.pdf
"https://doi.org/10.1177/2333794X17715831Global Pediatric Health Volume 4: 1 –12  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17715831 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Identified as a lymphoma in Uganda in the 1960s, Burkitt  lymphoma (BL) is the most common overall childhood cancer throughout the malaria-endemic regions of Africa.",Non-OADS,/arxiv_data1/oa_pdf/5d/dc/10.1177_2333794X17715831.PMC5484428.pdf
"https://doi.org/10.1177/2333393617715335Global Qualitative Nursing Research Volume 4: 1 –12 © The Author(s) 2017Reprints and permissions:  sagepub.com/journalsPermissions.nav DOI: 10.1177/2333393617715335 journals.sagepub.com/home/gqn Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0  License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the  work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/ en-us/nam/open-access-at-sage).Article Among Black adults, the risk of Type 2 diabetes mellitus  (T2DM) is more than twice that for Whites (National Diabetes Information Clearinghouse, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ff/39/10.1177_2333393617715335.PMC5484429.pdf
Retrieved from  http://www.diabetes.org/diabetes-basics/symptoms/?loc=db-slabnav American Heart Association.,Non-OADS,/arxiv_data1/oa_pdf/ff/39/10.1177_2333393617715335.PMC5484429.pdf
Retrieved from http://www.heart.org/HEARTORG/Conditions/Diabetes/PreventionTreatmentofDiabetes/Prevention-Treatment-of-Diabetes_UCM_002036_Article.,Non-OADS,/arxiv_data1/oa_pdf/ff/39/10.1177_2333393617715335.PMC5484429.pdf
"Retrieved from  http://www.cdc.gov/diabetes/statistics/esrd/fig5.htm Chesla, C. A., Fisher, L., Mullan, J. T., Skaff, M. M., Gardiner,  P., Chun, K., & Kantner, R. (2004).",OADS,/arxiv_data1/oa_pdf/ff/39/10.1177_2333393617715335.PMC5484429.pdf
"Retrieved from http://diabetes.niddk.nih.gov/dm/pubs/america/index.aspx Newton, R. L., Jr., Griffith, D. M., Kearney, W. B., & Bennett, G.  G. (2014).",Non-OADS,/arxiv_data1/oa_pdf/ff/39/10.1177_2333393617715335.PMC5484429.pdf
"Retrieved  from http://www.who.int/dietphysicalactivity/pa/en/ Author Biographies Tera R. (Hurt) Jordan, BS, MS, PhD, is an assistant professor of human development and family studies at Iowa State University in Ames, Iowa, United States.",Non-OADS,/arxiv_data1/oa_pdf/ff/39/10.1177_2333393617715335.PMC5484429.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/30/d6/10.1177_2325967117712448.PMC5484431.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bb/d0/10.1177_2325967117709966.PMC5484434.pdf
"https://doi.org/10.1177/1756283X17702614   https://doi.org/10.1177/1756283X17702614Ther Adv Gastroenterol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/04/ef/10.1177_1756283X17702614.PMC5484435.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology journals.sagepub.com/home/tag 537 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License   (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Transpapillary bile duct cannulation by endo-scopic retrograde cholangiopancreatography (ERCP) is the technique of choice for palliative as well as pre-operative drainage of distally obstruc-tive jaundice.",Non-OADS,/arxiv_data1/oa_pdf/04/ef/10.1177_1756283X17702614.PMC5484435.pdf
"https://doi.org/10.1177/1756283X17709974   https://doi.org/10.1177/1756283X17709974Ther Adv Gastroenterol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/64/be/10.1177_1756283X17709974.PMC5484438.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology journals.sagepub.com/home/tag 545 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License   (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Significant progress in the technology of colonic drug delivery has been recently obtained by the development of the Multimatrix ® (MMX®)  approach, which comprises lipophilic and hydro-philic excipients enclosed within a gastro-resist-ant, pH-dependent coating.",Non-OADS,/arxiv_data1/oa_pdf/64/be/10.1177_1756283X17709974.PMC5484438.pdf
"https://doi.org/10.1177/1756283X17710247   https://doi.org/10.1177/1756283X17710247Ther Adv Gastroenterol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a8/31/10.1177_1756283X17710247.PMC5484439.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology journals.sagepub.com/home/tag 529 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License   (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Hepatocellular carcinoma (HCC) is the sixth most frequent tumor type worldwide, and the second most common cause of cancer-related death.",Non-OADS,/arxiv_data1/oa_pdf/a8/31/10.1177_1756283X17710247.PMC5484439.pdf
"MeSH Keywords:  Adenocarcinoma, Mucinous • Ovarian Neoplasms • Venous Thromboembolism  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903214Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Internal Medicine, University of Cincinnati Medical Center,  Cincinnati, OH, U.S.A. 2 Department of Hematology/Oncology, Vontz Center for Molecular Studies,  Cincinnati, OH, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 669-673 DOI: 10.12659/AJCR.903214 669 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/b3/b0/amjcaserep-18-669.PMC5484457.pdf
"MeSH Keywords:  Hematoma • Kasabach-Merritt Syndrome • Thrombocytopenia  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/901947Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medical Imaging, Changhua Christian Hospital, Changhua, Taiwan 2 Department of Radiology, Tri-Service General Hospital, Taipei, Taiwan 3 School of Medical Imaging and Radiological Sciences, School of Medicine, Chung  Shan Medical University, Taichung, Taiwan 4 Department of Medical Imaging, Chung Shan Medical University Hospital,  Taichung, TaiwanISSN 1941-5923 © Am J Case Rep, 2017; 18: 682-686 DOI: 10.12659/AJCR.901947 682 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/d9/fa/amjcaserep-18-682.PMC5484458.pdf
"MeSH Keywords:  Cerebral Infarction • Embolism, Paradoxical • Hepatectomy • Laparoscopy  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903777Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Division of Gastroenterological Surgery, Department of Surgery, Asahikawa  Medical University, Asahikawa, Hokkaido, Japan 2 Division of Neurology, Department of Internal Medicine, Asahikawa Medical  University, Asahikawa, Hokkaido, Japan 3 Department of Anesthesiology, Asahikawa Medical University, Asahikawa,  Hokkaido, JapanISSN 1941-5923 © Am J Case Rep, 2017; 18: 687-691 DOI: 10.12659/AJCR.903777 687 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/f2/2e/amjcaserep-18-687.PMC5484459.pdf
"Retrieved from http://www.dqi.org.uk/case-studies/healthcare/ Dewulf, G., & Van Meel, J.",OADS,/arxiv_data1/oa_pdf/10/60/10.1177_1937586716679404.PMC5484461.pdf
"Retrieved from https://www.gov.uk/government/uploads/sys tem/uploads/attachment _data/file/316247/HBN_ 00-01-2.pdf Rittel, H. W., & Webber, M. M. (1973).",OADS,/arxiv_data1/oa_pdf/10/60/10.1177_1937586716679404.PMC5484461.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a7/a6/dmso-10-235.PMC5484507.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a7/a6/dmso-10-235.PMC5484507.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 235–245Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 235 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S135572 Effects of a tailored lifestyle self-management  intervention (TALENT) study on weight  reduction: a randomized controlled trial Dieter Melchart1,2 Peter Löw3 Erich Wühr4 Victoria Kehl5 Wolfgang Weidenhammer1 1Competence Center for  Complementary Medicine and  Naturopathy, Klinikum Rechts der Isar, T echnische Universität München,  Munich, Germany;  2Institute for  Complementary and Integrative Medicine, University Hospital Zurich, University of Zurich, Zurich,  Switzerland;  3Medical Practice for  Internal Medicine, Treuchtlingen,   4Faculty for Applied Health Care  Science, Deggendorf Institute of T echnology, Deggendorf,  5Institute for  Medical Statistics and Epidemiology,  Munich Trial Centre, Klinikum Rechts der Isar, T echnische Universität München, Munich, GermanyObjective: Overweight and obesity are globally increasing risk factors for diseases in the  context of metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/a7/a6/dmso-10-235.PMC5484507.pdf
"2,3 Obesity is associated with many comorbid conditions that have major implications  on longevity, quality of life, and health-care costs.4,5 It could be shown that a strong  and linear association exists between BMI (>20) and the risk of developing type 2 diabetes, hypertension, cardiovascular disease, and other chronic diseases in both men Correspondence: Wolfgang  WeidenhammerCompetence Center for Complementary Medicine and Naturopathy, Klinikum Rechts der Isar, Technische Universität München, 9 Kaiserstrasse, Munich 80801, GermanyTel +49 89 726 6970Email wolfgang.weidenhammer@tum.deJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Melchart et alRunning head recto: Effects of lifestyle self-management on weight reductionDOI: http://dx.doi.org/10.2147/DMSO.S135572",Non-OADS,/arxiv_data1/oa_pdf/a7/a6/dmso-10-235.PMC5484507.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a7/a6/dmso-10-235.PMC5484507.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 245 Effects of lifestyle self-management on weight reduction  15.,Non-OADS,/arxiv_data1/oa_pdf/a7/a6/dmso-10-235.PMC5484507.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/dddt-11-1827.PMC5484508.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1827–1837Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1827Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13694 8 comparison of posttransplant outcomes in  patients with no, acute, or chronic amiodarone  use before heart transplantation rasmus rivinius1 Matthias helmschrott1 arjang ruhparwar2 Fabrice F Darche1 Dierk Thomas1 T om Bruckner3 hugo a Katus1 andreas O Doesch1 1Department of cardiology,   angiology and Pneumology,   2Department of cardiac surgery,   heidelberg University hospital,   3institute for Medical Biometry and  informatics, University of heidelberg,   heidelberg, germanyBackground:  Major concerns about the safety of pretransplant amiodarone use have been raised.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/dddt-11-1827.PMC5484508.pdf
"Keywords:  amiodarone, atrial fibrillation, bradycardia, heart transplantation, pacemaker,  survival Introduction Major concerns about the safety of pretransplant amiodarone use in patients with  congestive heart failure have been raised.1 As a result of its long half-life, the cardiac  allograft is exposed to amiodarone posing potential risks.2 Several studies reported correspondence: andreas O Doesch Department of cardiology, angiology  and Pneumology, heidelberg University  hospital, im neuenheimer Feld 410,  69120 heidelberg, germany Tel +49 6221 56 39936 Fax +49 6221 56 4105 email andreas.doesch@med.uni- heidelberg.d e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Rivinius et al Running head recto: Outcomes of pretransplant amiodarone use DOI: http://dx.doi.org/10.2147/DDDT.S136948",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/dddt-11-1827.PMC5484508.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/dddt-11-1827.PMC5484508.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/4a/dddt-11-1827.PMC5484508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/38/dddt-11-1815.PMC5484509.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1815–1825Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1815Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10250 0 intranasal agomelatine solid lipid nanoparticles to  enhance brain delivery: formulation, optimization  and in vivo pharmacokinetics ahmed M Fatouh1 ahmed h elshafeey1,2 ahmed abdelbary1 1Department of Pharmaceutics  and industrial Pharmacy, Faculty of  Pharmacy, cairo University, cairo,   egypt; 2school of Pharmacy, University  of Waterloo, Waterloo, On , canadaPurpose:  Agomelatine is a novel antidepressant drug suffering from an extensive first-pass  metabolism leading to a diminished absolute bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/3c/38/dddt-11-1815.PMC5484509.pdf
"On the other hand, AGM can be transported directly from  the nasal cavity into the brain avoiding the blood–brain barrier (BBB) through the correspondence: ahmed h elshafeey Department of Pharmaceutics and  industrial Pharmacy, Faculty of Pharmacy,  cairo University, Kasr el eyni street,  cairo, egypt Tel +20 100 584 0261 email ahmed.elshafeey@pharma.cu.edu.e g Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Fatouh et al Running head recto: Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery DOI: http://dx.doi.org/10.2147/DDDT.S102500",Non-OADS,/arxiv_data1/oa_pdf/3c/38/dddt-11-1815.PMC5484509.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3c/38/dddt-11-1815.PMC5484509.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/38/dddt-11-1815.PMC5484509.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/d7/dddt-11-1803.PMC5484510.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1803–1813Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1803Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13312 7 Virtual screening for potential inhibitors of  Mcl-1 conformations sampled by normal modes,  molecular dynamics, and nuclear magnetic  resonance Yitav glantz-gashai* T omer Meirson* eli reuveni abraham O samson Faculty of Medicine in the galilee,   Bar ilan University, safed, israel *These authors contributed equally  to this workAbstract:  Myeloid cell leukemia-1 (Mcl-1) is often overexpressed in human cancer and is an  important target for developing antineoplastic drugs.",Non-OADS,/arxiv_data1/oa_pdf/8a/d7/dddt-11-1803.PMC5484510.pdf
"To complicate things further, upregulation of Mcl-1 is a key factor in the development correspondence: abraham O samson Faculty of Medicine in the galilee, Bar  ilan University, 8 henrietta szold street,  safed, israel Tel +972 54 795 8894 email avraham.samson@biu.ac.i l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Glantz-Gashai et al Running head recto: Virtual screening for potential inhibitors of Mcl-1 conformations DOI: http://dx.doi.org/10.2147/DDDT.S133127",Non-OADS,/arxiv_data1/oa_pdf/8a/d7/dddt-11-1803.PMC5484510.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8a/d7/dddt-11-1803.PMC5484510.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/d7/dddt-11-1803.PMC5484510.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/df/dddt-11-1839.PMC5484511.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1839–1847Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1839Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13284 1 enzymatic synthesis and in vitro evaluation  of folate-functionalized liposomes Bohong guo Danqiao Xu Xiaohong liu Jun Yi Department of Pharmaceutics,   guangdong Pharmaceutical University,    guangzhou, chinaAbstract:  In this study, folate–poly(ethylene glycol)3400–cholesterol conjugates (FA–PEG–   Chol) were enzymatically synthesized in one step and incorporated into liposomes to prepare  folate (FA)-functionalized liposomes for targeted drug delivery.",Non-OADS,/arxiv_data1/oa_pdf/1b/df/dddt-11-1839.PMC5484511.pdf
"Biocatalytic processes have become a useful and green alternative in stereoselective  synthesis due to their multiple advantages.12–14correspondence: Bohong guo Department of Pharmaceutics,  guangdong Pharmaceutical University,  280 Wai huan Dong lu, guangzhou  higher education Mega center,  guangzhou 510006, china Tel +86 20 3935 2117 Fax +86 20 3935 2129 email guobohong@gdpu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Guo et al Running head recto: Synthesis and evaluation of folate-functionalized liposomes DOI: http://dx.doi.org/10.2147/DDDT.S132841",Non-OADS,/arxiv_data1/oa_pdf/1b/df/dddt-11-1839.PMC5484511.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1b/df/dddt-11-1839.PMC5484511.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/df/dddt-11-1839.PMC5484511.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2017:11 71–79Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  71 Original research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S134920autophagy regulates the stemness of cervical  cancer stem cells Yi Yang1,2 li Yu1 Jin li1 Ya hong Yuan1 Xiao li Wang1 shi rong Yan1 Dong sheng li1 Yan Ding1 1hubei Key laboratory of embryonic  stem cell research, 2reproductive  center, Taihe hospital, hubei  University of Medicine, shiyan,   People’s republic of chinaAbstract: Cancer stem cells (CSCs) are a rare population of multipotent cells with the capacity  to self-renew.",Non-OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
"The correspondence: Yan Ding; shi rong Yan hubei Key laboratory of embryonic stem cell research, Taihe hospital, hubei University of Medicine, 32 renmin road, shiyan city, hubei 442000, People’s republic of chinaTel +86 71 9880 1133email dyywzx@163.com; judecia@163.comJournal name: Biologics: Targets and Therapy Article Designation: Original ResearchY ear: 2017V olume: 11Running head verso: Y ang et alRunning head recto: Autophagy regulates the stemness of cervical cancer stem cellsDOI: http://dx.doi.org/10.2147/BTT.S134920",Non-OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
Beclin 1 sgRNAs were constructed online (http://crispr.mit.edu/) and then cloned into the pGK1.2 vector according to the manufacture’ s instruction.,OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
"Biologics: Targets and Therapy 2017:11submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 79 autophagy regulates the stemness of cervical cancer stem cells 18.,Non-OADS,/arxiv_data1/oa_pdf/48/67/btt-11-071.PMC5484512.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/b9/pmw006.PMC5484547.pdf
"Mode of ac- tion classiﬁcation brochure, Fourth Edition (4.1) – June 2015, (http://www.irac-online.org/documents/moa-brochure/?ext¼pdf) (accessed 30 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/8f/b9/pmw006.PMC5484547.pdf
"https://doi.org/10.1177/1179546817714478 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights: Cardiology Volume 11: 1–2 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179546817714478 Case Presentation We present a case of 57-year-old man with dual-chamber  permanent pacemakers (PPM) implanted initially for sinus node dysfunction who had “pacing spikes all over” on telem-etry 1 day after mitral valve repair and coronary artery bypass  grafting.",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/10.1177_1179546817714478.PMC5484548.pdf
"https://doi.org/10.1177/1179546817713204 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights: Cardiology Volume 11: 1–9 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179546817713204 Background Hepatitis C virus (HCV) poses a real health threat being one  of the most prominent causes of chronic liver diseases world-wide.",Non-OADS,/arxiv_data1/oa_pdf/07/42/10.1177_1179546817713204.PMC5484549.pdf
http://content.govdelivery.com/accounts/USFDA/ bulletins/f97c71.,Non-OADS,/arxiv_data1/oa_pdf/07/42/10.1177_1179546817713204.PMC5484549.pdf
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ Surveillance/AdverseDrugEffects/ucm082196.htm.,Non-OADS,/arxiv_data1/oa_pdf/07/42/10.1177_1179546817713204.PMC5484549.pdf
"https://doi.org/10.1177/1178630217715237 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Environmental Health Insights Volume 11: 1–13 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178630217715237 The number of women in agricultural employment is increas- ing worldwide; women now account for about 43% of the total workforce in agriculture.",Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
http://www.fao.org/docrep/013/i2050e/i2050e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
http://www.fao.org/fileadmin/ templates/agphome/documents/horticulture/WHO/arusha/Tanzania_TAHA.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://drive.google.com/file/d/0B-YpKmnnEgb2c - m9aQVZmMUFxWW8/view.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
http://www.who.int/ ipcs/publications/pesticides_hazard_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/html/endosulfan_ fs.html.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/pdf/2540fact.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
http://npic.orst.edu/factsheets/archive/l_cyhalotech.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pes - ticides/reregistration/web/pdf/dimethoate_ired_revised.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/pdf/0445tredfact.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6600.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
http://npic.orst.edu/factsheets/archive/chlorptech.html.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/html/ carbofuran_ired_fs.html.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregis - tration/web/pdf/aldicarb_red.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
Chlorothalonil RED facts https://archive.epa.gov/pesticides/reregistration/web/pdf/0097fact.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://www3.epa.gov/pesticides/chem_search/reg_actions/reregistration/fs_UG-6_01- Aug-2006.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/html/diazinon_ ired_fs.html.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/pdf/malathion-red-revised.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/ html/pirimiphosmethyl_ired_fs.html.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/pdf/carbaryl_ factsheet.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistration/web/pdf/0031fact.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
https://archive.epa.gov/pesticides/reregistra - tion/web/pdf/triforine_red.pdf.,OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
http://www.wfp.org.za/publications/general-reports/doc_view/77-pes - ticides-final-report.html; 2010.,Non-OADS,/arxiv_data1/oa_pdf/a9/e1/10.1177_1178630217715237.PMC5484550.pdf
"https://doi.org/10.1177/1177271917715443 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Biomarker Insights Volume 12: 1–9 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177271917715443 Introduction Pancreatic cancer ranks the fourth leading cause of cancer- related death and is estimated to be the second leading cause of cancer death by 2020.",Non-OADS,/arxiv_data1/oa_pdf/4c/b0/10.1177_1177271917715443.PMC5484551.pdf
"https://doi.org/10.1177/1177625017710941 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Gene Regulation and Systems Biology Volume 11: 1–15 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177625017710941 Introduction Increased plasma low-density lipoprotein cholesterol (LDL- C) is a risk factor for major cardiovascular disease.1 Statin  administration can result in significant reductions in cardio-vascular mortality and morbidity.",Non-OADS,/arxiv_data1/oa_pdf/21/58/10.1177_1177625017710941.PMC5484552.pdf
15 https://doi.org/10.1161/CIRCULATIONAHA.116.025253.,Non-OADS,/arxiv_data1/oa_pdf/21/58/10.1177_1177625017710941.PMC5484552.pdf
"MeSH Keywords:  Apoptosis • Connexin 43 • Glioma  Abbreviations:  GBM – glioblastoma multiforme; Cx43  – Connexin43; TMZ – temozolomide; GJIC – gap junction intercel - lular communication  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/905130Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Ophthalmology, China-Japan Union Hospital of Jilin University,  Changchun, Jilin, P.R.",Non-OADS,/arxiv_data1/oa_pdf/48/3e/medscimonit-23-2917.PMC5484555.pdf
"MeSH Keywords:  Cystic Fibrosis • Endoplasmic Reticulum Stress • Hypertension, Renovascular  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902536Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Cardiology, The Second People’s Hospital of Yunnan Province,  Kunming, Yunnan, P.R.",Non-OADS,/arxiv_data1/oa_pdf/f2/86/medscimonit-23-2939.PMC5484556.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 215–224Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  215 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S113382Emerging use of everolimus in the treatment   of neuroendocrine tumors  Pablo Gajate    Olga Martínez-Sáez   T eresa Alonso-Gordoa   Enrique Grande Medical Oncology Department,   Ramon y Cajal University Hospital,  Madrid, SpainAbstract: Neuroendocrine tumors (NETs) consist of a diverse family of malignan- cies, which are derived from neuroendocrine cells, most commonly originating from the   gastroenteropancreatic (GEP) tract or the bronchopulmonary system.",Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
"Colmenar Viejo, km 9100, 28029 Madrid, Spain   Tel/fax +34 91 336 8263   Email pgajate@oncologiahrc.comJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Gajate et alRunning head recto: Everolimus in neuroendocrine tumorsDOI: http://dx.doi.org/10.2147/CMAR.S113382",Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
Available from: https://www.cancer.gov/about-cancer/treatment/drugs/fda-everolimus.,Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 224 Gajate et al  55.,Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
Available from: https://www.xcovery.com/wordpress/wp-content/uploads/Xcovery-Presents-Phase-1-Clinical-Results-at-ASCO.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/88/cmar-9-215.PMC5484559.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1437–1446Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1437 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S130016Cross-cultural adaptation of the German Pain  Solutions Questionnaire: an instrument to  measure assimilative and accommodative coping  in response to chronic pain Robert Sielski1   Julia Anna Glombiewski1  Winfried Rief1  Geert Crombez2  Antonia Barke1 1Department for Clinical Psychology  and Psychotherapy, Philipps- University of Marburg, Marburg,  Germany;  2Faculty of Psychology  and Educational Sciences, Ghent University, Ghent, BelgiumAbstract:  According to the dual process model of coping, assimilative or accommodative  strategies can be applied to deal with aversive life situations.",Non-OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
"5–7Correspondence: Antonia Barke   Department for Clinical Psychology and  Psychotherapy, Philipps-University of Marburg, Gutenbergstraße 18, 35032 Marburg, Germany   Tel +49 6421 282 4045   Fax +49 6421 282 8904   Email abarke@gwdg.deJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Sielski et alRunning head recto: German Pain Solutions QuestionnaireDOI: http://dx.doi.org/10.2147/JPR.S130016",Non-OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
The German version can be downloaded here:  (https://doi.org/10.5281/zenodo.801502).,Non-OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1446 Sielski et al  19.,Non-OADS,/arxiv_data1/oa_pdf/62/4c/jpr-10-1437.PMC5484560.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/10/ijn-12-4509.PMC5484561.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4509–4517International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4509OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13466 1 Photothermal therapy of melanoma tumor using  multiwalled carbon nanotubes Zahra sobhani1,2 Mohammad ali Behnam3  Farzin emami3 amirreza Dehghanian4 Iman Jamhiri5 1Quality control Department,   Faculty of Pharmacy, 2center for  Nanotechnology in Drug Delivery,   Faculty of Pharmacy, shiraz University  of Medical sciences, 3Opto- electronic  research center, electrical and  electronics engineering Department,   shiraz University of T echnology,   4Pathology Department, 5stem cell  T echnology research center, shiraz  University of Medical sciences,   shiraz, IranAbstract:  Photothermal therapy (PTT) is a therapeutic method in which photon energy is  transformed into heat rapidly via different operations to extirpate cancer.",Non-OADS,/arxiv_data1/oa_pdf/5d/10/ijn-12-4509.PMC5484561.pdf
"Therefore,  heat generation based on laser irritation could elevate malignant tissues’ temperature  and destroy tumors.15 Inducing high temperature for a sufficient time causes physical  damage like protein denaturation and membrane lysis and could increase oxidative correspondence: Mohammad ali Behnam  Opto-electronic research center,  electrical and electronics engineering  Department, airport Boulevard, shiraz  University of Technology, shiraz,  71557-13876, Iran  Tel +98 71 3735 3500  Fax +98 71 3735 4514  email m.behnam@sutech.ac.i r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sobhani et al Running head recto: Photothermal therapy of melanoma tumor DOI: http://dx.doi.org/10.2147/IJN.S134661",Non-OADS,/arxiv_data1/oa_pdf/5d/10/ijn-12-4509.PMC5484561.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5d/10/ijn-12-4509.PMC5484561.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/10/ijn-12-4509.PMC5484561.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijn-12-4505.PMC5484562.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4505–4508International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4505EdItorIalopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJN.S14008 3 Editor’s choice: recent research highlights from  the International Journal of Nanomedicine Farooq a Shiekh1 abdul-rahman M  abu-Izzah2 Vivian J lee2 Syed Mudassar1 1department of Clinical Biochemistry,   Sher-I-Kashmir Institute of Medical  Sciences (SKIMS), Srinagar, India;   2department of Basic Medical  Sciences, avalon University School of  Medicine, Curacao, the NetherlandsIs nanomedicine really less harmful?",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijn-12-4505.PMC5484562.pdf
"Importantly, the engineering of such carriers would further enable  researchers to improve their design to form advanced “delivery platforms” that accom - pany an escort intelligent enough to evade destruction and minimize toxicity.9 It is  likely that we will be able to make those smart artificial machines or vehicles at the  nanoscale, which could be used, for example, to develop new types of computers, do  finely targeted drug delivery, or carry out computations inside the body for diagnostic  evaluations with fewer side effects.10Correspondence: Farooq a Shiekh department of Clinical Biochemistry,  Sher-I-Kashmir Institute of Medical  Sciences (SKIMS), Srinagar 190011, India tel +91 194 240 1013 Fax +91 194 240 3470 Email shiekh.fa@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Editorial Y ear: 2017 Volume: 12 Running head verso: Shiekh et al Running head recto: Research highlights from the IJN DOI: http://dx.doi.org/10.2147/IJN.S140083",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijn-12-4505.PMC5484562.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijn-12-4505.PMC5484562.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijn-12-4505.PMC5484562.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/42/74/ijnrd-10-159.PMC5484563.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/42/74/ijnrd-10-159.PMC5484563.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 159–166International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 159 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S130738 Point prevalence of complications between the  Y connection technique and the usual care  technique for blood restitution in patients of an  outpatient hemodialysis unit: a comparison Nadine Tacchini-Jacquier1 Henk Verloo2,3 1Development of Nursing Practices  Unit, Valais Hospital, 2School of Health  sciences, HES-SO Valais – Wallis,   University of Applied Sciences and Arts Western Switzerland;  3Nursing  Department, Valais Hospital, Sion,  SwitzerlandBackground: Central venous catheter-related infections (CVCIs) in patients on maintenance  hemodialysis (HD) have been documented due to unsafe/unsterile manipulations by nurses during  HD machine deconnection and reconnection.",Non-OADS,/arxiv_data1/oa_pdf/42/74/ijnrd-10-159.PMC5484563.pdf
"1–3 The mean age at the  start of therapy was 61 years old (SD=14).1 Among the different etiologies, hereditary  diseases were more frequently documented than vascular nephropathies.2 Valais had  fewer patients on peritoneal dialysis (6% vs 19%) and transplant waiting lists (12% vs Correspondence: Nadine  Tacchini-JacquierDevelopment of Nursing Practices Unit, Valais Hospital, Avenue du Grand-Champsec, 86 CH-1951 Sion, SwitzerlandTel +41 27 603 6752Email nadine.tacchini@hopitalvs.chJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Tacchini-Jacquier and VerlooRunning head recto: Technical device and complications among chronic hemodialysis patientsDOI: http://dx.doi.org/10.2147/IJNRD.S130738",Non-OADS,/arxiv_data1/oa_pdf/42/74/ijnrd-10-159.PMC5484563.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/42/74/ijnrd-10-159.PMC5484563.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 166 Tacchini-Jacquier and Verloo Supplementary material Figure S1 Usual care technique with direct access between tunneled CVC and the  HD machine.,Non-OADS,/arxiv_data1/oa_pdf/42/74/ijnrd-10-159.PMC5484563.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 235–241Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 235 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S140989Simulated interprofessional learning activities   for rural health care services: perceptions   of health care students Selina Taylor1  Yaqoot Fatima1,2  Navaratnam Lakshman1  Helen Roberts1 1Mount Isa Centre for Rural and  Remote Health, James Cook  University, Mount Isa, 2School  of Public Health, University of Queensland, Brisbane, QLD, AustraliaBackground: The literature on interprofessional learning (IPL) has limited empirical evidence  on the impact of simulated IPL sessions in promoting collaborative health care services in rural  settings.",Non-OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
"6 Interprofessional learning (IPL) activities provide  an opportunity to appreciate the differing roles and differing approaches to clinical Correspondence: Yaqoot Fatima   Mount Isa Centre for Rural and Remote  Health, James Cook University, PO Box 2572, 100 Joan Street, Mount Isa, QLD 4825, Australia Tel +61 7 4745 4529   Email yaqoot.fatima@jcu.edu.auJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Taylor et alRunning head recto: Simulated IPL and rural health careDOI: http://dx.doi.org/10.2147/JMDH.S140989",Non-OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 241 Simulated IPL and rural health care  12.,Non-OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
Available from: http://eprints.uwe.ac.uk/7240.,Non-OADS,/arxiv_data1/oa_pdf/49/7c/jmdh-10-235.PMC5484564.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ea/99/ijgm-10-171.PMC5484566.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ea/99/ijgm-10-171.PMC5484566.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 171–175International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 171 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S137614Bacteriotherapy with Streptococcus salivarius  24SMB and Streptococcus oralis 89a nasal spray  for preventing recurrent acute otitis media in children: a real-life clinical experience Ignazio La Mantia Attilio Varricchio Giorgio Ciprandi Associazione Italiana Vie Aeree  Superiori, Naples, ItalyAbstract:  Recurrence of acute otitis media (RAOM) is a relevant issue in the clinical prac- tice.",Non-OADS,/arxiv_data1/oa_pdf/ea/99/ijgm-10-171.PMC5484566.pdf
"International guidelines on AOM management define Correspondence: Giorgio Ciprandi Via Boselli 5, 16146 Genoa, ItalyTel +39 103 533 8120Email gio.cip@libero.itJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: La Mantia et alRunning head recto: Bacteriotherapy with S. salivarius 24SMB and S. oralis 89a DOI: http://dx.doi.org/10.2147/IJGM.S137614",Non-OADS,/arxiv_data1/oa_pdf/ea/99/ijgm-10-171.PMC5484566.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/ea/99/ijgm-10-171.PMC5484566.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 175 Bacteriotherapy with S. salivarius 24SMB and S. oralis 89aReferences  1.,Non-OADS,/arxiv_data1/oa_pdf/ea/99/ijgm-10-171.PMC5484566.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ijn-12-4519.PMC5484567.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4519–4526International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4519OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13315 6 The effects of grafted mesenchymal stem cells  labeled with iron oxide or cobalt-zinc-iron  nanoparticles on the biological macromolecules  of rat brain tissue extracts Bozena Novotna1 Vit herynek2 Pavel rossner Jr1 Karolina T urnovcova3 Pavla Jendelova3 1Department of genetic Toxicology  and Nanotoxicology, Institute of  experimental Medicine as cr, v.v.i.,    2Magnetic resonance Unit,   radiodiagnostic and Interventional  radiology Department, Institute for  clinical and experimental Medicine,   3Department of Tissue culture and  stem cells, Institute of experimental  Medicine as cr, v.v.i., Prague,   czech republicIntroduction:  Rat mesenchymal stem cells (rMSCs) labeled with 1) poly- l-lysine-coated  superparamagnetic iron oxide nanoparticles or 2) silica-coated cobalt-zinc-iron nanoparticles  were implanted into the left brain hemisphere of rats, to assess their effects on the levels of  oxidative damage to biological macromolecules in brain tissue.",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ijn-12-4519.PMC5484567.pdf
"The  application of MRI in vivo requires the use of a safe contrast agent, that is, the achieve - ment of a sufficient level of cell labeling for MRI and, simultaneously, biocompatibility  of the label with stem cells and the host tissue without any side effects on their biological  properties and functions.1 Due to their physicochemical properties, superparamagnetic correspondence: Bozena Novotna Department of genetic Toxicology and  Nanotoxicology, Institute of experimental  Medicine as cr, v.v.i., Videnska 1083,  142 20 Prague 4, czech republic Tel +420 241 062 209 Fax +420 241 062 785 email novotna@biomed.cas.c z Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Novotna et al Running head recto: Oxidative damage in rat brain with magnetically labeled graft DOI: http://dx.doi.org/10.2147/IJN.S133156",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ijn-12-4519.PMC5484567.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ijn-12-4519.PMC5484567.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/45/ijn-12-4519.PMC5484567.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2017:10 133–140Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 133 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S133225 The electrolarynx: voice restoration after   total laryngectomy Rachel Kaye1 Christopher G Tang2 Catherine F Sinclair3 1Department of Otolaryngology,   New Y ork Center for Voice and  Swallowing Disorders, New Y ork,  NY,  2Department of Otolaryngology,   Kaiser Permanente San Francisco Medical Center, San Francisco, CA,   3Department of Otolaryngology,   Mount Sinai Icahn School of Medicine,  New Y ork, NY, USAAbstract:  The ability to speak and communicate with one’ s voice is a unique human char - acteristic and is fundamental to many activities of daily living, such as talking on the phone  and speaking to loved ones.",Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
"1Correspondence: Catherine F Sinclair Department of Otolaryngology, Mount Sinai Icahn School of Medicine, 425 West 59th Street, 10th Floor, New York, NY 10019, USATel +1 212 262 4444Email catherine.sinclair@mountsinai.orgJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Kaye et alRunning head recto: The electrolarynxDOI: http://dx.doi.org/10.2147/MDER.S133225",Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
Addi-tional information can be found in http://www.nu-vois.com/.,Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
Additional information on the product can be obtained at http://www.servona.de/.,Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
31 Additional information on the TruTone  electrolarynx can be found at http://www.griffinlab.com/.,Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
"After the denture is placed in the mouth, the patient has control of the device with a  wireless miniature fingertip switch on a controller.32 Additional infor - mation can be obtained at http://www.ultravoice.com.",Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
Available from:http://www.merriam-webster.,Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
"Medical Devices: Evidence and Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/c1/c9/mder-10-133.PMC5484568.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7e/8e/imcrj-10-209.PMC5484569.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7e/8e/imcrj-10-209.PMC5484569.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 209–212International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 209 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S138398Bilateral herpes zoster in a patient with end-stage  kidney disease T etsu Akimoto Shigeaki Muto Daisuke Nagata Division of Nephrology, Department  of Internal Medicine, Jichi Medical University, Shimotsuke-Shi, T ochigi,  JapanAbstract:  Herpes zoster (HZ) is caused by the reactivation of a latent varicella-zoster virus  (VZV) infection within the cranial or dorsal root ganglia.",Non-OADS,/arxiv_data1/oa_pdf/7e/8e/imcrj-10-209.PMC5484569.pdf
"Laboratory evaluations revealed  Correspondence: Tetsu Akimoto Division of Nephrology, Department of Internal Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-Shi, Tochigi 329-0498, Japan Tel +81 28 558 7346Fax +81 28 544 4869Email tetsu-a@jichi.ac.jpJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Akimoto et alRunning head recto: Herpes zoster and kidney diseaseDOI: http://dx.doi.org/10.2147/IMCRJ.S138398",Non-OADS,/arxiv_data1/oa_pdf/7e/8e/imcrj-10-209.PMC5484569.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/7e/8e/imcrj-10-209.PMC5484569.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 212 Akimoto et al,Non-OADS,/arxiv_data1/oa_pdf/7e/8e/imcrj-10-209.PMC5484569.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/76/ijn-12-4479.PMC5484570.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4479–4491International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4479OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13079 8 α-bisabolol-loaded lipid-core nanocapsules  reduce lipopolysaccharide-induced pulmonary  inflammation in mice ana Paula l D’almeida1,* Maria T Pacheco de  Oliveira1,* Éverton T de souza1 Diego de sá coutinho1 Bianca T ciambarella1 cristiano r gomes1 Thatiana T erroso2 sílvia s guterres2 adriana r Pohlmann3 Patrícia M r silva1 Marco a Martins1 andressa Bernardi1 1laboratory of Inflammation,   Oswaldo cruz Institute, Oswaldo  cruz Foundation, rio de Janeiro,   Brazil; 2Pharmaceutical sciences  Post- graduation Program, college of  Pharmacy, Federal University of rio  grande do sul, Porto alegre, Brazil;   3Department of Organic chemistry,   Institute of chemistry, Federal  University of rio grande do sul,   Porto alegre, Brazil *These authors contributed equally  to this workAbstract:  Acute respiratory distress syndrome (ARDS) is a severe clinical condition of  respiratory failure due to an intense inflammatory response with different etiologies.",Non-OADS,/arxiv_data1/oa_pdf/11/76/ijn-12-4479.PMC5484570.pdf
"Keywords:  acute respiratory distress syndrome, nanotechnology, drug delivery, pulmonary  inflammation, α-bisabolol, anti-inflammatory effects Introduction Acute respiratory distress syndrome (ARDS) is a severe inflammatory lung condition  that is characterized by the damage of the alveolar capillary barrier, leading to extrava - sation of exudate into the airspace, decreased lung compliance, and hypoxemia.1,2  Despite considerable recent advances in the understanding of the mechanism under - lying ARDS pathogenesis, supportive therapies remain the mainstay of treatment of  this disease.3,4 Because of the high mortality rate and its substantial impact on public  health, novel therapeutic approaches for ARDS are badly needed.5 Originally based in popular use by successive generations, traditional medicine  has been a source of pharmacotherapy for millions of people worldwide.6–8 Plants correspondence: andressa Bernardi Fundação Oswaldo cruz, avenida  Brasil 4365, Manguinhos, rio de Janeiro,  21040-360, Brazil email andressa.bernardi@ioc.fiocruz.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: D’Almeida et al Running head recto: Effectiveness of α-bis-LNCs on LPS-induced pulmonary inflammation DOI: http://dx.doi.org/10.2147/IJN.S130798",Non-OADS,/arxiv_data1/oa_pdf/11/76/ijn-12-4479.PMC5484570.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/11/76/ijn-12-4479.PMC5484570.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/76/ijn-12-4479.PMC5484570.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2017:9 73–80Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  73 Original rEsEarch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S133778Diuretic activity of the aqueous crude extract   and hot tea infusion of Moringa stenopetala    (Baker f.) cufod.",Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
"3 Various reports also show the antileshmanial, antitrypanosomal,4,5  antifertility,6 and antidiabetic activities of M. stenopetala.7,8 In particular, people with  high blood pressure boil the leaves and drink the water to get relief from their aliment.9correspondence: netsanet Fekadu Directorate of Traditional and Modern Medicine research, Ethiopian Public health institute, PO Box 1242, addis ababa, Ethiopia Email netsawit@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Fekadu et alRunning head recto: Diuretic activity of Moringa stenopetalaDOI: http://dx.doi.org/10.2147/JEP .S133778",Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
Avail-able from: http://www.worldagroforestry.org/search/node/moringa.,Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
Available from: http://eco-library.theplanetfixer.org/docs/trees/moringa/the-multi-purpose-moringa-tree-in-ethiopia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
"Journal of Experimental Pharmacology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
Available from: http://www.fda.gov/ohrms/dockets/98fr/02d-0492-gdl0002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/48/85/jep-9-073.PMC5484571.pdf
"https://doi.org/10.1177/1176935117716405 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Cancer Informatics Volume 16: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176935117716405 Background MicroRNAs (miRNAs) regulate gene expression by either  repressing translation of messenger RNAs (mRNAs) or by inducing mRNA degradation by complementarity binding of target sequences.",Non-OADS,/arxiv_data1/oa_pdf/be/ff/10.1177_1176935117716405.PMC5484592.pdf
Slattery et al 3 obtained from http://genome.ucsc.edu.,OADS,/arxiv_data1/oa_pdf/be/ff/10.1177_1176935117716405.PMC5484592.pdf
"2,3,14 We identified experimentally validated tar- get gene these miRNAs using miRNA-mRNA pairs from miRTarBase v6.0.11 As our miRNA names are those from  Agilent v19 (corresponding to miRBase v19) and miRTar-Base v6.0 includes newer associations, we determined the new nomenclature for any miRNAs whose names did not match using archived miRBase (http://www.mirbase.org) 20  “miRNA.diff.zip” files.",OADS,/arxiv_data1/oa_pdf/be/ff/10.1177_1176935117716405.PMC5484592.pdf
"As miRTarBase uses findings from many different investigations spanning across years and alignments, we used FASTA sequences generated from both GRCh37 and GRCh38 Homo sapiens alignments, using UCSC Table Browser  (https://genome.ucsc.edu/cgi-bin/hgTables).",OADS,/arxiv_data1/oa_pdf/be/ff/10.1177_1176935117716405.PMC5484592.pdf
"Accessed July 16,  2015. http://genespring-support.com/files/gs_12_6/GeneSpring-manual.pdf.",Non-OADS,/arxiv_data1/oa_pdf/be/ff/10.1177_1176935117716405.PMC5484592.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4493–4504International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4493RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S13463 0 Nanoparticle–allergen complexes for allergen  immunotherapy Gabriella Di Felice1 Paolo Colombo2 1National Center for Drug Research  and evaluation, Istituto Superiore di  Sanità, Rome, 2Institute of Biomedicine  and Molecular Immunology, National  Research Council, Palermo, ItalyAbstract:  Allergen-specific immunotherapy was introduced in clinical settings more than  100 years ago.",Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
"Keywords:  allergy, nanocarriers, immunotoxicity, immune modulation, immunotherapy,  allergens Introduction Allergic disorders are a growing global health problem affecting more than 25% of  populations in industrialized countries,1,2 and there has been a significant worldwide  increase in the prevalence of asthma and allergic rhinitis since 1960.3 Immunologi - cally, allergic subjects manifest a higher frequency of allergen-specific CD4 + Th2  cells secreting IL-4, IL-5, and IL-13 than healthy subjects, leading to the production  of allergen-specific immunoglobulin E (IgE) antibodies.4 Allergen-specific immunotherapy To date, allergen-specific immunotherapy (AIT) has been the only treatment with the  demonstrated capacity to ameliorate allergic symptoms, preventing the onset of new  sensitizations to different allergens, as well as reducing the development of asthma  in patients with allergic rhinitis.5 In particular, clinical trials using different pharmacological combinations and  diverse routes of administration have demonstrated the crucial role of regulatory  T- and B-cells (Treg and Breg, respectively)6,7 and the upregulation of IgG1, IgG4,  IgA antibodies.8 The production of allergen-specific Treg is triggered by IL-109 and  TGF-β10 which are induced during AIT due to the increase of CD25 + CD3+ FOXP3+ Correspondence: Gabriella Di Felice National Center for Drug Research and  evaluation, Istituto Superiore di Sanità,  viale Regina elena 299, 00161 Rome, Italy Tel +39 6 4990 2871 email gabriella.difelice@iss.i t Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Di Felice and Colombo Running head recto: Nanocarriers and allergens DOI: http://dx.doi.org/10.2147/IJN.S134630",Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
"Since its 2006 Reflection  Paper, the European Medicine Agency (EMA) has empha - sized the complexity of nanomedicine properties and the  consequent need to involve specialized experts in their evalu - ation ( http://www.ema.europa.eu/docs/en_GB/document_ library/ Regulatory_and_procedural_guideline /2010/01/ WC500069728.pd f).",Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
"Until now, no specific regulatory documents have been  developed to assess the immunotoxicity of nanomedicines,  which are currently evaluated on the basis of guidelines, such  as the International Council for Harmonisation of Technical  Requirements for Pharmaceuticals for Human Use Safety  Guideline 8 (ICHS8) on immunotoxicity studies for human  pharmaceuticals, which are in force for conventional medicinal  products ( http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2009/09/WC500002851.pd f).",Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
Available from: http://eur-lex.europa.eu/LexUriServ/LexUriSer v.do?,Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/13/ijn-12-4493.PMC5484593.pdf
"MeSH Keywords:  Spinal Cord Injuries • Cell Transplantation • Diffusion Tensor Imaging • Magnetic Resonance Imaging  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902126Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Orthopaedics, Second Affiliated Hospital of Xi’an Jiaotong  University, Xi’an, Shaanxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/80/cc/medscimonit-23-2961.PMC5484594.pdf
"https://doi.org/10.1177/1179558117713016 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights:   Reproductive Health  Volume 11: 1–6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179558117713016 Background Birth control, also known as contraception and fertility control,  is a method or device used to prevent pregnancy.1 Planning,  making available, and use of birth control is called family plan-ning (FP).",Non-OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
http://www.medicinenet.,Non-OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
http://www.who.int/reproductivehealth/topics/family_planning/en/.,Non-OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
http://www.prb.org/pdf08/fpds08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
351.  http://who.int/mediacentre/factsheets/fs351/en/.,Non-OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
http://www.popline.org/node/522993.,Non-OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
"http://apps.who.int/iris/bit - stream/10665/44028/1/9780978856373_eng.pdf, Revised 2011 Update.",OADS,/arxiv_data1/oa_pdf/18/50/10.1177_1179558117713016.PMC5484599.pdf
"MeSH Keywords:  Cyclooxygenase 2 • Immunohistochemistry • rhoA GTP-Binding Protein  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902367Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Gastroenterology, Beijing Luhe Hospital of Capital Medical  University, Beijing, P.R.",Non-OADS,/arxiv_data1/oa_pdf/9d/c5/medscimonit-23-2979.PMC5484605.pdf
"MeSH Keywords:  Coronary Disease • Nicorandil • Percutaneous Coronary Intervention  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902324Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Cardiology, Tianjin Union Medical Center, Tianjin, P.R.",Non-OADS,/arxiv_data1/oa_pdf/72/5f/medscimonit-23-2924.PMC5484606.pdf
"MeSH Keywords:  Biological Markers • Myeloid Cells • Neurogenic Inflammation • Parkinsonian Disorders •  T-Lymphocytes, Helper-Induc  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904240Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Neurosurgery, No.",Non-OADS,/arxiv_data1/oa_pdf/23/3a/medscimonit-23-2972.PMC5484607.pdf
"MeSH Keywords:  Behavior, Addictive • Glioma • Protein Tyrosine Phosphatase, Non-Receptor Type 11  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904381Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical  University, Urumqi, Xinjiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/9b/09/medscimonit-23-2931.PMC5484608.pdf
"ncbi.nih.gov/ , http://www.hprd.org/  FOXO3a, SHP-2 empty plas - mid was designed using FastPCR, Primer 5.0, and other soft - ware.",OADS,/arxiv_data1/oa_pdf/9b/09/medscimonit-23-2931.PMC5484608.pdf
"MeSH Keywords:  Atherosclerosis • Macrophage Activation • Plaque, Atherosclerotic • STAT6 Transcription Factor •   Wnt Signaling Pathway  Full-text PDF:  http://www.basic.medscimonit.com/abstract/index/idArt/904014Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Cardiovascular Internal Medicine, The First Affiliated Hospital of  Xi’an Jiaotong University, Xi’an, Shaanxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/5e/8c/medscimonitbasicres-23-240.PMC5484610.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/64/rru-9-101.PMC5484622.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/64/rru-9-101.PMC5484622.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 101–105Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  101 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S135375Does intraperitoneal injection of propofol  prior to detorsion improve testes weight and  histopathological findings in a rat model?",Non-OADS,/arxiv_data1/oa_pdf/95/64/rru-9-101.PMC5484622.pdf
"5 Therefore, surgical detorsion  should be performed as early as possible.1,6,7 While the mechanism underlying testicular tissue damage during torsion is not com- pletely understood, current studies have demonstrated that the primary pathophysiological event is ischemia followed by reperfusion injury, 1,8,9 which results in the production of abun-Correspondence: Sasan Mehrabi Urology & Nephrology Research Center, Beheshti Hospital, Eram Boulevard, Hamadan 6516757666, IranTel +98 811 838 0704 Fax +98 811 838 0098 Email mehrabi.sasan@yahoo.com Journal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Amirhassani et alRunning head recto: Intraperitoneal injection of propofol prior to detorsion in a rat modelDOI: http://dx.doi.org/10.2147/RRU.S135375",Non-OADS,/arxiv_data1/oa_pdf/95/64/rru-9-101.PMC5484622.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/95/64/rru-9-101.PMC5484622.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 105 Intraperitoneal injection of propofol prior to detorsion in a rat model 4.,Non-OADS,/arxiv_data1/oa_pdf/95/64/rru-9-101.PMC5484622.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/23/45/rru-9-107.PMC5484623.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/23/45/rru-9-107.PMC5484623.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 107–112Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  107 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S134817Surgical intervention for renal cell carcinoma  with inferior vena cava extension combined with  laparoscopic procedure T oshio Kamimura1 Kazutaka Kida1 Masashi Takeda1 Shunsuke Sato1 Masato Fujii1 Masahiro Inoue1 Hiromasa Tsukino1 Shoichiro Mukai1 Atsushi Nanashima2 Kunihide Nakamura2 T oshiyuki Kamoto1 1Department of Urology, Faculty of  Medicine, University of Miyazaki,   Miyazaki, Japan; 2Department  of Surgery, Faculty of Medicine,  University of Miyazaki, Miyazaki, JapanAbstract: Clear cell renal cell carcinoma (ccRCC) shows extreme hypervascularity, which may  cause significant bleeding during surgery.",Non-OADS,/arxiv_data1/oa_pdf/23/45/rru-9-107.PMC5484623.pdf
"6 Therefore, early interception of  arterial Correspondence: Shoichiro Mukai Department of Urology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanEmail syoichiro_mukai@med.miyazaki-u.ac.jpJournal name: Research and Reports in Urology Article Designation: CASE SERIESY ear: 2017V olume: 9Running head verso: Kamimura et alRunning head recto: Surgical intervention for RCC with IVC extensionDOI: http://dx.doi.org/10.2147/RRU.S134817",Non-OADS,/arxiv_data1/oa_pdf/23/45/rru-9-107.PMC5484623.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/23/45/rru-9-107.PMC5484623.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 112 Kamimura et al current case recovered successfully from the perioperative  state; however, careful follow-up is required.",Non-OADS,/arxiv_data1/oa_pdf/23/45/rru-9-107.PMC5484623.pdf
"https://doi.org/10.1177/1176934317715421 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Evolutionary Bioinformatics Volume 13: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176934317715421 Introduction Brassica rapa comprises a variety of vegetables, including Chinese  cabbage (B rapa  ssp pekinensis), which is one of the most highly  consumed vegetables throughout Eastern Asian countries, such as China, Japan, and Korea.",Non-OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"We have developed a Web tool called RapaNet (http://bioinfo.mju.ac.kr/arraynet/brassica300k/query/), which is based on a data set of 143 B rapa microarrays compiled from various organs and at different developmental stages during exposure to biotic or abiotic stress.",OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"In this report, we present the B rapa  Array Network  (RapaNet; http://bioinfo.mju.ac.kr/arraynet/brassica300k/query/), which was constructed using 143 Brassica microarrays based on the Brassica rapa 300k Microarray v2.0.",OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"Development environment RapaNet was constructed using Django (http://www.django-project.com/), a framework for Web application development that adopts an Model-View-Template (MVT) pattern in the Python programming language (http://www.python.org/).",OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"The Database Management System (DBMS) PostgreSQL  (http://www.postgresql.org/), a popular open-source DBMS available for various operating systems, such as Linux, Mac, and Windows, was employed.",OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"Kim et al 3 Apache server, was used as the Apache HTTP server module  (http://www.modpython.org/).",OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"In addition, hierarchical clustering is performed on the nor-malized intensity data using the PyCluster package in Python, and the clustering diagrams are displayed by JAVA TreeView (http://jtreeview.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
"4 Evolutionary Bioinformatics   www.djangoproject.com/), a framework for Web application  development in the Python programming language (http://www.python.org/, Supplementary 2).",Non-OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
PostgreSQL (http://www.postgresql.org/) was used as the DBMS.,OADS,/arxiv_data1/oa_pdf/a8/56/10.1177_1176934317715421.PMC5484627.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tacg-10-037.PMC5484628.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/1e/tacg-10-037.PMC5484628.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2017:10 37–41The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 37 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S139788 Genotype and phenotype correlation in  intracranial hemorrhage in neonatal factor VII  deficiency among Thai children Chanchai Traivaree1 Chalinee Monsereenusorn1 Arunotai  Meekaewkunchorn2 Premsak Laoyookhong3 Saranya Suwansingh4 Boonchai Boonyawat5 1Division of Hematology/Oncology,   Department of Pediatrics,   Phramongkutklao Hospital and College of Medicine,  2Division of  Hematology/Oncology, Department of Pediatrics,  3Division of Neonatology,   Department of Pediatrics, Queen Sirikit National Institute of Child Health, Bangkok,  4Division of  Hematology/Oncology, Department of Pediatrics, Chiangrai Prachanukroh Hospital, Chiang Rai,  5Division of  Genetics, Department of Pediatrics,  Phramongkutklao Hospital and College of Medicine, Bangkok,  ThailandAbstract:  Congenital factor VII (FVII) deficiency is a rare inherited coagulopathy.",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tacg-10-037.PMC5484628.pdf
"Mutations in the F7 gene are also identified and affect the severity of congenital FVII deficiency with ICH.Correspondence: Chanchai Traivaree Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, Bangkok 10400, ThailandTel/fax +66 2 644 4130Email ctrivaree@yahoo.comJournal name: The Application of Clinical Genetics Article Designation: CASE SERIESY ear: 2017V olume: 10Running head verso: Traivaree et alRunning head recto: Effect of genetic information on congenital FVII deficiency with ICHDOI: http://dx.doi.org/10.2147/TACG.S139788",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tacg-10-037.PMC5484628.pdf
"The Application of Clinical Genetics 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tacg-10-037.PMC5484628.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 41 Effect of genetic information on congenital FVII deficiency with ICH  2.,Non-OADS,/arxiv_data1/oa_pdf/0d/1e/tacg-10-037.PMC5484628.pdf
"http://immunenetwork.org 133pISSN 1598-2629 · eISSN 2092-6685 The Role of Lipids in Development of Allergic Responses Manuel Gómez del Moral1 and Eduardo Martínez-Naves2* Departments of 1Cell Biology, 2Microbiology and Immunology, Complutense University School of Medicine, Madrid 28040, Spainhttps://doi.org/10.4110/in.2017.17.3.133REVIEW ARTICLE INTRODUCTION Allergies are a group of complex diseases characterized  by an abnormal immune response or hypersensitivity to  foreign but harmless substances or antigens called al- lergens.",Non-OADS,/arxiv_data1/oa_pdf/a2/e3/in-17-133.PMC5484643.pdf
Lipids in Allergy http://immunenetwork.org 135which results in up-regulation of CD1d molecule on their  cell surface and the subsequent activation of NKT cells  (58).,Non-OADS,/arxiv_data1/oa_pdf/a2/e3/in-17-133.PMC5484643.pdf
"Lipids in Allergy http://immunenetwork.org 137pOlleN assOCIa TeD lIpIDs meDIa TORs (palms)  When exposed to water, pollen grains are able to release a  number of lipids named pollen-associated lipid mediators  (PALMs) which are homologous to eicosanoids, and that  can act as adjuvants enhancing the inflammatory respons- es (Table II) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/a2/e3/in-17-133.PMC5484643.pdf
Lipids in Allergy http://immunenetwork.org 139lIpIDs may INflUeNCe The INTeRaCTIONs be- TweeN pOTeNTIal alleRgeNs aND The epIThe-lIal baRRIeR Of RespIRa TORy aND INTesTINal  mUCOsa  Lipids can interfere the relationship between the epithe - lium barrier and the potential allergenic proteins in a wide  variety of forms (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a2/e3/in-17-133.PMC5484643.pdf
Lipids in Allergy http://immunenetwork.org 14130.,Non-OADS,/arxiv_data1/oa_pdf/a2/e3/in-17-133.PMC5484643.pdf
Lipids in Allergy http://immunenetwork.org 14374.,Non-OADS,/arxiv_data1/oa_pdf/a2/e3/in-17-133.PMC5484643.pdf
"144pISSN 1598-2629 · eISSN 2092-6685 TLR/MyD88-mediated Innate Immunity in Intestinal  Graft-versus-Host Disease Young-Kwan Lee1, Myungsoo Kang2 and Eun Young Choi1,2* 1Department of Biomedical Sciences and 2BioMembrane Plasticity Research Center (MPRC), Seoul National University College of  Medicine, Seoul 03080, Koreahttps://doi.org/10.4110/in.2017.17.3.144REVIEW ARTICLE INTRODUCTION Allogeneic (allo) hematopoietic stem cell transplantation  (HSCT) is an effective treatment for hematological disor - ders, including lymphoma and leukemia (1-4).",Non-OADS,/arxiv_data1/oa_pdf/58/ff/in-17-144.PMC5484644.pdf
TLR/MyD88 Signaling in Intestinal GVHD http://immunenetwork.org 145TLR/MyD88-mediated innate immunity in acute intesti- nal GVHD.,Non-OADS,/arxiv_data1/oa_pdf/58/ff/in-17-144.PMC5484644.pdf
TLR/MyD88 Signaling in Intestinal GVHD http://immunenetwork.org 147ed acute GVHD severity (29).,Non-OADS,/arxiv_data1/oa_pdf/58/ff/in-17-144.PMC5484644.pdf
TLR/MyD88 Signaling in Intestinal GVHD http://immunenetwork.org 1496.,Non-OADS,/arxiv_data1/oa_pdf/58/ff/in-17-144.PMC5484644.pdf
TLR/MyD88 Signaling in Intestinal GVHD http://immunenetwork.org 1512016.,Non-OADS,/arxiv_data1/oa_pdf/58/ff/in-17-144.PMC5484644.pdf
"152pISSN 1598-2629 · eISSN 2092-6685 Dendritic Cell Dysfunction in Patients with End-stage  Renal Disease Ji Ung Kim1, Miyeon Kim1, Sinae Kim2,3, Tam Thanh Nguyen2,3, Eunhye Kim2,3, Siyoung Lee2,4,  Soohyun Kim2,3,5* and Hyunwoo Kim1* 1Division of Nephrology, Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of  Medicine, Jeju 63241, 2Laboratory of Cytokine Immunology, Department of Biomedical Science and Technology, 3College of Veterinary  Medicine, Konkuk University, Seoul 05029, 4YbdYbiotech research center, Seoul 08589, 5College of Veterinary Medicine, Veterinary  Science Research Institute, Konkuk University, Seoul 05029, Koreahttps://doi.org/10.4110/in.2017.17.3.152REVIEW ARTICLE INTRODUCTION Chronic kidney disease (CKD) is defined by a reduced  glomerular filtration rate (GFR) and/or the presence of pathological damage or markers of kidney damage such  as proteinuria or hematuria for more than 3 months (1).",Non-OADS,/arxiv_data1/oa_pdf/01/bc/in-17-152.PMC5484645.pdf
Dendritic Cell Dysfunction in End-stage Renal Disease http://immunenetwork.org 153to meet the needs of daily life.,Non-OADS,/arxiv_data1/oa_pdf/01/bc/in-17-152.PMC5484645.pdf
"Dendritic Cell Dysfunction in End-stage Renal Disease http://immunenetwork.org 155able to stimulate T cells than those from healthy controls,  owing to a decreased expression of the pivotal costimula-tory molecules (13,19,20).",Non-OADS,/arxiv_data1/oa_pdf/01/bc/in-17-152.PMC5484645.pdf
Dendritic Cell Dysfunction in End-stage Renal Disease http://immunenetwork.org 157mal myeloid and plasmacytoid DCs.,Non-OADS,/arxiv_data1/oa_pdf/01/bc/in-17-152.PMC5484645.pdf
Dendritic Cell Dysfunction in End-stage Renal Disease http://immunenetwork.org 159HBV Ab concentration in patients who were pre-dialysis  or undergoing HD or PD (90).,Non-OADS,/arxiv_data1/oa_pdf/01/bc/in-17-152.PMC5484645.pdf
Dendritic Cell Dysfunction in End-stage Renal Disease http://immunenetwork.org 161Vaziri.,Non-OADS,/arxiv_data1/oa_pdf/01/bc/in-17-152.PMC5484645.pdf
"http://immunenetwork.org 163pISSN 1598-2629 · eISSN 2092-6685 Clonal Expansion of Allergen-specific CD4+ T Cell in the  Lung in the Absence of Lymph Nodes Garam Choi1,2, Byung-Seok Kim1,2, Young-Jun Park1, Inbo Shim1 and Yeonseok Chung1,2 1Laboratory of Immune Regulation, Research Institute of Pharmaceutical Sciences, 2BK21 Plus Program, College of Pharmacy, Seoul  National University, Seoul 08826, Koreahttps://doi.org/10.4110/in.2017.17.3.163ORIGINAL ARTICLE INTRODUCTION T cell clonal expansion is an explosive increase of  antigen-specific T cells which are essential for efficient  adaptive immunity against invading foreign antigens (1,2).",Non-OADS,/arxiv_data1/oa_pdf/47/40/in-17-163.PMC5484646.pdf
"Clonal Expansion of CD4+ T Cells in the Lung http://immunenetwork.org 165flow cytometry For the flow cytometry analysis, cells were stained with  PE-Cyanine7-conjugated anti-mouse CD4 (RM4-5), Per - CP/Cy5.5-conjugated anti-mouse CD45.2 (104), Pacific Blue-conjugated anti-mouse CD45.1 (A20) and APC- conjugated anti-mouse TCR V a2 (B20.1).",Non-OADS,/arxiv_data1/oa_pdf/47/40/in-17-163.PMC5484646.pdf
Clonal Expansion of CD4+ T Cells in the Lung http://immunenetwork.org 167analysis of allergen-specific T cell proliferation to intra- nasal allergen.,Non-OADS,/arxiv_data1/oa_pdf/47/40/in-17-163.PMC5484646.pdf
"Clonal Expansion of CD4+ T Cells in the Lung http://immunenetwork.org 169providing signal 1, 2 and 3.",Non-OADS,/arxiv_data1/oa_pdf/47/40/in-17-163.PMC5484646.pdf
"http://immunenetwork.org 171pISSN 1598-2629 · eISSN 2092-6685 Effects of Cellular 11 b-hydroxysteroid Dehydrogenase 1  on LPS-induced Inflammatory Responses in Synovial Cell  Line, SW982 Young Sik Cho1*, Ki Nam Kim1 and Jung Hyun Shim2  1Department of Pharmacy, Keimyung University, Daegu 42601, 2Department of Pharmacy, College of Pharmacy, Mokpo National  University, Mokpo 58554, Koreahttps://doi.org/10.4110/in.2017.17.3.171ORIGINAL ARTICLE INTRODUCTION Cortisol is a glucocorticoid hormone (GH) mainly pro - duced in the adrenal gland and is tightly regulated via the  hypothalamic-pituitary-adrenal (HPA) axis (1).",Non-OADS,/arxiv_data1/oa_pdf/8e/84/in-17-171.PMC5484647.pdf
Intracellular Conversion of Cortisone into Cortisol Downregulates LPS-stimulated Inflammatory Responses http://immunenetwork.org 173Detection of inflammatory cytokines induced by lps stimu- lation SW982 cells were stimulated with LPS and then the level  of its downstream inflammatory cytokines were moni- tored and correlated with the levels of 11 b-HSD1 expres- sion.,OADS,/arxiv_data1/oa_pdf/8e/84/in-17-171.PMC5484647.pdf
"Intracellular Conversion of Cortisone into Cortisol Downregulates LPS-stimulated Inflammatory Responses http://immunenetwork.org 175effect of cellular 11 b-hsD1 activity on lps-stimulated in- flammatory responses As mentioned previously, expression levels of cytokines  after treatment of cells with LPS were preliminarily  evaluated by RT-PCR (Fig.",OADS,/arxiv_data1/oa_pdf/8e/84/in-17-171.PMC5484647.pdf
Intracellular Conversion of Cortisone into Cortisol Downregulates LPS-stimulated Inflammatory Responses http://immunenetwork.org 177RefeReNCes 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/84/in-17-171.PMC5484647.pdf
"http://immunenetwork.org 179pISSN 1598-2629 · eISSN 2092-6685 Diclofenac Inhibits 27-hydroxycholesterol-induced  Differentiation of Monocytic Cells into Mature Dendritic  Cells Yonghae Son1,3, Bo-Young Kim1, Young Chul Park2 and Koanhoi Kim1* Departments of 1Pharmacology, 2Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612,   3Institute of Marine BioTechnology, Pusan National University, Busan 46241, Koreahttps://doi.org/10.4110/in.2017.17.3.179ORIGINAL ARTICLE INTRODUCTION Dendritic cells (DCs) are responsible for the initiation of  antigen-specific immune responses.",Non-OADS,/arxiv_data1/oa_pdf/10/cc/in-17-179.PMC5484648.pdf
"Diclofenac Inhibits Oxysterol-induced DC Differentiation http://immunenetwork.org 18119.0% to 5.7% in the presence of 27OHChol; however,  the reduced activity was restored to 11.6%, 16.5%, and  18.8% by treatment with 5, 10, and 25 mg/ml diclofenac,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/10/cc/in-17-179.PMC5484648.pdf
"Diclofenac Inhibits Oxysterol-induced DC Differentiation http://immunenetwork.org 183examined whether diclofenac affected the expression of  CD197, a homing molecule, by flow cytometry (Fig.",Non-OADS,/arxiv_data1/oa_pdf/10/cc/in-17-179.PMC5484648.pdf
Diclofenac Inhibits Oxysterol-induced DC Differentiation http://immunenetwork.org 185dendritic cells.,Non-OADS,/arxiv_data1/oa_pdf/10/cc/in-17-179.PMC5484648.pdf
"186pISSN 1598-2629 · eISSN 2092-6685 Moderate Exercise Enhances the Production of Interferon-γ  and Interleukin-12 in Peripheral Blood Mononuclear Cells Alireza Zamani1,2, Iraj Salehi3,4 and Mahdi Alahgholi-Hajibehzad1,2* 1Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, 2Molecular Immunology Research Group,  Research Center for Molecular Medicine, Hamadan University of Medical Sciences, 3Research Center for Molecular Medicine, Hamadan  University of Medical Sciences, 4Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan 6517838736, Iranhttps://doi.org/10.4110/in.2017.17.3.186BRIEF COMMUNICATION INTRODUCTION The two major arms of the immune system are interferon  (IFN)-g producing T helper 1 (Th1) and interleukin (IL)-4  producing Th2 cells (1).",Non-OADS,/arxiv_data1/oa_pdf/a8/b3/in-17-186.PMC5484649.pdf
Moderate Exercise and Cytokine http://immunenetwork.org 187tokine response.,Non-OADS,/arxiv_data1/oa_pdf/a8/b3/in-17-186.PMC5484649.pdf
"Moderate Exercise and Cytokine http://immunenetwork.org 189samples (93±18.3 vs. 49.7±7.04, p=0.01).",Non-OADS,/arxiv_data1/oa_pdf/a8/b3/in-17-186.PMC5484649.pdf
Moderate Exercise and Cytokine http://immunenetwork.org 191and B. K. Pedersen.,Non-OADS,/arxiv_data1/oa_pdf/a8/b3/in-17-186.PMC5484649.pdf
"192pISSN 1598-2629 · eISSN 2092-6685 Exacerbation of Japanese Encephalitis by CD11chi  Dendritic Cell Ablation Is Associated with an Imbalance in  Regulatory Foxp3+ and IL-17+CD4+ Th17 Cells and in   Ly-6Chi and Ly-6Clo Monocytes Jin Young Choi1, Jin Hyoung Kim1, Ajit Mahadev Patil1, Seong Bum Kim1, Erdenebelig Uyangaa1,  Ferdaus Mohd Altaf Hossain1 and Seong Kug Eo1,2* 1College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, 2Department of Bioactive  Material Sciences, Graduate School, Chonbuk National University, Jeonju 54896, Koreahttps://doi.org/10.4110/in.2017.17.3.192BRIEF COMMUNICATION Received on February 27, 2017.",Non-OADS,/arxiv_data1/oa_pdf/6f/9e/in-17-192.PMC5484650.pdf
"Treg/Th17 and Ly-6Chi/Ly-6Clo Cell Regulation by CD11chi DCs http://immunenetwork.org 193INTRODUCTION Mosquito-borne flaviviruses, including Japanese en- cephalitis (JE), West Nile (WN), and Zika viruses, are  major current and emerging threats to millions of people  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/6f/9e/in-17-192.PMC5484650.pdf
maTeRIals aND meThODs ethics statement All animal experiments described in the present study  were conducted at Chonbuk National University accord- ing to the guidelines set by the Institutional Animal Care  and Use Committees (IACUC) of Chonbuk National Uni- versity (http://lac.honamlife.com/research/research_05.,Non-OADS,/arxiv_data1/oa_pdf/6f/9e/in-17-192.PMC5484650.pdf
Treg/Th17 and Ly-6Chi/Ly-6Clo Cell Regulation by CD11chi DCs http://immunenetwork.org 195tion of the target was confirmed by a melting curve analy- sis.,Non-OADS,/arxiv_data1/oa_pdf/6f/9e/in-17-192.PMC5484650.pdf
Treg/Th17 and Ly-6Chi/Ly-6Clo Cell Regulation by CD11chi DCs http://immunenetwork.org 197CD11c-DTR mice (Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/9e/in-17-192.PMC5484650.pdf
Treg/Th17 and Ly-6Chi/Ly-6Clo Cell Regulation by CD11chi DCs http://immunenetwork.org 199RefeReNCes 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/9e/in-17-192.PMC5484650.pdf
"TaqMan primers available from ABI were used for amplicon detection (see Supplementary Digital Content 1, http://links.lww.com/ MENO/A216 for sequences of primers used for quantitative polymerase chain reaction [qPCR]).",OADS,/arxiv_data1/oa_pdf/35/ab/menop-24-838.PMC5484719.pdf
"Specificity of GFP-immunostaining is illustrated in Supplemental Digital Content 2, http://links.lww.com/ MENO/A217 in which sections of the injured vaginal wall 3 hours after injection of GFP-labeled MSCs were developed with primary antibody for GFP or PBS.",Non-OADS,/arxiv_data1/oa_pdf/35/ab/menop-24-838.PMC5484719.pdf
"Furthermore, estrogen-induced modest increases in epithelial thickness of the uninjured anterior vaginal wall at both 1 and 3 week time points (see Supplementary Digital Content 3, http://links.lww.com/MENO/A218 in which epithelial thickness was quantified in ovariectomized rats treated with placebo cream þplacebo injection vs estrogen creamþplacebo injection 1 and 3 weeks after injury).",Non-OADS,/arxiv_data1/oa_pdf/35/ab/menop-24-838.PMC5484719.pdf
Multidimensional scaling of healthy control and Crohn’s patient microbiome samples from the Lewiset al 14study with bio2mds (https://CRAN.R-project.org/ package = bios2mds) established a high-dimensional space into which longitudinal data from this study were projected using the method of Abdi.23The Bray-Curtis distance between microbiome samples was calculated using vegan(https://CRAN.R-project.org/package = vegan).,OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"MICROBIOME Metagenomic sequencing of DNA extracted from stool for 9 of the 12 patients identiﬁed 201 bacterial species in 28 longitudinal samples (Table S1A, SupplementalDigital Content 1, http://links.lww.com/JCG/A297).",OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"Spe-cies that increased, or decreased, in relative abundance from baseline by >0.5% at the 2-week follow-up are tabulated by patient in Table S1B, Supplemental DigitalContent 2, http://links.lww.com/JCG/A297.",Non-OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"Shannon diversity is shown in Table S1C, Supplemental Digital Content 3, http://links.lww.com/JCG/A297.",OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"Change in bacterial genera ( > 0.5%) at the 2-week timepoint are shown in Table S1D, Supplemental Digital Content 4, http://links.lww.com/JCG/A297.",OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"Median relative abun- dance of genera and proportions is shown in Table S1E, Supplemental Digital Content 5, http://links.lww.com/JCG/A297.",OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"Bacteroides andParabacteroides had the largest decrease in median abundance and Eubacterium ,Rumi- noccocus , and Subdoligranulum had the largest increase (Table S1E, Supplemental Digital Content 6, http://link-s.lww.com/JCG/A297).",OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
"Changes in phylum abundance are shown in Table S1F, Supplemental Digital Content 7, http://links.lww.com/JCG/A297.",OADS,/arxiv_data1/oa_pdf/b3/fb/mcg-52-155.PMC5484760.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/d5/main.PMC5484779.pdf
E-mail address: daxer@gutsehen.at http://dx.doi.org/10.1016/j.optom.2016.06.003 1888-4296/© 2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/fa/d5/main.PMC5484779.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/d5/main.PMC5484779.pdf
Este  es  un art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/d5/main.PMC5484779.pdf
"2016,  http://dx.doi.org/ 10.1016/j.optom.2016.01.002 .",OADS,/arxiv_data1/oa_pdf/fa/d5/main.PMC5484779.pdf
http://dx.doi.org/10.1016/j.optom.2016.08.002 1888-4296/© 2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/14/7c/main.PMC5484780.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/7c/main.PMC5484780.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/7c/main.PMC5484780.pdf
Este  es  un art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/7c/main.PMC5484780.pdf
"Supplementary  data Supplementary data  associated  with  this  article  can  be found, in  the  online  version,  at  http://dx.doi.org/10.1016/ j.optom.2016.08.002 .",OADS,/arxiv_data1/oa_pdf/14/7c/main.PMC5484780.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/73/main.PMC5484781.pdf
http://dx.doi.org/10.1016/j.optom.2016.07.003 1888-4296/© 2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/79/73/main.PMC5484781.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/73/main.PMC5484781.pdf
Este  es  un art´ıculo Open Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/73/main.PMC5484781.pdf
Available  from:  http://handbook.cochrane.org/ chapter  9/9  4  11  use  of  vote  counting  for  meta  analysis.htm [cited  15.08.16].,OADS,/arxiv_data1/oa_pdf/f0/e7/main.PMC5484782.pdf
http://dx.doi.org/10.1016/j.optom.2016.11.004 1888-4296/ ©  2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/f0/e7/main.PMC5484782.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/e7/main.PMC5484782.pdf
"refer  to  ‘‘the  CASP  checklist’’,  but  in fact there are eight  CASP  critical  appraisal  tools  for  dif- ferent types  of  study.3These  include  CASP  checklists  for DOI  of  original  articles: http://dx.doi.org/10.1016/j.optom.2016.11.004randomised  controlled  trials,  case  control  trials,  and  cohort studies and  so  were  well  suited  to  our  task  of  reviewing  a heterogeneous literature.",Non-OADS,/arxiv_data1/oa_pdf/f0/e7/main.PMC5484782.pdf
"http://dx.doi.org/10.1016/j.optom.2017.05.001 1888-4296/ © 2017  Published by Elsevier  Espa˜na,  S.L.U.",Non-OADS,/arxiv_data1/oa_pdf/f0/e7/main.PMC5484782.pdf
This  is  an  open  access  article  under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/e7/main.PMC5484782.pdf
http://dx.doi.org/10.1016/j.optom.2017.05.002 1888-4296/©  2017  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/c0/cd/main.PMC5484783.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/cd/main.PMC5484783.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/c7/main.PMC5484784.pdf
http://dx.doi.org/10.1016/j.optom.2016.10.001 1888-4296/© 2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/46/c7/main.PMC5484784.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/c7/main.PMC5484784.pdf
Este  es  un art´ıculo Open Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/c7/main.PMC5484784.pdf
http://dx.doi.org/10.1111/cxo.12496 .,Non-OADS,/arxiv_data1/oa_pdf/46/c7/main.PMC5484784.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/49/main.PMC5484785.pdf
http://dx.doi.org/10.1016/j.optom.2016.09.001 1888-4296/© 2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/76/49/main.PMC5484785.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/49/main.PMC5484785.pdf
Este  es  un art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/49/main.PMC5484785.pdf
"Furthermore,  the  authors  appear  to  have ‘cherry-picked’ the  domains  of  bias  used  for  each  system; DOI of  original  article: http://dx.doi.org/10.1016/j.optom.2017.05.001the  domains  of  bias  listed  in  Table  2  which  evaluate  studies of Intuitive  Overlays  are  different  to  those  listed  in  Table  3 which they  used  to  evaluate  studies  involving  the  Intuitive Colorimeter.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/main.PMC5484786.pdf
Available  from:  http://handbook.cochrane.org/ chapter  9/9  4  11  use  of  vote  counting  for  meta  analysis.htm [cited  15.08.16].,OADS,/arxiv_data1/oa_pdf/8a/43/main.PMC5484786.pdf
http://dx.doi.org/10.1016/j.optom.2016.11.004 1888-4296/ ©  2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/8a/43/main.PMC5484786.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/43/main.PMC5484786.pdf
"refer  to  ‘‘the  CASP  checklist’’,  but  in fact there are eight  CASP  critical  appraisal  tools  for  dif- ferent types  of  study.3These  include  CASP  checklists  for DOI  of  original  articles: http://dx.doi.org/10.1016/j.optom.2016.11.004randomised  controlled  trials,  case  control  trials,  and  cohort studies and  so  were  well  suited  to  our  task  of  reviewing  a heterogeneous literature.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/main.PMC5484786.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/24/main.PMC5484787.pdf
http://dx.doi.org/10.1016/j.optom.2016.10.003 1888-4296/© 2016  Spanish  General  Council  of  Optometry.,Non-OADS,/arxiv_data1/oa_pdf/12/24/main.PMC5484787.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/24/main.PMC5484787.pdf
Este  es  un art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/24/main.PMC5484787.pdf
Available  at  http://arxiv.org/ftp/arxiv/ papers/1208/1208.6109.pdf  Accessed  07.07.15.,Non-OADS,/arxiv_data1/oa_pdf/12/24/main.PMC5484787.pdf
"24Guidelines for Drinking-Water Quality , World Health Organization, 4th edn, 2011, also available at http://www.who.int/water_sanitation_health/publications/2011/dwq_guidelines/en/, accessed March 2014.",Non-OADS,/arxiv_data1/oa_pdf/28/d7/SC-006-C4SC02618G.PMC5484789.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9a/ad/main.PMC5484965.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.03.013 288,OADS,/arxiv_data1/oa_pdf/9a/ad/main.PMC5484965.pdf
e00327 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
"However, the studies which demonstrated factors that may Article No~e00327 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
"The offspring that were born from dam received LPS are termed the maternal LPSgroup, and the offspring that were born from the sham group were termed the Article No~e00327 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
"Values are mean ± SE, *; P<0.05 Article No~e00327 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
"It is reported that allergic rhinitis patients had higher serum levels of leptin and lower serum levels of adiponectin than control, and both of them were Article No~e00327 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
doi:http://dx.doi.org/10.1111/j.1399-3038.2009.00878.x[doi] .,OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Role of MAPK phosphatase-1 in the induction of monocyte Article No~e00327 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
Article No~e00327 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00327 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/main.PMC5484967.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/f7/main.PMC5484968.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.026 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/f8/f7/main.PMC5484968.pdf
"All analyses were conducted with JMP version 11.0 (SAS Inc., Cary, NC) and EZR ([Saitama Medical Center, Jichi Medical University; http://www.jichi.ac.jp/saitama-sct/ SaitamaHP.",OADS,/arxiv_data1/oa_pdf/f8/f7/main.PMC5484968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/60/main.PMC5484969.pdf
http://dx.doi.org/10.1016/j.jare.2017.03.001 2090-1232/ /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.,Non-OADS,/arxiv_data1/oa_pdf/f0/60/main.PMC5484969.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of Cairo University.,Non-OADS,/arxiv_data1/oa_pdf/f0/60/main.PMC5484969.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/36/main.PMC5484971.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.08.005 .,OADS,/arxiv_data1/oa_pdf/75/36/main.PMC5484971.pdf
E-mail address: Jlynch6@hfhs.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.08.005 2352-3441/ ©2016 Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/75/36/main.PMC5484971.pdf
This is an open access article under the CC BY-NC-ND lice nse (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 119 e124,Non-OADS,/arxiv_data1/oa_pdf/75/36/main.PMC5484971.pdf
"Interestingly, 4 out of 7 (57%) patients, showing an improvement in FD-related clinical status after starting home http://dx.doi.org/10.1016/j.ymgmr.2017.06.005 Received 22 February 2017; Received in revised form 14 June 2017; Accepted 14 June 2017⁎Corresponding author at: Department Medical and Surgical Science, Pediatric Unit, University “Magna Graecia ”of Catanzaro, “Pugliese-Ciaccio ”Hospital, Viale Pio X, 88100 Catanzaro, Italy.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"105 (1999) 151 –156, http://dx.doi.org/10.1007/ s004399900075 .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"Carrey, Prevalence of lysosomal sto- rage disorders, JAMA 281 (1999) 249 –254, http://dx.doi.org/10.1001/jama.281.3.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"79 (2006) 31 –40,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"43 (3) (2006) 347 –352, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"[5] S. Gupta, M. Ries, S. Kotsopoulos, R. Schi ﬀmann, The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically a ﬀected heterozygous women, Medicine (Baltimore) 84 (5) (2005) 261 –268, http://dx.doi.org/10.1097/01.md.0000178976.62537.6b .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"24 (7) (2001) 715 –724, http://dx.doi.org/10.1023/A:1012993305223 .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"168 (11) (2009) 1355 –1363, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"95 (1) (2006) 86 –92,http://dx.doi.org/10.1111/j.1651-2227.2006.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"162 (11) (2003) 767 –772, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"93 (2008) 112 –128, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"24 (2009) 2102 –2111, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"Germain, Fabry disease: a review of current management strategies, QJM 103 (2010) 641 –659, http://dx.doi.org/10.1093/qjmed/hcq117 .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"5 (2011) 155 –173, http://dx.doi.org/10.2147/DDDT.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"Rep. 5 (3) (2015)21–27,http://dx.doi.org/10.1016/j.ymgmr.2015.02.002 .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"15 (6) (2006)330–333, http://dx.doi.org/10.12968/bjon.2006.15.6.20681 .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"16 (22) (2007) 1386 –13891384, http://dx.doi.org/10.12968/bjon.2007.",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
"65 (4) (2004) 299 –307, http://dx.doi.org/10.1111/j.1399-0004.2004.00219.x .",Non-OADS,/arxiv_data1/oa_pdf/84/07/main.PMC5484973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bd/main.PMC5484974.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.07.002 .,OADS,/arxiv_data1/oa_pdf/e8/bd/main.PMC5484974.pdf
E-mail address: frederic.picard@gjnh.scot.nhs.uk Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.07.002 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/bd/main.PMC5484974.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 111 e117,Non-OADS,/arxiv_data1/oa_pdf/e8/bd/main.PMC5484974.pdf
e00328 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"All patients (N = 61802) Sum Males (N = 23928) Sum Females (N = 37874) Sum New cancer (N = 441) Recurrent cancer (N = 70) Symptoms Cancer PPVcNo cancerCancer PPVcNo cancerCancer PPVcNo cancerAbdominal Non-ab- dominalAdominal Non-ab- dominal N = 511 (0.8b)N= 61291N = 231 (1.0b)N= 23697N = 280 (0.7b)N= 37594N = 251 N = 190 N = 43 N = 27 Abdominal symptoms Abdominal pain, upper part45 2.1 2053 2098 23 3.1 722 745 22 1.6 1331 1353 34 8 2 1 Abdominal pain, lower part37 1.7 2101 2138 17 2.5 658 675 20 1.4 1443 1463 25 8 3 1 Constipation 22 3.1 679 701 10 4.6 208 218 12 2.5 471 483 19 2 1 0 Diarrhea 16 1.4 1107 1123 7 1.6 429 436 9 1.3 678 687 9 4 3 0 Distended abdomen, bloating27 2.6 1016 1043 14 3.8 353 367 13 1.9 663 676 21 4 2 0 Increased belching, flat- ulence17 3.4 489 506 12 6.4 176 188 5 1.6 313 318 11 4 2 0 Acid regurgitation 14 2.0 673 687 7 2.9 235 242 7 1.6 438 445 12 1 1 0 Rectal bleeding 18 4.4 387 405 4 2.6 147 151 14 5.5 240 254 16 0 1 1Unexpected genital blee- ding a4 2.0 195 199 0 12 12 4 2.1 183 187 3 0 1 0 Haematuria, macroscop- ic7 4.7 143 150 5 6.1 77 82 2 2.9 66 68 7 0 0 0 Increased urinary fre- quency14 1.9 737 751 9 3.6 244 253 5 1.0 493 498 12 2 0 0 Other abdominal pro- blems34 2.9 1123 1157 20 4.8 397 417 14 1.9 726 740 20 7 3 4 One symptom only 66 1.9 3374 3440 29 2.3 1215 1244 37 1.7 2159 2196 44 13 6 3 (Continued ) Article No~e00328 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"In order to assess the effect of possible variation in GP symptom recording, conditional logistic regression was performed with statistical stratification for the Article No~e00328 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"N% Single actions Lab tests only 1350 X-ray/imaging 174 Referral/hospitalisation 698 Follow-up appointment with GP 643 Sum 2865 45.7 Combination of 2 actions Lab tests + X-ray/imaging 193 Lab tests + Referral/hospitalisation 339 Lab tests +Follow up appointment with GP 685X-ray/imaging + Referral/hospitalisation 23 X-ray/imaging + Follow up appointment with GP 43 Referral/hospitalisation+ Follow up appointment with GP 44 Sum 1327 21.2 Combination of 3 actions Lab tests + X-ray/imaging + Referral/Hospitalisation 46 Lab tests + X-ray/imaging + Follow up appointment with GP 137 Lab tests + Referral/hospitalisation + Follow up appointment with GP 65X-ray/imaging + Referral/hospitalisation + Follow up appointment with GP 7 Sum 255 4.1 All 4 actions Lab tests + X-ray/imaging + Referral/hospitalisation + Follow up appointment with GP 30 0.5 Sum, number of patients with actions recorded 4477 71.5 Patients with recordings that they had none of these actions 1521 24.3 Patients with missing data 266 4.2 Total, patients with any abdominal symptom 6264 100 Article No~e00328 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"Discussion within the context of the literature Failure to appropriately suspect cancer may result from an insufficient medicalhistory, lack of a focused clinical examination, inappropriate supplementarytesting or follow-up of positive tests [1], but also from lack of consideration of contextual data related to the patient and the patient environment [12].Aw e l l - recognised doctor ’s cognitive fallacy is to stop gathering new data after reaching a diagnosis and thus neglecting other possibilities, or to make symptoms fit a prototypical context or frame, missing atypical variants [14].T h eG P s ’reporting of intuition as an important basis for suspecting cancer, may be rooted in an Article No~e00328 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"Fortunately, many components of the diagnostic process contribute constructively Article No~e00328 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"We find many similarities in the nature of generalpractice consultations across the six included countries, even if the respective Article No~e00328 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Oslo: Cancer Registry of Norway 2016. https://www.kreftregisteret.no/Generelt/Publikasjoner/Cancer- in-Norway/cancer-in-norway-2015/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"Primary care in the driver'sseat?, Organizational reform in European primary care: Open University Press, Maidenhead, 2006. http://www.euro.who.int/__data/assets/pdf_file/ 0006/98421/E87932.pdf .",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Available from: http://www.ca-pri.org/index.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
"Holtedahl, Probability revision in general practice: the cases of occult blood in stool in patients with indigestion, and daily smoking in patients who cough, Allgemeinmedizin 19 (1990) 35 –38.http://www2.uit.no/ikbViewer/ Content/237422/Probability.pdf .",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Available from: https://www.ncbi.nlm.nih.gov/pubmed/26180880.,OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
Article No~e00328 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00328 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/4a/main.PMC5484975.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/15/main.PMC5484976.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.08.004 .,OADS,/arxiv_data1/oa_pdf/30/15/main.PMC5484976.pdf
E-mail address: jamesbrowne@virginia.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.08.004 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/15/main.PMC5484976.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 99 e103,Non-OADS,/arxiv_data1/oa_pdf/30/15/main.PMC5484976.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/03/main.PMC5484977.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.05.002 291,OADS,/arxiv_data1/oa_pdf/73/03/main.PMC5484977.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.06.005 2211-3355/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/54/5d/main.PMC5484978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/5d/main.PMC5484978.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/54/5d/main.PMC5484978.pdf
https://www.bloomberg.com/news/articles/2017- 01-12/sorry-wal-mart-amazon-wants-your-food-stamp-customers-as-well .,Non-OADS,/arxiv_data1/oa_pdf/54/5d/main.PMC5484978.pdf
e00332 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
1HEALPix can be found at http://healpix.sourceforge.net Article No~e00332 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"Instead, a hybrid partition is used wherein different regions of Article No~e00332 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"In the NESTED cell scheme, the cell index grows with consecutive hierarchical subdivisions on a tree structure seeded by the twelve Article No~e00332 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Depending on the size of the disc and the resolution ofthe HEALPix data structure there could be many thousands of HEALPix indexes Article No~e00332 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"To guarantee that all returned points are within the query range, an additional filter step must be used to screen out all data points that Article No~e00332 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"However, to distinguish between theseMortonNodes in the MLQ, the colliding MortonNode has a subaddress value Article No~e00332 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"For all four query types, the Article No~e00332 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Range query HEALPix MRH DiscON HPXðÞ ON MRHðÞ PolygonON HPXðÞ ON MRHðÞ Latitude stripON HPXðÞ ON MRHðÞ NeighborO1ðÞ ON MRHðÞ Article No~e00332 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 26 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
It is hypothesized that an artifact of the random data point generator was producing data points that disproportionately fellalong the equatorial region between the maximum (north pole) and minimum Article No~e00332 27 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
MLQ # Fragmentation NOAA SDSS Synthetic 1 122 9120 5982 165012 2 1050 4747 45744 164246 3 1165 0 44928 164696 4 131 1 3381 164658 5 196 0 36396 94765 6 1266 3320 1705 943307 379 0 30499 94797 8 1369 0 4312 95151 9 1286 0 904 165160 10 51 0 40 163978 11 32 0 181 16429912 1253 0 48 164309 Average 692 5729 14510 141283 Article No~e00332 28 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
MLQ # Fragmentation NOAA SDSS Synthetic 1 3.70 8.21 8.36 8.82 2 5.27 8.36 8.28 8.82 3 5.36 0.00 8.17 8.82 4 3.85 1.00 7.66 8.82 5 4.11 0.00 8.05 8.27 6 5.34 8.12 7.63 8.267 5.23 0.00 7.97 8.27 8 5.52 0.00 7.83 8.26 9 5.42 0.00 7.97 8.81 10 3.63 0.00 7.10 8.82 11 3.22 0.00 7.86 8.8112 5.44 0.00 6.29 8.81 Average 4.67 8.23 7.76 8.63 Article No~e00332 29 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"In contrast, when the Article No~e00332 30 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"Metric Dataset HEALPix MRH Bytes (K)Fragmentation 14,155,776 920 NOAA 14,155,776 1908 SDSS 14,155,776 19,242 Synthetic 14,155,776 189,045 Quadtree size (nodes)Fragmentation 201,326,592 8300 NOAA 201,326,592 17,188 SDSS 201,326,592 174,120 Synthetic 201,326,592 1,695,401 Article No~e00332 31 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"Query typeDataset Queries × repsHEALPix MRH Sum Mean Std dev Sum Mean Std dev Disc Fragmentation 30 × 30 80,638 89.60 58.15 1,030 1.14 0.92 NOAA 30 × 30 5,554 6.17 4.43 3,744 4.16 3.28 SDSS 30 × 30 110,916 123.24 25.81 59,046 65.61 33.02 Synthetic 30 × 30 82,051 91.17 67.82 185,281 205.87 136.57 Polygon Fragmentation 30 × 30 49,169 54.63 50.69 7,035 7.82 8.81 NOAA 30 × 30 20,498 22.78 28.87 55,584 61.76 82.46 SDSS 30 × 30 163,957 182.17 118.34 240,129 266.81 246.51 Synthetic 30 × 30 403,754 448.62 630.11 1,217,455 1352.73 1544.36 Latitude stripFragmentation 30 × 30 736,228 818.03 484.91 1,200 1.33 0.60 NOAA 30 × 30 406,271 451.41 593.89 2,323 2.58 1.23 SDSS 30 × 30 768,036 853.37 483.97 30,406 33.78 14.31 Synthetic 30 × 30 4,658,295 5,175.88 3398.76 324,636 360.71 145.92 Neighbor Fragmentation 30 × 30 1 <0.01 0.0 1 <0.01 0.0 NOAA 30 × 30 1 <0.01 0.0 16 0.02 0.10 SDSS 30 × 30 1 <0.01 0.0 30 0.03 0.13 Synthetic 30 × 30 1 <0.01 0.0 32 0.04 0.14 All All 480 × 30 7,485,371 693.09 371.61 2,127,948 197.03 138.65 Article No~e00332 32 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"As point density increases, MRH begins to lose its advantages in memory utilization and query performance, but HEALPix data structures must be built at Article No~e00332 33 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"An example of latter is describedin[45], in which spatially gridded point data representing ocean and atmosphere Article No~e00332 34 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 35 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 36 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"), The Quadrilateralized Spherical Cube and Quad-Tree for All Sky Article No~e00332 37 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
"November 20 2003, Accessed January 11 2017 http://lambda.gsfc.nasa.gov/product/cobe/ skymap_info_new.cfm .",Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 38 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Retrieved October 1 2015 https://www.ncdc.noaa.gov/ data-access/land-based-station-data/la nd-based-datasets/cooperative-observ- er-network-coop/ .,OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Accessed October 1 2015 http://skyserver.sdss.org/CasJobs/ .,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 39 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
Article No~e00332 40 http://dx.doi.org/10.1016/j.heliyon.2017.e00332 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/2d/main.PMC5484980.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/6e/main.PMC5484981.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.05.004 284,OADS,/arxiv_data1/oa_pdf/b3/6e/main.PMC5484981.pdf
"November 19, 2016. http://dx.doi.org/10.1111/bjd.15193 [Epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/b3/6e/main.PMC5484981.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/94/main.PMC5484982.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.025 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/dc/94/main.PMC5484982.pdf
"http://www.who.int/features/factiles/cancer/en/ accessed , June 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/dc/94/main.PMC5484982.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/a5/main.PMC5484983.pdf
The  patient  also  had  family  history  of  lung  can- http://dx.doi.org/10.1016/j.ijscr.2017.06.031 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/95/a5/main.PMC5484983.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.04.002 .,OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5484984.pdf
E-mail address: trousdale.robert@mayo.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.04.002 2352-3441/Copyright ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5484984.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 105 e109,Non-OADS,/arxiv_data1/oa_pdf/a9/72/main.PMC5484984.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.05.007,Non-OADS,/arxiv_data1/oa_pdf/ec/f0/main.PMC5484985.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,2 8–33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/f0/main.PMC5484985.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,2 8–33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/f0/main.PMC5484985.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,2 8–33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/f0/main.PMC5484985.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,2 8–33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/f0/main.PMC5484985.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,2 8–33 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/f0/main.PMC5484985.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/70/main.PMC5484986.pdf
Presentation of  case A 71-year-old  Japanese  male  presented  at  our  hospital  due  to  left back  pain and an abnormal chest  computed  tomography  (CT)  scan showing a  80  ×  70  ×  60-mm  tumor  located  in  the  left  middle  apex http://dx.doi.org/10.1016/j.ijscr.2017.06.028 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/52/70/main.PMC5484986.pdf
"http://dx.doi.org/10.1016/j.idcr.2017.06.004 Received 22 May 2017; Accepted 11 June 2017⁎Corresponding author at: Pediatric Infectious Disease, Providence St Vincent Medical Center, 9427 SW Barnes Road, Suite 395, Portland, OR 97225, USA.",Non-OADS,/arxiv_data1/oa_pdf/d7/79/main.PMC5484987.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/79/main.PMC5484987.pdf
2017; 2017 https://www.cdc.gov/hai/pdfs/labsettings/klebsiella_or_ecoli.,OADS,/arxiv_data1/oa_pdf/d7/79/main.PMC5484987.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/e2/2e/DOM-19-874.PMC5484989.pdf
320. https://www.pmda.go.jp/files/000203635.pdf#search= ’canagliflozin+pyelonephritis+PMDA ’.,Non-OADS,/arxiv_data1/oa_pdf/e2/2e/DOM-19-874.PMC5484989.pdf
327. https://www.pmda.go.jp/ files/000208624.pdf#search= ’canagliflozin+pyelonephritis+PMDA ’.,Non-OADS,/arxiv_data1/oa_pdf/e2/2e/DOM-19-874.PMC5484989.pdf
https://www.pmda.go.jp/files/000153316.pdf#search= ’teneligliptin+interstitial+pneumonia ’.,Non-OADS,/arxiv_data1/oa_pdf/e2/2e/DOM-19-874.PMC5484989.pdf
318. https://www.pmda.go.jp/ files/000197892.pdf#search= ’teneligliptin++intestinal+obstruction ’.,Non-OADS,/arxiv_data1/oa_pdf/e2/2e/DOM-19-874.PMC5484989.pdf
https://doi.org/10.1111/dom.12898882 KADOWAKI ET AL.,OADS,/arxiv_data1/oa_pdf/e2/2e/DOM-19-874.PMC5484989.pdf
"[*]Dr.S.Chandra, Dr.N.Shirahata ,Prof.F.M.Winnik WPI Internation alCentre forNanoarc hitectonics (MANA) National Institute forMateria lsscience (NIMS) 1-1Namiki, Tsukuba 305-0044 (Japan) E-mail :SHIRAHA TA.Naoto@ nims.go.jp Dr.Y.Masuda National Institute ofAdvanced Industrial Science andTechnology (AIST) Shimoshid ami, Moriyama ,Nagoya (Japan) Prof. F.M.Winnik Departemen tdeChimie, Universi tedeMontreal CP6128 Succursa leCentre Ville, Montreal QCH3C 3J7(Canada) and Department ofChemist ryandFaculty ofPharma cy Universit yofHelsink i 00014 Helsinki (Finland) E-mail :francoise.wi nnik@umontre al.ca Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2017004 36.",Non-OADS,/arxiv_data1/oa_pdf/b7/c9/ANIE-56-6157.PMC5484998.pdf
In Eurotransplant Manual – version 4.8 ; 2015. https://www.eurotransplant.org/cms/mediaobject.php?file=chapter5_elas35.pdf [accessed 21 February 2017].,Non-OADS,/arxiv_data1/oa_pdf/98/e6/BJS-104-907.PMC5484999.pdf
"de S.Eckert, Dr.P.S.Miedema, Dr.M.Beye,Dr.M.Fondell, Dr.W.Quevedo, Dr.B.Kennedy ,M.Hantschman n,Dr.A.Pietzsch, Prof. Dr.A.Fçhlisch Institute forMethod sandInstrume ntation forSynchrotron Radiation Research Helmholtz -Zentrum Berlin f/C252rMaterial ienund Energie GmbH Albert-Ein stein-Strasse 15,12489 Berlin (Germany ) J.Norell, Prof. Dr.M.Odelius Department ofPhysics ,Stockholm University AlbaNova Universi tyCenter,10691 Stockholm (Sweden) E-mail :jesper .norell@fysi k.su.se Dr.B.E.VanKuiken, Dr.M.Ross, Prof. Dr.M.Khalil Department ofChemist ry,University ofWashington Seattle, WA98195 (USA) Dr.M.P.Minitti, Dr.S.P.Moeller ,Dr.W.F.Schlotter LCLS, SLAC National Accelerat orLaboratory 2575 Sand HillRoad, Menlo Park, CA94025 (USA) Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2017002 39.",Non-OADS,/arxiv_data1/oa_pdf/0e/62/ANIE-56-6088.PMC5485001.pdf
distributions and was fitted using the EM algorithm in the R package (https://www.r-project.org) using the mix- toolsfunction.,OADS,/arxiv_data1/oa_pdf/c3/70/CNCR-123-2459.PMC5485004.pdf
"Statistical analysis softwares used were the SigmaPlot platform (version 12.5; SPSS Science, Chica-go, IL), Case Control Studies (http://ihg.gsf.de/cgi-bin/ hw/hwa1.pl; Helmholtz Center, Munich, Germany), and MedCalc (https://www.medcalc.org/calc/test_one_pro- portion.php; Ostend, Belgium).",OADS,/arxiv_data1/oa_pdf/c3/70/CNCR-123-2459.PMC5485004.pdf
"Finally, it is interesting to note that the assumed “protective ”variant TP53 72C allele was the most com- mon allele found in our patients (C, 52% vs G, 48%; patients and controls combined, n 5545) and appears to be overtransmitted in our population including bothsexes, as we have previously reported and deposited at theNational Center for Biotechnology Information website (https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?",Non-OADS,/arxiv_data1/oa_pdf/c3/70/CNCR-123-2459.PMC5485004.pdf
http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/c3/70/CNCR-123-2459.PMC5485004.pdf
The number of osterix-positive osteoblasts or TRAP-positive osteoclasts in thesecondary spongiosa was obtained by using Image J software (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/89/2e/JCP-232-2569.PMC5485010.pdf
2011. https://data.epo.org/publication- server/rest/v1.0/publication-dates/20111123/patents/ EP2387989NWA2/document.pdf .,OADS,/arxiv_data1/oa_pdf/e2/54/DOM-19-1032.PMC5485013.pdf
"U.S. Label information, 25 February 2015.http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event= overview.process&ApplNo=206538 .",OADS,/arxiv_data1/oa_pdf/e2/54/DOM-19-1032.PMC5485013.pdf
https://doi.org/10.1111/dom.12938HEISE ET AL.,OADS,/arxiv_data1/oa_pdf/e2/54/DOM-19-1032.PMC5485013.pdf
Materials and Methods PacBio ASSEMBLIES We downloaded raw PacBio reads from ftp://ftp.hgsc.bcm.,OADS,/arxiv_data1/oa_pdf/e6/d6/EVO-71-1285.PMC5485016.pdf
"After trimming with Trim Galore (v0.4.0; http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/), we mapped all reads to the genome using a pipeline modified from Lack et al.",OADS,/arxiv_data1/oa_pdf/e6/d6/EVO-71-1285.PMC5485016.pdf
(2015; https://github.com/justin-lack/Drosophila-Genome-Nexus/blob/master/round1_assembly.pl).,Non-OADS,/arxiv_data1/oa_pdf/e6/d6/EVO-71-1285.PMC5485016.pdf
"Briefly, we used bwa mem (v0.7.12; Li and Durbin 2010), picard (v1.114; http://picard.sourceforge.net), and stampy (v1.0.23; Lunter and Goodson 2011).",OADS,/arxiv_data1/oa_pdf/e6/d6/EVO-71-1285.PMC5485016.pdf
We performed statistical analyses and plotted figures in R(v3.1.2) with “agricolae” (v1.2-3; https://cran.r-project.org/web/ packages/agricolae/index.html) and “ggplot2” (v2.1.0; https:// cran.r-project.org/web/packages/ggplot2/index.html).,OADS,/arxiv_data1/oa_pdf/e6/d6/EVO-71-1285.PMC5485016.pdf
<http://www.repeatmasker.org >.,Non-OADS,/arxiv_data1/oa_pdf/e6/d6/EVO-71-1285.PMC5485016.pdf
4|MATERIALS AND METHODS 4.1 |Specimen collection All procedures were approved by the Western Institutional Review Board (https://www.wirb.com/Pages/Default.aspx; Protocol#20152233).,Non-OADS,/arxiv_data1/oa_pdf/07/89/MRD-84-408.PMC5485017.pdf
"https://doi.org/10.1002/mrd.22803 Chang, M. C. (1951).",Non-OADS,/arxiv_data1/oa_pdf/07/89/MRD-84-408.PMC5485017.pdf
https://doi.org/10.1002/mrd.22801422| MOODY ET AL.,OADS,/arxiv_data1/oa_pdf/07/89/MRD-84-408.PMC5485017.pdf
https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/f6/fa/CNCR-123-2206.PMC5485018.pdf
https://pediatric-data.foundationmedicine.,Non-OADS,/arxiv_data1/oa_pdf/f6/fa/CNCR-123-2206.PMC5485018.pdf
Available at: https://www.gov .uk/government/publications/a-white-paper-on-tobacco (accessed 6 December 2016)(Archived at http://www.webcitation.org/6mYUy2ANq).,Non-OADS,/arxiv_data1/oa_pdf/6c/48/ADD-112-1229.PMC5485022.pdf
Available at:https://www.gov .uk/government/publications/the-tobacco-control-plan-for-england (a ccessed 5 December 2016) (Ar- chived at http://www.webcitation.org/6mX5jrqhu).,Non-OADS,/arxiv_data1/oa_pdf/6c/48/ADD-112-1229.PMC5485022.pdf
Available at: http://www.tcdat a.org.nz/TobaccoSectorOver- view.aspx (accessed 5 December 2016) (Archived at http:// www.webcitation.org/6mWzQuoiC).,Non-OADS,/arxiv_data1/oa_pdf/6c/48/ADD-112-1229.PMC5485022.pdf
Available at: http://www.mediacom.,Non-OADS,/arxiv_data1/oa_pdf/6c/48/ADD-112-1229.PMC5485022.pdf
https://www.questback.com/ (accessed 18/04/ 2016).,Non-OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
Archived by WebCite at https://www.webcitation.,OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
https://www.sealedenvelope.com/power/binary-noninferior (accessed 12/04/ 2016).,Non-OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
Archived by WebCite at https://www.webcitation.,OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
https://www.wma.,Non-OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
Archived by WebCite at http://www.webcitation.org/6hb61FDlz.,OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
https://forskningsprosjekter.ihelse.net/prosjekt/ HST959-10 (accessed 12/04/2016).,Non-OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
Archived by WebCiteat http://www.webcitation.org/6giJSsbSY.,OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
http://ghdx.healthdata.org/gbd-results-tool?params=que rytool-permalink/1e1e0e0f14ead39cf9d234147f456129(accessed 21/11/2016) 31.,Non-OADS,/arxiv_data1/oa_pdf/33/e4/ENE-24-807.PMC5485023.pdf
Stockholm: EASD; 2015. http://www.easdvirtualmeeting.org/ resources/second-line-treatment-with-sulfonylurea-compared-to-dpp4-inhibitors-demonstrated-associations-w ith-earlier-treatment-intensification- with-insulin –3.,Non-OADS,/arxiv_data1/oa_pdf/94/95/DOM-19-831.PMC5485030.pdf
2014. http://www.pharmo.nl/uploads/ pdf/Posters/T2DM%20treatment%20patterns%20across%20Europe_ ISPOR2014_20141030.pdf.,Non-OADS,/arxiv_data1/oa_pdf/94/95/DOM-19-831.PMC5485030.pdf
"There are several multiple-case family stud-ies.Forhumanlongevity,GeneticsofHealthyAgeing[4]usedthesamestudydesignastheLLS.Otherexamples are Genetics in Familial Thrombosis (with at least two cases with thrombosis) [5,6] and theongoing study from Leiden Family Lab (famlab: https://www.leidenfamilylab.nl), which recruits fami-lies with at least two cases with social anxiety disorder.",Non-OADS,/arxiv_data1/oa_pdf/2b/81/SIM-36-2288.PMC5485037.pdf
The Leiden Family Lab (https://www.leidenfamilylab.nl) aimsto identify endophenotypes for social anxiety disorder.,Non-OADS,/arxiv_data1/oa_pdf/2b/81/SIM-36-2288.PMC5485037.pdf
"Available at: http://www.afro.who.int/en/downloads/doc_download/6638-sic kle-cell-disease-a-strategy-for-the-who-african-re gion.html, accessed 7 November 2016. WHO.",Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
"Available at: http://www.who.int/malaria/news/ WHO_policy_recommendation_IPTi_032010.pdf, accessed 7 November 2016. WHO.",Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
"Available at: http://www.who.int/en tity/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf, accessed 7 November 2016. WHO.",Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
"Available at:http://apps.who.int/iris/bitstream/10665/200018/ 1/9789241565158_eng.pdf?ua=1, accessed 7 November 2016. WHO.",Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
"Available at: http://apps.who.int/ iris/bitstream/10665/161988/1/9789241549042_e ng.pdf?ua=1, accessed 7 November 2016.",Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
"Available at: http://www.who.int/nutrition/publications/micronutrients/wheat_maize_fort.pdf,accessed 7 November 2016.",Non-OADS,/arxiv_data1/oa_pdf/ee/77/BJH-177-905.PMC5485039.pdf
"Box18,6160 MD, Geleen (The Netherlands ) Dr.M.Lutz Crystal andStructural Chemistry ,Bijvoet Center forBiomole cular Research, Utrecht University Padualaa n8,3584CH, Utrecht (The Netherla nds) Prof. Dr.E.A.Pidko ITMO University Kronversksk iypr.,49,197101, St.Petersburg (Russia) Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2017013 65.",OADS,/arxiv_data1/oa_pdf/1b/05/ANIE-56-7531.PMC5485043.pdf
http://www.fda.gov/Safety/Med watch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm 506554.htm.,Non-OADS,/arxiv_data1/oa_pdf/03/41/DOM-19-897.PMC5485046.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM5 08422.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/41/DOM-19-897.PMC5485046.pdf
https://doi.org/10.1111/dom.12876900 DESAI ET AL.,OADS,/arxiv_data1/oa_pdf/03/41/DOM-19-897.PMC5485046.pdf
"Physiol Rep 2: e12085 –e12100.https://www.ncbi.nlm.nih.gov/pubmed/25052490 Cameron-Smith D, Burke LM, Angus DJ, Tunstall RJ, Cox GR, Bonen A, Hawley JA, Hargreaves M. 2003.",OADS,/arxiv_data1/oa_pdf/34/18/JCP-232-2373.PMC5485047.pdf
"https://www.ncbi.nlm.nih.gov/pubmed/26625902 Hegarty BD, Cooney GJ, Kraegen EW, Furler SM.",OADS,/arxiv_data1/oa_pdf/34/18/JCP-232-2373.PMC5485047.pdf
J Biol Chem 284:16522 –16530.https://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/34/18/JCP-232-2373.PMC5485047.pdf
https://doi.org/10.1002/jcp.257742406| WANG ET AL.,OADS,/arxiv_data1/oa_pdf/74/e4/JCP-232-2396.PMC5485048.pdf
"Eli Lilly and Company, Indianapolis, IN.March 2016 [cited July 8, 2016].URL http://uspl.lilly.com/taltz/taltz.html#pi.",Non-OADS,/arxiv_data1/oa_pdf/a6/ae/JDV-31-1004.PMC5485049.pdf
Available at https://www.gov.uk/gove rnment/uploads/system/uploads/attachment_data/file/544585/Interim_QA_Standards_v1_11_final_issue.pdf Last accessed 28 August2016.10 Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/b0/f1/DME-34-993.PMC5485053.pdf
Available at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/543686/Diabe tic_eye_screening_pathway_standards.pdf Last accessed 26 January 2017.,Non-OADS,/arxiv_data1/oa_pdf/b0/f1/DME-34-993.PMC5485053.pdf
Available at https://www.england.nhs.uk/statistics/statistical-work-areas/integrated-performance-measures-monitoring/diabetes-data Last accessed 26 January 2017.,Non-OADS,/arxiv_data1/oa_pdf/b0/f1/DME-34-993.PMC5485053.pdf
Available at https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015 Last accessed 16 December 2016.,Non-OADS,/arxiv_data1/oa_pdf/b0/f1/DME-34-993.PMC5485053.pdf
"16 Cook M, Forrest D, Watts G. Diabetic retinopathy screening: health equity audit for Bolton Diabetes Screening Programme 2014.Available at http://www.boltonshealthmatters.org/knowledgehub/ health-equity-audit-bolton-diabetes-screening-programme-2014 Last accessed 26 January 2017.",Non-OADS,/arxiv_data1/oa_pdf/b0/f1/DME-34-993.PMC5485053.pdf
http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm513602.htm.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/DOM-19-953.PMC5485056.pdf
https://doi.org/10.1111/ dom.12902ALATORRE ET AL.,OADS,/arxiv_data1/oa_pdf/b0/86/DOM-19-953.PMC5485056.pdf
https://doi.org/ 10.1002/ajmg.b.32534ZHANG ET AL.,OADS,/arxiv_data1/oa_pdf/f5/de/AJMG-174-451.PMC5485058.pdf
"All but two of the first twenty genes which are most correlated with asnB a r ei n v o l v e di nc e l l wall metabolism, which is not the case for asnH orasnO (http://genome.jouy.inra.fr/cgi-bin/seb/index.py).",Non-OADS,/arxiv_data1/oa_pdf/66/36/MMI-104-972.PMC5485061.pdf
Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2017003 43.,Non-OADS,/arxiv_data1/oa_pdf/1c/b5/ANIE-56-4215.PMC5485067.pdf
"https://doi.org/10.1002/mrd.22801 Neri, Q. V., Husserl, P. J., Vairo, L., Rosenwaks, Z., Travis, A. J., & Palermo, G. D. (2013).",OADS,/arxiv_data1/oa_pdf/95/1c/MRD-84-423.PMC5485082.pdf
https://doi.org/10.1002/mrd.22803CARDONA ET AL.,OADS,/arxiv_data1/oa_pdf/95/1c/MRD-84-423.PMC5485082.pdf
"K. W. M. ’s financial disclosures after August 1, 2013 can be viewed at http://med.stanford.edu/ profiles/kenneth-mahaffey.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
"January 10, 2013. http://www.fda.gov/downloads/AdvisoryCommittees/Committees MeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisory Committee/UCM334551.pdf.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
"February 17, 2014. https://clinicaltrials.gov/ct2/ show/NCT02065791.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
2008. http://www.fda.gov/downloads/ Drugs/ …/Guidances/ucm071627.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
"January 10, 2013. http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/Endocrinologicand MetabolicDrugsAdvisoryCommittee/UCM334550.pdf.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
"May 18, 2016. http://www.fda.gov/Drugs/DrugSafety/ucm500965.htm.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
"February 10, 2017. http://www.ema.europa.eu/ema/in dex.jsp?curl=pages/medicines/ human/referrals/SGLT2_inhibitors_(previously_Canagliflozin)/human_ referral_prac_000059.jsp&mid=WC0b01ac05805c516f .Accessed February 15, 2017.",Non-OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
https://doi.org/ 10.1111/dom.12924NEAL ET AL.,OADS,/arxiv_data1/oa_pdf/8f/14/DOM-19-926.PMC5485085.pdf
"Box 217, 7500 AE Enschede (The Netherlands)E-mail: j.huskens@utwente.nl Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/celc.201600872 ©2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/61/a0/CELC-4-1470.PMC5485161.pdf
2017;19:989 – 996. https://doi.org/10.1111/dom.12909996 LEITER ET AL.,OADS,/arxiv_data1/oa_pdf/53/4f/DOM-19-989.PMC5485164.pdf
"wileyonlinelibrary.com/journal/ijcp	  | 	1 of 15 https://doi.org/10.1111/ijcp.12944 © 2017 The Authors International Journal of Clinical Practice Published by John Wiley & Sons LtdReceived:	20	February 	2017  | Accepted:	26	February 	2017 DOI: 10.1111/ijcp.12944 ORIGINAL PAPER Cardiovascular safety in refractory incontinent patients with  overactive bladder receiving add- on mirabegron therapy to  solifenacin (BESIDE) Marcus J. Drake1 | Scott MacDiarmid2 | Christopher R. Chapple3 | Adil Esen4 |   Stavros Athanasiou5 | Javier Cambronero Santos6 | David Mitcheson7 |   Sender Herschorn8 | Emad Siddiqui9 | Moses Huang9 | Matthias Stoelzel10 1University of Bristol and Bristol Urological  Institute, Bristol, UK 2Alliance	Urology 	Specialists,	Greensboro,	 NC,	USA 3Royal	Hallamshire	Hospital	and	Sheffield	 Hallam	University,	Sheffield,	UK 4Dokuz	Eylül	University 	School	of	Medicine,	 İzmir,	Turkey 5University	of	Athens	Medical	School,	 Athens,	 Greece 6Infanta	Leonor 	Hospital,	Madrid,	Spain 7St	Elizabeth’s	Medical	Center,	Brighton,	MA,	 USA 8Sunnybrook	Health	Sciences	Centre,	 University	of	Toronto,	Toronto,	ON,	Canada 9Astellas	Pharma	Europe	Ltd,	Chertsey,	Surrey,	 UK 10Astellas	Pharma	Global	Development,	 Leiden,	The	Netherlands Correspondence Marcus	J.	Drake,	University 	of	Bristol	and	 Bristol	Urological	Institute,	Southmead	 Hospital, Bristol, UK.Email: marcus.drake@bui.ac.uk Funding information Astellas	Pharma	Europe	Ltd;	 Astellas	Pharma	 Global	DevelopmentSummary Aims/objectives: 	In	the	BESIDE	study,	combination	therapy	(antimuscarinic	 [solifena- cin] and β3-	adrenoceptor	 agonist	[mirabegron])	 improved	efficacy	over	solifenacin	 monotherapy without exacerbating anticholinergic side effects in overactive bladder  (OAB)	patients;	however,	a	potential	synergistic	effect	on	the	cardiovascular	 (CV)	sys- tem requires investigation.",Non-OADS,/arxiv_data1/oa_pdf/32/dd/IJCP-71-na.PMC5485167.pdf
https://doi.org/10.1111/ijcp.12944,Non-OADS,/arxiv_data1/oa_pdf/32/dd/IJCP-71-na.PMC5485167.pdf
"Available at: http://www.who.int/vmnis/indicators/hae moglobin/en/ [Accessed November 18, 2015].",OADS,/arxiv_data1/oa_pdf/dd/b5/BJH-177-884.PMC5485170.pdf
Available at: http://www.who.int/nutrition/publications/micronutrients/guidelines/daily_ifa_supp_pregnant_women/en/.,Non-OADS,/arxiv_data1/oa_pdf/dd/b5/BJH-177-884.PMC5485170.pdf
Available at: http://www.who.int/nutri tion/publications/micronutrients/guidelines/guideline_intermittent_ifa_non_anaemic_pregnancy/en/.,Non-OADS,/arxiv_data1/oa_pdf/dd/b5/BJH-177-884.PMC5485170.pdf
Available at: http://apps.who.int/iris/bitstream/10665/177094/1/9789241564960_eng.pdf?ua= 1&ua=1.,Non-OADS,/arxiv_data1/oa_pdf/dd/b5/BJH-177-884.PMC5485170.pdf
https://doi.org/10.1111/dom.12908988 GADDE ET AL.,OADS,/arxiv_data1/oa_pdf/52/27/DOM-19-979.PMC5485171.pdf
E-mail: m.j.brandt@tilburguniversity.edu This article earned Open Data and Open Materials badges through Open Practices Disclosure from the Center for Open Science: https://osf.io/tvyxz/wiki.,Non-OADS,/arxiv_data1/oa_pdf/da/8c/PER-31-266.PMC5485172.pdf
The data and material are permanently andopenly accessible at https://osf.io/f54qe/.,OADS,/arxiv_data1/oa_pdf/da/8c/PER-31-266.PMC5485172.pdf
"31: 266–278 (2017) DOI: 10.1002/per1For more information on the ESS, including raw data, codebooks and methodological details visit: http://www.europeansocialsurvey.org/.268 M. J. Brandt and C. Reyna",Non-OADS,/arxiv_data1/oa_pdf/da/8c/PER-31-266.PMC5485172.pdf
"Retrieved from https://web.archive.org/web/20170128202101/ http://www.people-press.org/2015/11/23/1-trust-in-government- 1958-2015/ Pratto, F., Sidanius, J., Stallworth, L. M., & Malle, B. F. (1994).",Non-OADS,/arxiv_data1/oa_pdf/da/8c/PER-31-266.PMC5485172.pdf
Available at http://www.nice.org.uk/guidance/ng18 Last accessed 13 February 2017. ª2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/56/DME-34-983.PMC5485173.pdf
Available at https://www.nice.org.uk/guidance/qs6 Last accessed 16 February2017.,Non-OADS,/arxiv_data1/oa_pdf/d3/56/DME-34-983.PMC5485173.pdf
Available at http://www.rcpch.ac.uk/improving-child-health/quality-improvement-and-clinical- audit/national-paediatric-diabetes-audit-n-0#2013-14 Last accessed 16 February 2017.,Non-OADS,/arxiv_data1/oa_pdf/d3/56/DME-34-983.PMC5485173.pdf
"Dr.M.Melle-F ranco CICECO— AveiroInstitute ofMaterial s Department ofChemist ry,University ofAveiro 3810-193 Aveiro(Portugal) Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2017002 71.",Non-OADS,/arxiv_data1/oa_pdf/85/19/ANIE-56-6946.PMC5485174.pdf
Code availability R implementation of the multi-label classi ﬁers and the validation methods can be freely obtained for academic use at http://acgt.cs.tau.ac.il/adeptus/CONFLICT OF INTEREST The authors declare no con ﬂict of interest.,Non-OADS,/arxiv_data1/oa_pdf/cd/1c/onc2016489a.PMC5485176.pdf
Available at: https://arxiv.org/abs/1508.04409.,Non-OADS,/arxiv_data1/oa_pdf/cd/1c/onc2016489a.PMC5485176.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Analysis of numerous somatic mutation studies D Amar et al 3383 Oncogene (2017) 3375 –3383",Non-OADS,/arxiv_data1/oa_pdf/cd/1c/onc2016489a.PMC5485176.pdf
"Inaddition, analysis of RNA-sequencing data from The CancerGenome Atlas (TCGA) Prostate Adenocarcinoma (PRAD) cohort (http://xena.ucsc.edu) revealed increased NRP1 mRNA expression to be associated with increasing pathological stage and nodestatus in a large cohort ( n= 498) of primary tumor samples (Figure 5b).",OADS,/arxiv_data1/oa_pdf/2d/1c/onc2016482a.PMC5485179.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)NRP1 promotes metastatic progression and therapy failure BWC Tse et al 3427 Oncogene (2017) 3417 –3427",Non-OADS,/arxiv_data1/oa_pdf/2d/1c/onc2016482a.PMC5485179.pdf
The array data was subjected to the DNA-Chip Analyzer Software (DChip; http://www.dchip.org) for comparative analysis.,OADS,/arxiv_data1/oa_pdf/5c/43/onc2016509a.PMC5485181.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)TNFα-TGFα-EGFR loop promotes ovarian cancer metastasis T-S Lau et al 3587 Oncogene (2017) 3576 –3587",Non-OADS,/arxiv_data1/oa_pdf/5c/43/onc2016509a.PMC5485181.pdf
"Image analysis was performed using Image J (https://imagej.nih.gov) to measure the red ﬂuorescent intensity, which was converted to a corrected mean red ﬂuorescent intensity (background subtraction) of the region of interest.",OADS,/arxiv_data1/oa_pdf/cd/a5/onc2016495a.PMC5485216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Hypoxia-independent ubiquitination of AURKA by VHL E Hasanov et al 3463 Oncogene (2017) 3450 –3463",Non-OADS,/arxiv_data1/oa_pdf/cd/a5/onc2016495a.PMC5485216.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/3c/main.PMC5485220.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.11.006 .,OADS,/arxiv_data1/oa_pdf/db/3c/main.PMC5485220.pdf
E-mail address: Joshua.Campbell2@cshs.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.11.006 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/main.PMC5485220.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 83 e87,Non-OADS,/arxiv_data1/oa_pdf/db/3c/main.PMC5485220.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/16/main.PMC5485223.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2017.01.004 .,OADS,/arxiv_data1/oa_pdf/c1/16/main.PMC5485223.pdf
E-mail address: bostromm@hss.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2017.01.004 2352-3441/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/16/main.PMC5485223.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 89 e92,Non-OADS,/arxiv_data1/oa_pdf/c1/16/main.PMC5485223.pdf
2014. http://www.fda.gov/downloads/medicaldevices/ deviceregulationandguidance/guidancedocuments/ucm415799.pdf ; [accessed 22.02.17].K.,OADS,/arxiv_data1/oa_pdf/c1/16/main.PMC5485223.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2017.02.002 .,OADS,/arxiv_data1/oa_pdf/4e/15/main.PMC5485224.pdf
E-mail address: etkin@ajrr.net Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2017.02.002 2352-3441/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/15/main.PMC5485224.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 67 e69,Non-OADS,/arxiv_data1/oa_pdf/4e/15/main.PMC5485224.pdf
"Subsequent annual reports have been released each November, in conjunction with the AAHKS Annual Meeting ( http://www.ajrr.net/publications-data ).",Non-OADS,/arxiv_data1/oa_pdf/4e/15/main.PMC5485224.pdf
2000. https://www.cdc.gov/nchs/data/databriefs/db210.pdf ; [accessed 30.01.17].,OADS,/arxiv_data1/oa_pdf/4e/15/main.PMC5485224.pdf
2000. https://www.cdc.gov/nchs/data/databriefs/db186.pdf ; [accessed 30.01.17].,OADS,/arxiv_data1/oa_pdf/4e/15/main.PMC5485224.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
"Received March 24, 2017 /C15Revision received April 6, 2017 /C15Accepted April 20, 2017 /C15Available online 27 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.006 Brief Communication 770MOLECULAR METABOLISM 6 (2017) 770 e779/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
The Novo Nordisk Foundation Center for Basic Meta-bolic Research (http://www.metabol.ku.dk) is supported by an unconditional grant from the Novo Nordisk Foundation to University of Copenhagen.,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1113/jphysiol.2010.189860 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1371/ journal.pone.0087308 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/nature10112 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/ncb2211 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Nature 494(7435):111 e 115. http://dx.doi.org/10.1038/nature11793 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Genome Medicine2(2):9. http://dx.doi.org/10.1186/gm130 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1007/s00125-014-3434-2 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Cell Metabolism 7(1):33 e44.http://dx.doi.org/10.1016/ j.cmet.2007.11.011 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1016/ j.numecd.2012.02.002 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1016/j.jamda.2013.02.006 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.2337/dc06- 2537.Additional .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.2337/db05-1183 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.2337/diabetes.51.4.921 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.2337/diabetes.52.6.1319 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1371/journal.pone.0039657 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1152/japplphysiol.01399.2010 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1371/journal.pone.0051132 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1093/nar/gks494 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/ 10.1152/physrev.00019.2003 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Nature Genetics 38(2):228 e 233. http://dx.doi.org/10.1038/ng1725 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1128/MCB.01009-10 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Journal of Cell Science 126(Pt 24):5610 e 5625. http://dx.doi.org/10.1242/jcs.132563 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/ijo.2015.193 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/ 10.15283/ijsc.2014.7.2.118 .Brief Communication 778MOLECULAR METABOLISM 6 (2017) 770 e779/C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1152/physi- olgenomics.00037.2014 physiolgenomics.00037.2014.,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Journal of Biological Chemistry 289(32):21909 e 21925. http://dx.doi.org/10.1074/jbc.M114.561845 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
Biochemical and Biophysical Research Communications349(1):59 e68.http://dx.doi.org/10.1016/j.bbrc.2006.07.207 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1371/journal.pone.0008760 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1152/physiolgenomics.00042.2009 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1371/ journal.pone.0087687 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1016/S0092-8674(03)00193-4 .,OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/sj.onc.1207693 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1186/ s13046-016-0307-1 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/cr.2015.23 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1152/ajpcell.00055.2003 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.4161/epi.6.9.16683 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/ sj.onc.1208615 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
http://dx.doi.org/10.1038/cdd.2014.189 .,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/66/main.PMC5485225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
"Abbreviations: AKH, Adipokinetic hormone; AKHR, Adipokinetic Hormone Receptor; GO, Gene Ontology; bmm ,brummer Received February 15, 2017 /C15Revision received March 21, 2017 /C15Accepted March 27, 2017 /C15Available online 26 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.012 Original Article MOLECULAR METABOLISM 6 (2017) 631 e639/C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
Annals of the New York Academy of Sciences 1212:59e77http://dx.doi.org/10.1111/j.1749-6632.2010.05838.x .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1038/ nrg2579 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1038/nature08494 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.3945/ajcn.2008.27038 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/ 10.2337/db10-0385 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
BMC Genetics 15:12. http://dx.doi.org/10.1186/1471-2156-15-12 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1136/jmedgenet-2014- 102577 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1126/scien- ce.aad7977 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
Journal of Anatomy 215(1):36 e51.http://dx.doi.org/10.1111/ j.1469-7580.2008.00977.x .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1042/BJ20091861 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1016/ j.cell.2015.02.021 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.2337/db08-0490 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
Scienti ﬁc Reports 5:9266. http://dx.doi.org/ 10.1038/srep09266 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1530/REP-15-0595 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/ 10.1016/j.gde.2014.03.008 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1016/j.cell.2014.11.005 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1242/dmm.011924 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1371/journal.- pone.0059530 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1371/journal.- pone.0160857 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/ 10.1093/hmg/ddq332 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1016/j.cell.2013.09.002 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.2217/epi.10.26 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
Nature 431(7006):316 e 320. http://dx.doi.org/10.1038/nature02897 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1371/journal.pbio.0050137 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1016/j.devcel.2007.11.001 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1038/nprot.2008.211 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1093/nar/gkn923 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1016/ j.cmet.2005.04.003 .,OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1006/ bbrc.2001.5067 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1371/journal.- pone.0010925 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/10.1371/journal.pgen.1002925 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1000221 .,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/5e/main.PMC5485226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/d0/main.PMC5485227.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2017.05.003 .,OADS,/arxiv_data1/oa_pdf/63/d0/main.PMC5485227.pdf
E-mail address: mcgrob1@mmc.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2017.05.003 2352-3441/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/d0/main.PMC5485227.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 137 e140,Non-OADS,/arxiv_data1/oa_pdf/63/d0/main.PMC5485227.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/ea/main.PMC5485230.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.11.002 .,OADS,/arxiv_data1/oa_pdf/a4/ea/main.PMC5485230.pdf
E-mail address: BenWinston24@yahoo.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.11.002 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/ea/main.PMC5485230.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 77 e82,Non-OADS,/arxiv_data1/oa_pdf/a4/ea/main.PMC5485230.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/ba/main.PMC5485231.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.10.004 .,OADS,/arxiv_data1/oa_pdf/52/ba/main.PMC5485231.pdf
E-mail address: rrunner@emory.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.10.004 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/ba/main.PMC5485231.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 71 e76,Non-OADS,/arxiv_data1/oa_pdf/52/ba/main.PMC5485231.pdf
"[17] FDA guidelines can be found at, http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHip Implants/ucm241667.htm#3 [accessed 21.11.16].R.P.",Non-OADS,/arxiv_data1/oa_pdf/52/ba/main.PMC5485231.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/62/main.PMC5485232.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.09.009 .,OADS,/arxiv_data1/oa_pdf/a3/62/main.PMC5485232.pdf
E-mail address: sslotki1@hfhs.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.09.009 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/62/main.PMC5485232.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 131 e136,Non-OADS,/arxiv_data1/oa_pdf/a3/62/main.PMC5485232.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/10/main.PMC5485233.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.09.008 .,OADS,/arxiv_data1/oa_pdf/8d/10/main.PMC5485233.pdf
E-mail address: jpmartinezc@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.09.008 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/10/main.PMC5485233.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 3 (2017) 125 e130,Non-OADS,/arxiv_data1/oa_pdf/8d/10/main.PMC5485233.pdf
This article is available under the Creative Commons License CC-BY-NC http://creativecommons.org/licenses/by-nc/4.0.,Non-OADS,/arxiv_data1/oa_pdf/fa/13/cyber.2016.0669.PMC5485234.pdf
Future efforts to improve mental health in rural India should focus on  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/ee/nihms866723.PMC5485235.pdf
"Available at: http://europepmc.org/ abstract/eth/309411  [Accessed August 12, 2014] 18.",Non-OADS,/arxiv_data1/oa_pdf/42/ee/nihms866723.PMC5485235.pdf
"Switzer-land: World Health Organization; 2010. p. 115-35.Available at: http://www.who.int/entity/ social_determinants/tools/EquitySDandPH_eng.pdf#page=125  [Accessed April 26, 2011] 34.",Non-OADS,/arxiv_data1/oa_pdf/42/ee/nihms866723.PMC5485235.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
"Abbreviations: ADAMTS, A disintesgrin and metalloproteinase with a thrombospondin type-1 motif; AT, adipose tissue; BAT, brown adipose tissue; b3-AR, beta-3 adrenergic receptor; CREB, cAMP responsive element-binding protein; ECM, extracellular matrix; GON, gonadal; HFD, high-fat diet; %ID/g, percentage injecte d dose per gram; SC, subcutaneous; SUV, standardized uptake value; TLG, total lesion glycolysis; UCP1, uncoupling protein 1; WAT, white adipose tissue Received April 11, 2017 /C15Revision received April 28, 2017 /C15Accepted May 6, 2017 /C15Available online 10 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.004 Original Article MOLECULAR METABOLISM 6 (2017) 715 e724/C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
http://dx.doi.org/10.2337/db15 e1372 .,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
http://dx.doi.org/10.1016/ j.cmet.2016.12.007 .,OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/b5/main.PMC5485238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
"Received February 15, 2017 /C15Accepted March 27, 2017 /C15Available online 6 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.003 Original Article MOLECULAR METABOLISM 6 (2017) 725 e736/C2112017 The Author(s).",OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
"Received February 24, 2017 /C15Revision received April 13, 2017 /C15Accepted April 25, 2017 /C15Available online 4 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.009 Original Article 640MOLECULAR METABOLISM 6 (2017) 640 e650/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/main.PMC5485240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
"Received March 30, 2017 /C15Revision received April 21, 2017 /C15Accepted April 24, 2017 /C15Available online 27 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.007 Original Article MOLECULAR METABOLISM 6 (2017) 681 e692/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1016/j.diabres.2013.11.002 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1016/ j.cmet.2016.06.021 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1007/s11695-011-0390-5 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1097/ 01.sla.0000183349.16877.84 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1097/SLA.0b013e3180caa3e3 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.1210/jc.2007-2851 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Annals of Surgery 252(1):50 e56.http://dx.doi.org/10.1097/SLA.0b013e3181d3d21f .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1016/j.physbeh.2011.05.026 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1177/0148607110381403 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Obesity Surgery20(1):56e60.http://dx.doi.org/10.1007/s11695-009-9989-1 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1053/gast.2002.37062 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1126/ science.1235103 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1146/annurev-physiol-021113-170317 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1053/j.gastro.2007.03.054 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1210/jc.2003-030049 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.1080/00365520802538195 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1080/00365520410004424 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1053/gast.2001.22555 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Gastroenterology130(1):44 e54.http://dx.doi.org/10.1053/j.gastro.2005.10.004 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1136/gut.2008.165886 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.2967/jnumed.106.038679 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1097/MIB.0000000000000847 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1210/en.2013-1934 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Endocrinology 154(1):4 e8http://dx.doi.org/10.1210/en.2012-2124 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1074/jbc.M009382200 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1210/en.2004-0100 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1053/j.gastro.2005.11.005 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1152/ajpgi.00389.2012 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1074/jbc.M005510200 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Regulatory Peptides 124(1 e3):105e 112. http://dx.doi.org/10.1016/j.regpep.2004.07.009 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1038/nm1196-1211 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Endocrinology 153(3):1141 e 1151. http://dx.doi.org/10.1210/en.2011-1954 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1016/j.cmet.2017.02.008 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.1016/j.mce.2012.08.008 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Diabetes 63(4):1224 e 1233. http://dx.doi.org/10.2337/db13-1440 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Gastrointestinal and Liver Physiology 296(3):678 e 684. http://dx.doi.org/10.1152/ajpgi.90587.2008 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1016/j.regpep.2012.05.063 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1007/s00429-002-0235-z .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.1053/j.gastro.2006.05.055 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1053/ j.gastro.2009.05.057 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
Gastrointestinal and Liver Physiology 301:1 e8.http://dx.doi.org/10.1152/ajpgi.00039.2011 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1371/ journal.pone.0065696 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1210/en.2012-1131 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.2337/db12-1498 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1210/en.2016-1302 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1136/gutjnl-2015-309871 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1007/s11695-014-1547-9 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.1007/s11695-012-0622-3 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/ 10.1152/ajpendo.00533.2012 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1152/ajpregu.00125.2016 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1007/s11695-009-9954-z .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1016/j.soard.2009.11.019 .,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
http://dx.doi.org/10.1007/s11695-012-0850-6 .,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
RegulatoryPeptides 189:31 e39.http://dx.doi.org/10.1016/j.regpep.2014.01.002 .Original Article 692MOLECULAR METABOLISM 6 (2017) 681 e692/C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/76/main.PMC5485241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
"Received April 2, 2017 /C15Revision received May 6, 2017 /C15Accepted May 10, 2017 /C15Available online 19 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.005 Original Article MOLECULAR METABOLISM 6 (2017) 651 e663/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
"Sperm to establish our colony of these mice was obtained from the Knock Out Mouse Project ( https://www.komp.org/index.php )a t University of California, Davis.",Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/dc/main.PMC5485242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
"Received April 10, 2017 /C15Revision received May 1, 2017 /C15Accepted May 2, 2017 /C15Available online 19 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.001 Original Article MOLECULAR METABOLISM 6 (2017) 703 e714/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
"Published ChIP-Seq datasets (SRP006743/GSE25308 [18]), and SRP057271/GSE67962 [19] were downloaded from NIH GEO/SRA servers ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
"To visualize ChIP-Seq signals, bedgraph ﬁles were generated using makeUCSC ﬁleand loaded into IGV (Integrative Ge- nomics Viewer) ( https://www.broadinstitute.org/igv/ ).",OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
Gene Ontology (GO) analysis Gene Ontology and gene-list enrichment analysis were performed with ToppGene server ( http://toppgene.cchmc.org ).,OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1038/nrm3118 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/ 10.1038/nrd4100 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1210/mend.9.12.8614403 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1038/nsmb1344 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1126/sci- ence.1150179 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/ 10.1152/ajpregu.00690.2003 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
Nature Medicine 19(8):1039 e 1046. http://dx.doi.org/10.1038/nm.3213 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1242/jcs.120519 pub- lished Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/ 10.1093/nar/gkq180 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1016/ j.bbagrm.2016.02.011 published Online First: Epub Date.,OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1091/mbc.E02-09- 0600 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1152/physiolgenomics.90207.2008 pub- lished Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1073/ pnas.1102223108 published Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1016/ j.yexcr.2014.08.041 published Online First: Epub Date.,OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1021/cb1002575 pub- lished Online First: Epub Date.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
http://dx.doi.org/10.1038/na- ture11030 published Online First: Epub Date.Original Article 714MOLECULAR METABOLISM 6 (2017) 703 e714/C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/main.PMC5485243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
"Abbreviations: UCP2, Uncoupling protein 2; GSIS, Glucose-stimulated insulin secretion; LG, Low glucose; HG, High glucose; ZT, Zeitgeber time; MIN6, Mouse insulin oma 6; Ucp2-bKO,bcell-speci ﬁcUcp2 knockout; Ins2-cre, Ins2 promoter-driven cre recombinase; i.p.GTT, intraperitoneal glucose tolerance test; T2D, Type 2 diabetes; WT, wild type Received February 15, 2017 /C15Revision received April 16, 2017 /C15Accepted April 24, 2017 /C15Available online 27 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.008 Brief Communication 760MOLECULAR METABOLISM 6 (2017) 760 e769/C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fe/main.PMC5485245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
"Received May 11, 2017 /C15Accepted May 16, 2017 /C15Available online 22 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.009 Original Article MOLECULAR METABOLISM 6 (2017) 621 e630/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
"Transcriptomic and lipidomic data analyses The transcriptomic data were analyzed using GSEA (Broad Institute; MA,USA, accessed at http://software.broadinstitute.org/gsea/ ).",OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/main.PMC5485306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
"Received February 10, 2017 /C15Revision received May 3, 2017 /C15Accepted May 10, 2017 /C15Available online 15 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.006 Original Article 748MOLECULAR METABOLISM 6 (2017) 748 e759/C2112017 Published by Elsevier GmbH.",Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/ad/main.PMC5485307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
"Abbreviations: CD, celiac disease; HLA-DQ, human leukocyte antigen; LPLC, low-performance liquid chromatography; NCD, non-celiac-disease; CEL3B, gastrointes tinal elastase 3B; CEL2A, gastrointestinal elastase 2A; CBPA1, human carboxypeptidase A1; ATIs, a-Amylase/trypsin inhibitors Received April 7, 2017 /C15Revision received May 9, 2017 /C15Accepted May 15, 2017 /C15Available online 22 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.008 Original Article MOLECULAR METABOLISM 6 (2017) 693 e702/C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
"Proceedings of SPIE eThe Inter- national Society for Optical Engineering, 9112. http://dx.doi.org/10.1117/ 12.2058730 .",Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/65/main.PMC5485308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
"Received March 17, 2017 /C15Revision received May 9, 2017 /C15Accepted May 12, 2017 /C15Available online 17 May 2017 http://dx.doi.org/10.1016/j.molmet.2017.05.007 Original Article 664MOLECULAR METABOLISM 6 (2017) 664 e680/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/ 10.1210/er.2010-0026 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1016/j.cellimm.2007.09.010 .,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Pharmacological Re-views 62(2):199 e236 http://dx.doi.org/10.1124/pr.109.002469 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1210/en.2003-1274 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1016/S0140-6736(97)06467-2 .,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/ 10.1210/jcem.77.6.8263142 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1172/ JCI12969 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1007/s00125-008-1087-8 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1038/nrg2988 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Methods in Enzymology 507:229 e 254. http://dx.doi.org/10.1016/B978-0-12-386509-0.00012-0 .,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1007/s00125-011-2070-3 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.2337/diabetes.55.04.06.db05-0927 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Journal of Biomedical Science 14(5):585 e 594. http://dx.doi.org/10.1007/s11373-007-9159-1 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.2337/db12-0134 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1210/me.2014-1299 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1038/nrg2628 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.2337/db13-0311 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/ 10.1146/annurev.immunol.23.021704.115643 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1172/JCI114657 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.2337/ db11-1086 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1172/JCI63455 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Diabetes 57(12):3281 e 3288. http://dx.doi.org/10.2337/db08-0688 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
EMBO Molecular Medicine 5(1):1 e3.http://dx.doi.org/10.1002/ emmm.201202291 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1038/gt.2010.141 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Cell Metabolism 3(2):87 e98.http://dx.doi.org/10.1016/j.cmet.2006.01.005 .,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/ 10.1016/j.cytogfr.2006.02.002 .,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1073/ pnas.191383798 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1242/ dmm.015362 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/ 10.2337/dc13-0626 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.2337/db13-0236 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1084/ jem.20100209 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Diabetes 61(9):2340 e 2348. http://dx.doi.org/10.2337/db12-0049 .,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
Molecular Therapy: The Journal of the American Society of Gene Therapy 13(4):747 e 755. http://dx.doi.org/10.1016/j.ymthe.2005.10.017 .,OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
http://dx.doi.org/10.1007/s11845-010-0570-7 .Original Article 680MOLECULAR METABOLISM 6 (2017) 664 e680/C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/12/main.PMC5485311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/90/main.PMC5485379.pdf
http://dx.doi.org/10.1016/j.ihj.2016.09.010 0019-4832/© 2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f1/90/main.PMC5485379.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 345 –348 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/f1/90/main.PMC5485379.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/41/main.PMC5485380.pdf
"Abbreviations: 2D-ECHO, two dimensional-echocardiogram; ACE, angiotensin converting enzyme; ANCOVA, analysis of covariance; ARBs, angiotensin receptorblockers; CHF, chronic heart failure; DPP, double pressure product; ECG,electrocardiography; EF, ejection fraction; FAS, Full Analysis Set; IHD, IschemicHeart Disease; HFRT, heart failure reversal therapy; HRR, heart rate recovery; LSMD,least square mean difference; MET, metabolic equivalents of tasks; NYHA, New YorkHeart Association; PLBS, post lunch blood sugar; PP, Per Protocol Set; QoL, quality oflife; SAS, statistical analysis system; SCT, standard CHF treatment; SD, standard deviation; SHS, sampurna hruyday shudhikaran; SS, Safety Set; TEAEs, treatment emergent adverse events; TOI, time to onset of ischemia; VO 2peak , peak oxygen uptake.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.10.012 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/01/41/main.PMC5485380.pdf
"Available from: http://www.heartfoundation.org.au/SiteCollectionDocuments/ Chronic-heart-failure-QRG-2011.pdf Accessed 10.05.16 6.Rehsia NS, Dhalla NS.",Non-OADS,/arxiv_data1/oa_pdf/01/41/main.PMC5485380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/8c/main.PMC5485381.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.010 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ea/8c/main.PMC5485381.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/b5/main.PMC5485382.pdf
E-mail address: gajendra.dubey119@gmail.com (G. Dubey).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.11.322 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/e8/b5/main.PMC5485382.pdf
Thus it continues to be practiced in http://dx.doi.org/10.1016/j.ihj.2017.01.013 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/47/7d/main.PMC5485383.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/bc/main.PMC5485386.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.011 0019-4832/© 2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/b4/bc/main.PMC5485386.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 305 –310 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/b4/bc/main.PMC5485386.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
http://dx.doi.org/10.1016/j.ihj.2017.04.003 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 357 –363 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
Available at http://www.nhsdg.scot.nhs.uk/dumfries/ ﬁles/2.05%20Guidelines %20on%20Single%20Use%20Devices.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
2008; (March (19)) http://online.wsj.com/article/SB120588469924246975.html .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
2010; http://www.hospitalmanagement.net/features/feature80981/ .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
http://www.triplepundit.com/2010/03/reuse-single-use-medical-devices .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
05 http://www.gao.gov/new.items/he00123.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
Guidance for Industry and for FDA Staff: Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals .http://www.fda.gov/downloads/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm107172.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
Safety and Performance Evaluation of Remanufactured Harmonic .http://www.amdr.org/wp-content/uploads/2010/09/White-Paper- Safety-and-Performance-Eval-of-Remfd-Harmonic-Scalpels.pdf .16.,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
"104, cited 7 November 2014] http://www.cadth.ca/ media/pdf/334A_Reprocessing-SUDs%20National-Survey_tr_e.pdf .",OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
http://www.ghtf.org/meetings/ conferences/8thconference/presentations/Re-Use/Reusepeter.PDF .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
Db 2006(04) v2.0 .http://www.Mhra.Gov.Uk/home/ groups/dtsiac/documents/publication/con2025021.pdf 2011 .,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
Available at: http://www.heartbeatintl.org/mission.,Non-OADS,/arxiv_data1/oa_pdf/9b/56/main.PMC5485387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5485388.pdf
"E-mail addresses: aritra_mukherji@yahoo.co.in (A. Mukherji), ananthdevi@gmail.com (R. Anantharaman), cardio@frontierlifeline.com (R. Subramanyan).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.10.009 0019-4832/ /C2232016 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5485388.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/39/main.PMC5485388.pdf
http://dx.doi.org/10.1016/j.ihj.2017.01.003 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/a6/67/main.PMC5485389.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 415 –416 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/a6/67/main.PMC5485389.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/89/main.PMC5485390.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.019 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/84/89/main.PMC5485390.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/84/89/main.PMC5485390.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/a9/main.PMC5485391.pdf
http://dx.doi.org/10.1016/j.ihj.2017.02.021 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/main.PMC5485391.pdf
The effects of intra-arterial vasodilators on radial artery size and spasm: implications for contemporary use of transradial http://dx.doi.org/10.1016/j.ihj.2017.01.008 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/23/2a/main.PMC5485394.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/73/main.PMC5485395.pdf
http://dx.doi.org/10.1016/j.ihj.2017.01.001 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/b0/73/main.PMC5485395.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 402 –404 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/b0/73/main.PMC5485395.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ihj.2017.01.001 .",OADS,/arxiv_data1/oa_pdf/b0/73/main.PMC5485395.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/ac/main.PMC5485396.pdf
http://dx.doi.org/10.1016/j.ihj.2017.02.015 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ee/ac/main.PMC5485396.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/2a/main.PMC5485397.pdf
http://dx.doi.org/10.1016/j.ihj.2017.01.011 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7a/2a/main.PMC5485397.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/95/main.PMC5485399.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.001 0019-4832/© 2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/2c/95/main.PMC5485399.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 349 –350 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/2c/95/main.PMC5485399.pdf
Available online 12 January 2017 http://dx.doi.org/10.1016/j.ihj.2017.01.002 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/a1/6f/main.PMC5485400.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 417 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/a1/6f/main.PMC5485400.pdf
Puavilai modi ﬁed formula correlated best with dLDLc at all levels of TG as compared to FF and Anandaraja http://dx.doi.org/10.1016/j.ihj.2017.01.007 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,OADS,/arxiv_data1/oa_pdf/ed/27/main.PMC5485401.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/89/main.PMC5485402.pdf
http://dx.doi.org/10.1016/j.ihj.2017.03.010 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/23/89/main.PMC5485402.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/1a/main.PMC5485403.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.008 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/0e/1a/main.PMC5485403.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/main.PMC5485404.pdf
E-mail address: drkm66@gmail.com (K. Muneer).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.007 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/main.PMC5485404.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/main.PMC5485404.pdf
http://dx.doi.org/10.1016/j.jacc.2008.12.007 .,OADS,/arxiv_data1/oa_pdf/dd/2d/main.PMC5485404.pdf
http://dx.doi.org/10.1016/ j.jacc.2013.11.031 .,OADS,/arxiv_data1/oa_pdf/dd/2d/main.PMC5485404.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/62/main.PMC5485406.pdf
Pathologically http://dx.doi.org/10.1016/j.ihj.2016.12.022 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/b4/62/main.PMC5485406.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/2c/main.PMC5485408.pdf
http://dx.doi.org/10.1016/j.ihj.2017.04.001 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/af/2c/main.PMC5485408.pdf
Available at http://www.servier.com.ve/sites/default/ ﬁles/spc-pil/spc-vastarel.pdf (Visited on 13 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/af/2c/main.PMC5485408.pdf
Available at http://www.servier.com/sites/default/ ﬁles/RCP_Vastarel20.pdf (Visited on 13 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/af/2c/main.PMC5485408.pdf
Available at http://www.gilead.com/ /C24/media/ ﬁles/ pdfs/medicines/cardiovascular/ranexa/ranexa_pi.pdf (Visited on 13 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/af/2c/main.PMC5485408.pdf
Available athttps://www.medicines.org.uk/emc/print-document?documentId=21402 (Visited on 13 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/af/2c/main.PMC5485408.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/39/main.PMC5485409.pdf
http://dx.doi.org/10.1016/j.ihj.2017.02.020 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/4f/39/main.PMC5485409.pdf
"7, Issue 7       http://www.thno .org 2003  TThheerraannoossttiiccss   2017; 7(7): 2003- 2014.  doi: 10.7150/ thno .19404  Research Paper   Drug-Bearing Supramolecular Filament Hydrogels as  Anti-Inflammatory Agents   Zhipeng Chen1,2,4*, Lei Xing3*, Qin Fan1,2*, Andrew G. Cheetham4, Ran Lin4, Barbara Holt4, Liwen Chen4,  Yanyu Xiao3 and Honggang Cui4,5,6  1.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2004  conditions, the long -term relief of localized  chronic  diseases would benefit greatly from alternative  approaches.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2005  3 mL).",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2006  concentrations of L-VEVE -(S)-Ket, D-VEVE -(S)-Ket  and ( S)-Ket for 48 h. After the incubation times, 20 µl  of 5 mg/ml 3 -(4,5-dimethylthiazol -2-yl)-2,5-diphenyl - tetrazolium bromide (MTT) solution in PBS (pH 7.4)  was added to each well.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2007  after  centrifugation at 4,000 rpm for 10 min and  immediately stored at −20 °C until analysis.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2008  matching with the chirality of the chosen amino acids.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2009    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2010    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2011  Due to potential chondrotoxicity , the two  Ket-conjugates were further investigated for  biocompatibility through incubation with primary  rabbit chondrocytes for 72 h at 37 °C (Figure S2).",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2012  To evaluate the potential of the hydrogels as a  local drug depot in an in vivo  environment , six male  rats were administered 200 μL of L-VEVE -(S)-Ket and  D-VEVE -(S)-Ket hydrogels (containing 400 μg  Ket-conjugate) via intra -articular injection (Figure 5c).",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
2016.  http://dx.doi.org/10.1016/j.addr.2016.06.015   8.,OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2013  9.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7      http://www.thno .org 2014  70.",Non-OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
2017.   http://dx.doi.org/10.1016/j.jconrel.2017.01.015  72.,OADS,/arxiv_data1/oa_pdf/59/09/thnov07p2003.PMC5485419.pdf
"7, Issue 7       http://www.thno .org 2015  TThheerraannoossttiiccss   2017; 7(7): 2015- 2032.  doi: 10.7150/ thno .19500  Research Paper   Melatonin Suppresses Neuropathic Pain via  MT2-Dependent and - Independent Pathways in Dorsal  Root Ganglia Neurons of Mice   Jia-Ji Lin1, 2*, Ye Lin1*, Tian -Zhi Zhao3*, Chun -Kui Zhang2, Ting Zhang2, Xiao -Li Chen1, Jia-Qi Ding1, Ting  Chang1, Zhuo Zhang1, Chao Sun1, Dai -Di Zhao1, Jun -Lin Zhu3, Zhu -Yi Li1, Jin-Lian Li2  1.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2016  Melatonin (Mel) is a circadian hormone that has  been widely reported to possess anti -oxidant and  anti-inflammatory properties [7 -9].",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2017  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2018  centrifuged for 2 min at 300 r/min at room  temperature.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2019  normalization and subsequent data processing were  performed using the GeneSpring -GXv11.5 software.",OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2020  the satellite cells of the DRG (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2021    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2022    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2023  DRG neurons treated with  100 μM Mel or 100  μM  8MP (P<0.001, Fig .",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2024    Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2025    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2026  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2027  mg/kg 8MP ( P<0.001, Fig.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2028  secretion of Mel  was variable in different types of  chronic pain that induced sleep deprivation and  mood disorder [26] .",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2029    Figure 9.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2030  6342 and 2148 DEGs were detected in the 100 μM 8MP  group and the 1  mM Mel group,  respectively.",OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2031  Both MT2 -dependent  (MAPK -calcium  channels)   and MT2 -independent (NOS1) pathways have  well -documented roles in regulating neuronal  activation, peptidergic neurons and  neuro -inflammation  [67-69].",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
"7, Issue 7      http://www.thno .org 2032  25.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/thnov07p2015.PMC5485420.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/e4/thnov07p2033.PMC5485421.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/2c/e4/thnov07p2033.PMC5485421.pdf
thno.org 2043  Functional annotation and enrichment map   DAVID (http://david.abcc.ncifcrf.gov/home.,Non-OADS,/arxiv_data1/oa_pdf/2c/e4/thnov07p2033.PMC5485421.pdf
"7, Issue 7       http://www.thno .org 2048  TThheerraannoossttiiccss   2017; 7(7): 2048- 2064.  doi: 10.7150/ thno .19883  Research Paper   PET Tracer 18F-Fluciclovine  Can Detect Histologically  Proven B one Metasta tic Lesions : A Preclinical Study in  Rat Osteolytic and Osteoblastic Bone Metastasis  Models   Shuntaro Oka1, Masaru Kanagawa1, Yoshihiro Doi1, David M. Schuster2, Mark M. Goodman2, Hirokatsu  Yoshimura1  1.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2049  Introduction   Breast cancer (BCa) and prostate cancer (PCa) are  the most common primary tumors for women and  men, respectively, and for patients with bone  metastasis [1].",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2050  Cell culture   A rat BCa cell line, MRMT -1, and a rat PCa cell  line, AT6.1, were procured from RIKEN BioResource  Center (Tsukuba, Japan; obtained in January 2014)  and European Collection of Authenticated Cell  Cultures (Salisbury, UK; obtained in October 2014),  respectively, and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum  (American Type Culture Collection , Rockville, MD,  USA), 100 μg/mL streptomycin, and 100 U/mL  penicillin.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2051  99mTc-HMDP in the PCa osteoblastic model (six hind  legs) and  the DH model (three hind legs).",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2052    Figure  1.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2053  Results   BCa osteolytic bone metastasis model   In the BCa osteolytic bone metastatic model, 52  tumor -relevant lesions (34 OL/OL, 16 pTBF/OL, and  2 Tumor/OL) were produced inside and/or outside  the bone marrow cavity (i.e., at the cortical bone  surface) of the tibiae and/or femora and  intramuscularly 12 ±  1 days postinjection of the  MRMT -1 cells.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2054  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2055  the tumor area.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2056    Figure  5.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2057    Figure  6.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2058    Figure  8.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2059  47/50 (94.0%), respectively, with 14C-fluciclovine; and  12/24 (50.0%), 12/29 (41.4%), and 33/50 (66.0%),  respectively, with 3H-choline (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2060    Figure  10.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2061  includes osteoids, osteoblasts, and osteoclasts, in  addition to tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2062  accumulated more in f ibrous tissue with high ALP  activity, whereas 3H-FDG accumulated more in tumor  parenchyma containing necrotic tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2063  Acknowledgements   We thank Masahiro Ono for his assistance in the  histological examinations and computed tomography  imaging; Sachiko Naito for her assistance in the daily  maintenance of the cell cultures and  reverse- transcription polymerase chain r eaction; Shiro  Yoshida for his assistance in the daily maintenance of  the animals; and our colleagues for their comments on  the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2064  29.",Non-OADS,/arxiv_data1/oa_pdf/19/94/thnov07p2048.PMC5485422.pdf
"7, Issue 7       http://www.thno .org 2078  TThheerraannoossttiiccss   2017; 7(7): 2078- 2091.  doi: 10.7150/ thno .19390  Research Paper   Metabolomics Identifies Metabolic Markers of  Maturation in Human Pluripotent Stem Cell- Derived  Cardiomyocytes   Vijesh J. Bhute1*, Xiaoping Bao1*, Kaitlin K. Dunn1, Kylie R. Knutson1, Eric C. McCurry1, Gyuhyung Jin1,  Wei-Hua Lee2, Sarah Lewis2, Akihiro Ikeda2, and Sean P. Palecek1  1.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2079  and clinical applications is limited by relatively  immature structural and functional properties of the  differentiated hPSC -CMs [6, 7] .",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2080  (PBS) (Life Technologies) plus 0.1% Triton X -100 and  0.5% bovine serum albumin (BSA) (AlbuMAX II).",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2081  statistical analysis using MetaboAnalyst [23, 24]  and  GENE -E [25].",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2082    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2083    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2084  3B).",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2085  We next performed two -way A NOVA to identify  statistically significant metabolic changes due to two  factors: a) time in culture and b) parent stem cell line  and we observed that while there were some  metabolites whose concentrations differed with  parent stem cell line, the majority o f the significant  changes were associated with time in culture (Table  1).",OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2086  includes glycerol phosphate shuttle and sp hingolipid  metabolism, are associated with cell membrane and  phospholipid synthesis and were exclusively enriched  in 3m hPSC -CMs compared to day 6 progenitors and  not in 1m hPSC -CMs relative to day 6 progenitors.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2087      Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2088  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2089    Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2090    Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7      http://www.thno .org 2091  References   [1]  Robinton DA, Daley GQ.",Non-OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"[25]  [Internet] GENE -E.  http://www.broadinstitute.org/cancer/software/   GENE -E/   [26]  Gao J, Tarcea VG, Karnovsky A, et al.",OADS,/arxiv_data1/oa_pdf/9e/57/thnov07p2078.PMC5485423.pdf
"7, Issue 7       http://www.thno .org 2092  TThheerraannoossttiiccss   2017; 7(7): 2092- 2107. doi: 10.7150/ thno .19884  Research Paper   c-Myc is Required for BRAFV600E-Induced Epigenetic  Silencing by H3K27me3 in Tumorigenesis  Yiping Qu1, Qi Y ang1, Juan Liu1, Bin gyin Shi1, 2, Meiju Ji3, Gang Li4, and Peng Hou1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2093  Aberrant activation of Ras/Raf/Mek/Erk  (MAPK/Erk) pathway promoting cell proliferation,  survival and metastasis is a commo n mechanism in  the genesis and progression of human cancers (10) .",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2094  Western blot analysis   Cells were lysed in prechilled RIPA buffer  containing protease inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
DAVI D  (http://david.abcc.ncifcrf.gov/home.jsp) functional  annotation cluster analysis was performed with a fold  change of ≥2 (21).,OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
The  pathway mapping analysis was performed using the  KEGG Automatic Annotation Server (KAAS)  (http://www.genome.jp/kegg/kaas/).,OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2095  Immunohistochemical staining   Sections were cut at 5  µm thickness,  deparaffinized and rehydrated.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2096  Identification of H3K27me3 -enriched genomic  regions associated with transcri ptional  silencing   ChIP -Seq and expression microarray were then  employed to determine altered profiles of H3K27me3  in BrafV600E target genes in BrafV600E cells versus BrafWT  cells (Figure 1B).",OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2097    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2098  significantly attenuated upon c -Myc depletion (Figure  4C).",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2099    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2100    Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2101  that c -Myc depletion dramatically inhibited the  regulatory effect of BrafV600E on the PRC2 components  in NIH3T3 cells (Figure 7A, upper -right panel).",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2102  levels and transcription are both regulated by the  activated H- Ras ( G12V) (37); however, Ras -induced  changes in H3K27me3 are not a trigger for, but rather a consequence of, changes in transcriptional activity.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2103    Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2104    Figure 8.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2105  elements in their promoters (38).",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2106    Figure 9.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7      http://www.thno .org 2107  21.",Non-OADS,/arxiv_data1/oa_pdf/2d/d2/thnov07p2092.PMC5485424.pdf
"7, Issue 7       http://www.thno .org 2134  TThheerraannoossttiiccss   2017; 7(7): 2134- 2149. doi: 10.7150/ thno .17665  Research Paper   Suppression Of β-catenin Nuclear Translocation By  CGP57380 De celerates  Poor Progression And  Potentiates Radiation -Induced Apoptosis in  Nasopharyngeal Carcinoma   Weiyuan  Wang1, Qiuyuan Wen1, Jiadi Luo1, Shuzhou Chu1, Lingjiao Chen1, Lina Xu1, Hongjing  Zang1,  Mohannad Ma Alnemah1, Jinghe Li2, Jianhua Zhou2, Songqing Fan1  1.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
This is an open access article distributed under the terms of the C reative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2135  human cancers .",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2136  (n=6/group) for treatment with vehicle control or  CGP57380 (25 mg/kg, three times per week, i.p  injection).",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2137  cell attachment, DMSO vehicle or CGP57380 was  added to the medi um to the required concentration.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2138  sequence detection system (Applied Biosystems,  Foster City, CA, US A).",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2139  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2140    Figure 1.  β-catenin signaling activates leading to poor prognosis and correlating with eIF4E phosphorylation in NPC A: Representative immunohistochemical staining of  p-eIF4E,  β-catenin, c yclin D1, c -Myc, and MMP -7 in NPC cases and non- cancerous nasopharyngeal epithel ial tissues (all images, 200 ×).",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2141  line HNE1 were chosen as candidates for follow -up  studies.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2142  CGP57380 regulates β -catenin distribution in  NPC cells leading to alteration of  epithelial- mesenchymal transition  morphology, cell cycle arrest and inhibition of  migration and invasion   To further investigate the distribution o f  β-catenin, we measured the β -catenin level in   cytosolic and nuclear extracts of CNE1 and HNE1 cell  lines following CGP57380 treatment.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2143  CGP57380 inhibits growth and metastasis of  NPC in vivo   Promotion of cellular proliferation, migration,  and EMT are important  functions of β -catenin  signaling in canc ers [39-41].",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2144    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2145  AKT and β-catenin in CNE1 could be abrogated by  CGP57380 through blocking eIF4E phosphorylation.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2146    Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2147  Discussion   As a result of a combination of lifestyle  modification and population screening coupled with  better imaging,  advances in radiotherapy, and more  effective systemic agents, the incidence and mortality  of NPC is gradually declining, even in endemic  regions (see review in ref.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2148  CGP57380 suppressed Axin2 expr ession, preventing  β-catenin phosphorylation at S33/37/Thr41 sites  without obvious inhibition of relative β-catenin  gene   expression.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2149  26.",Non-OADS,/arxiv_data1/oa_pdf/31/8f/thnov07p2134.PMC5485425.pdf
"7, Issue 7       http://www.thno .org 2150  TThheerraannoossttiiccss   2017; 7(7): 2150 -2163 .",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2151  hypermethylated genes offers molecular insight s into  potential screening, monitoring, and therapeutic  strategies to digestive cancers [3 -5].",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2152  demet hylated after 5 -Aza and TSA  treatment (Fig ure  1E, 1F), revealing a link between CGI methylation and  JPH3 silencing.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2153    Figure  2.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2154    Figure  3.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2155  some UPR -related proteins was examined.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2156  To further determine whether another  mitochondrial apoptogenic factor, AIF, was also   involved in JPH3 expression induced  apoptosis,  Western blot and immunofluorescence  experiments   were performed to confirm the nuclear translocation  of AIF (Fig ure 4C, 4D).",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2157  To further define the Ca2+-mediated signaling  pathway, we  examined whether calpain was activated  by JPH3 expression .",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2158      Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2159  neuronal JP H isoforms (JP H3 and JP H4), JPH3 null  mice exhibit adult onset, progressive  motor  dysfunction, whereas JPH3 hemizygous mice have  a  similar but milder phenotype.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2160  control s. So as in neuronal  cells, JPH3 expression  could also participates in the maintenance  of  intracellular Ca2+ homeostasis  in colorectal and gastric  tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2161  In conclusion, JPH3 was found to be a novel  tumor suppressor downregulated and methylated in  colorectal and gastric cancers, which increases  mitochondrial - mediated apoptosis through UPR  involving perturbed calcium homeostasis (Figure  7).",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2162  Calpain activity assay   Calpain activity was measured using the  cell-permeable fluorogenic calpain  substrate,  S-LLVY -AMC.",OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
JPH3  expression and processed clinical data  of gastric and colorectal patients in TCGA were  obtained from Fire browse database  (http://www.firebrowse.org).,OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
"7, Issue 7      http://www.thno .org 2163  8.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/thnov07p2150.PMC5485426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/73/main.PMC5485429.pdf
Ferreira).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.11.319 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/47/73/main.PMC5485429.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/73/main.PMC5485429.pdf
Available from: http://www.scielo.br/scielo.,Non-OADS,/arxiv_data1/oa_pdf/47/73/main.PMC5485429.pdf
Available from: http://www.scielo.br/scielo.,Non-OADS,/arxiv_data1/oa_pdf/47/73/main.PMC5485429.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/cd/main.PMC5485430.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.004 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/fa/cd/main.PMC5485430.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/7d/main.PMC5485433.pdf
http://dx.doi.org/10.1016/j.ihj.2017.04.014 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/49/7d/main.PMC5485433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 353 –354 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/49/7d/main.PMC5485433.pdf
Received 23 October 2016 Available online 18 May 2017 http://dx.doi.org/10.1016/j.ihj.2017.05.004 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/8d/83/main.PMC5485434.pdf
http://dx.doi.org/10.1016/j.ihj.2017.04.013 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/13/2a/main.PMC5485435.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ihj.2017.04.011 .",OADS,/arxiv_data1/oa_pdf/b4/c8/main.PMC5485436.pdf
"Received 13 April 2017 Available online 26 April 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.011 Making life simple —Letter to the Editor In the editorial S. Mishra1raised an important topic, the regulatory approval process of the medical devices.",Non-OADS,/arxiv_data1/oa_pdf/b4/c8/main.PMC5485436.pdf
"Received 19 April 2017 Available online 26 April 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.012 Dental considerations in cardiovascular patients: A practical perspective [8_TD$DIFF]Dear Dr. Mishra, above paper' Dental considerations in cardiovascular patients: A practical perspective.",Non-OADS,/arxiv_data1/oa_pdf/b4/c8/main.PMC5485436.pdf
Received 22 April 2017 Available online 16 May 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.019424 Correspondance / Indian Heart Journal 69 (2017) 422 –424,Non-OADS,/arxiv_data1/oa_pdf/b4/c8/main.PMC5485436.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ihj.2017.04.011 .",OADS,/arxiv_data1/oa_pdf/ad/df/main.PMC5485437.pdf
"Received 13 April 2017 Available online 26 April 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.011 Making life simple —Letter to the Editor In the editorial S. Mishra1raised an important topic, the regulatory approval process of the medical devices.",Non-OADS,/arxiv_data1/oa_pdf/ad/df/main.PMC5485437.pdf
"Received 19 April 2017 Available online 26 April 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.012 Dental considerations in cardiovascular patients: A practical perspective [8_TD$DIFF]Dear Dr. Mishra, above paper' Dental considerations in cardiovascular patients: A practical perspective.",Non-OADS,/arxiv_data1/oa_pdf/ad/df/main.PMC5485437.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/9e/main.PMC5485438.pdf
http://dx.doi.org/10.1016/j.ihj.2017.04.016 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/da/9e/main.PMC5485438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/43/main.PMC5485439.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.013 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/72/43/main.PMC5485439.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/5f/main.PMC5485440.pdf
"This is in line with the data of Uthayakumaran et al., who showed that a RCA-LSV with an http://dx.doi.org/10.1016/j.ihj.2017.05.001 0019-4832/© 2017 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/59/5f/main.PMC5485440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 411 –413 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/59/5f/main.PMC5485440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/08/main.PMC5485441.pdf
http://dx.doi.org/10.1016/j.ihj.2017.04.018 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/36/08/main.PMC5485441.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ihj.2017.04.011 .",OADS,/arxiv_data1/oa_pdf/3c/35/main.PMC5485442.pdf
"Received 13 April 2017 Available online 26 April 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.011 Making life simple —Letter to the Editor In the editorial S. Mishra1raised an important topic, the regulatory approval process of the medical devices.",Non-OADS,/arxiv_data1/oa_pdf/3c/35/main.PMC5485442.pdf
"Received 19 April 2017 Available online 26 April 2017 http://dx.doi.org/10.1016/j.ihj.2017.04.012 Dental considerations in cardiovascular patients: A practical perspective [8_TD$DIFF]Dear Dr. Mishra, above paper' Dental considerations in cardiovascular patients: A practical perspective.",Non-OADS,/arxiv_data1/oa_pdf/3c/35/main.PMC5485442.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/2d/main.PMC5485443.pdf
"Method Bias L/min mean Percentage error mean Esophageal Doppler /C00.77 42% Pulse wave transit time /C00.31 62% Pulse contour analysis /C00.21 45% Partial CO 2rebreathing /C00.20 40% Thoracic electric bioimpedance /C00.22 42% From reference 5,6.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2017.05.028 0019-4832/ /C2232017 Published by Elsevier, a division of Reed Elsevier India, Pvt.",Non-OADS,/arxiv_data1/oa_pdf/ca/2d/main.PMC5485443.pdf
This is an open access article und er the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/2d/main.PMC5485443.pdf
The prime interest was to identify presence of http://dx.doi.org/10.1016/j.gdata.2017.06.006 Received 28 April 2017; Received in revised form 7 June 2017; Accepted 13 June 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"13 (1990) 29 –33,http://dx.doi.org/10.1016/S0723-2020(11)80177-3 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"nov.: a new moderately halophilic gram-positive bacterium isolated from salted skate,Extremophiles 10 (2006) 531-6, http://dx.doi.org/10.1007/s00792-006-0532-1 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"57 (2007) 633-8, http://dx.doi.org/10.1099/ijs.0.64586-0 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"nov., a novel alkaliphile and moderate halophile isolated from Keke Salt Lake in Qinghai, China,Antonie Van Leeuwenhoek 98 (2010) 351-7, http://dx.doi.org/10.1007/s10482- 010-9449-x .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"57 (2007) 1901 –1905, http://dx.doi.org/10.1099/ijs.0.64967-0 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"59 (2009) 874 –879, http://dx.doi.org/10.1099/ijs.0.",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"60 (2010) 653 –658, http://dx.doi.org/10.1099/ijs.0.012047-0 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"García, E. Mellado, Halophilic bacteria as a source of novel hydrolytic enzymes, Lifestyles (Basel, Switzerland) 3 (2013) 38 –51, http://dx.doi.org/10.3390/life3010038 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"[9] H. Wang, L. Wang, H. Yang, Y. Cai, L. Sun, Y. Xue, B. Yu, Y. Ma, Comparative proteomic insights into the lactate responses of halophilic Salinicoccus roseus W12, Sci Rep 5 (2015) 13776, http://dx.doi.org/10.1038/srep13776 .",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"1 –7, ,http://dx.doi.org/10.1002/9781118960608.",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"Marth, Bamtools: a C++ API and toolkit for analyzing and managing BAM ﬁles, Bioinformatics 27 (2011) 1691 –1692, http://dx.doi.org/10.1093/bioinformatics/btr174 .",OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"9 (2008) 75, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"33 (2005) 455 –459, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
"41 (2013) 636 –647, http://dx.doi.org/10.1093/nar/gks1194 .Table 3 Quantitative comparison of coding sequence, RNA and subsystem.",OADS,/arxiv_data1/oa_pdf/f1/7d/main.PMC5485554.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/main.PMC5485555.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.017 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/main.PMC5485555.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/87/main.PMC5485556.pdf
Resection http://dx.doi.org/10.1016/j.ijscr.2017.06.006 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/36/87/main.PMC5485556.pdf
"Enzymatic characterization, lithium inhibition, and substrate binding have been also assessed to provide further insight into the properties of http://dx.doi.org/10.1016/j.btre.2017.06.004 Received 5 May 2017; Received in revised form 8 June 2017; Accepted 8 June 2017⁎Corresponding author at: Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.",Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
"10 (9) (2015) e0138436, http://dx.doi.org/10.1371/journal.pone.0138436 (PubMed PMID: 26397812; PubMed Central PMCID: PMCPMC4580611.).",OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
"164 (8) (2011) 1376 –1389, http://dx.doi.org/10.1007/s12010-011- 9219-x (PubMedPMID:21451980).",Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
"284 (6) (2009) 3784 –3792, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
"7 (539) (2011), http://dx.doi.org/10.1038/msb.2011.75 .",Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
"277 (25) (2002) 22863 –22874, http://dx.doi.org/10.1074/jbc.M201042200 (PubMedPMID:11940584).",Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC5485559.pdf
"13      http://www.ijbs.com  682  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 682-689. doi: 10.7150/ ijbs.19695  Research Paper   Sleep Duration and P attern s in Chinese Older Adults : a  Comprehensive M eta-analysis    Li Lu1*, Shi -Bin Wang1, 2*, Wen -Wang Rao3*, Gabor S. Ungvari4, 5, Chee H. Ng6, Helen F.K.",Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
"13      http://www.ijbs.com  683  including short and long sleep duration s have been  common in older adult population globally [1 -6, 12] .",Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
"13      http://www.ijbs.com  684  Results   Studies selection results and basic  characteristics   A total of 6,598 potential papers were identified,  of which 36 papers published in English (n=10) and  Chinese (n=26) with 150,616 subjects met the selection  criteria and were included for analyses (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
13      http://www.ijbs.com  685  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
13      http://www.ijbs.com  686  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
13      http://www.ijbs.com  687  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
"13      http://www.ijbs.com  688  as living rhythm, lifestyle, sleeping environment,  chronic medical conditions, psychiatric disorders and  outdoor activities, are significantly associated with  sleep durat ion in older adults [24, 26] .",Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
13      http://www.ijbs.com  689  22.,Non-OADS,/arxiv_data1/oa_pdf/0e/b8/ijbsv13p0682.PMC5485624.pdf
"13      http://www.ijbs.com  690  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 690-700. doi: 10.7150/ ijbs.17030  Research Paper   Micro RNA-142-3p and let -7g Negatively Regulates  Augmented IL -6 Production in Neonatal  Polymorphonuclear Leukocytes    Hsin- Chun Huang1, 2, Hong -Ren Yu1, Te-Yao Hsu3, I-Lun Chen1, 4, Hui -Chen Huang1, Jen -Chieh Chang1,  and Kuender D. Yang5,6  1.",Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  691  Certain miRNAs have been demonstrate d to  regulate LPS-induced endogenous  expressi on of IL -6  in mice model [8].,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  692              Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  693      Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  694    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  695  in cord than in adult PMN.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  696    Figure 5. miR-142-3p and let -7g precursors supressed IL -6 mRNA and protein expression in cord blood (CB) and adult blood (AB) PMN .,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  697  Stud y had shown controversial on over or under  expression of IL -6 by neutrophils [14] .,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  698  store d at -20°C until use.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  699  in replaced RPMI -1640 medium and were  supplemented with 10% fetal bovine serum.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
13      http://www.ijbs.com  700  chemoresponse to S -1 in colon cancer.,Non-OADS,/arxiv_data1/oa_pdf/45/c2/ijbsv13p0690.PMC5485625.pdf
"13      http://www.ijbs.com  701  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 701-711. doi: 10.7150/ ijbs.17534  Research Paper   Eupafolin Exhibits Potent Anti-Angiogenic and  Antitumor Activity in Hepatocellular Carcinoma    Honglei Jiang1, Dan Wu2, Dong Xu1, Hao Yu1, Zheming Zhao1, Dongyan Ma1, Junzhe Jin1  1.",Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
"13      http://www.ijbs.com  702  family kinase, focal adhesion kinase, and  phosphoinositide 3 -kinase/Akt/eNOS pathway [8, 9] .",Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
"13      http://www.ijbs.com  703  pre-coated with 0.1% gelatin in complete medium,  after cells reached 70 -80% confluence as a monolayer,  cells were treated with 10 μg/ml mitomycin for 2 h to   block  cell proliferation and then t he monolayer was  scratched with a new 10 μl pipette tip  across the  center of the well.",Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  704    Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  705  chemotacti c motility in HUVECs was assessed by  wound -healing migration assay and transwell cell  invasion assay.,OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  706    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  707    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  708  pathway was dramatically inhibited by eupafolin in a  dose dependent manner (Figure 5B).,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  709    Figure 5 .,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  710  eupafolin in a dose -dependent manner.,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
13      http://www.ijbs.com  711  7.,Non-OADS,/arxiv_data1/oa_pdf/67/45/ijbsv13p0701.PMC5485626.pdf
"13      http://www.ijbs.com  712  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 712-722. doi: 10.7150/ ijbs.19508  Review  Mechanism of ribosome translation through mRNA  secondary structures   Ping Xie1, 2, Hong Chen1  1.",Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
13      http://www.ijbs.com  713  L1-tRNA FRET efficiency exhibits the high value  (~0.8)  approximately once before undergoing mRNA  translocation  (see Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
"13      http://www.ijbs.com  714  Model I indicates that no matter when  translation through the mRNA secondary structure or  translation through the single -stranded mRNA, the  ribosomal complex samples the hybrid sta te (State H)  only once before undergoing  mRNA translocation at  saturating concentrations (e.g., 1  µM) of EF -G.GTP  (the smFRET data showed that the translocation time  decreases with increasing EF -G.GTP concentrations  up to 0.5  µM and levels [5], and the smOT data  showed that the translation rate becomes saturating at EF-G.GTP concentrations larger than 0.2  µM [3]), but  with the lifetime of the hybrid state being longer for  the former than for the latter.",Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
"13      http://www.ijbs.com  715  secondary structure or translation through the  single -stranded mRNA, at saturating EF -G.GTP the  ribosomal complex samples the hybrid state (State H)  only once  befo re undergoing mRNA translocation,  which is inconsistent with the smFRET data of Kim et  al.",Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
13      http://www.ijbs.com  716    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
"13      http://www.ijbs.com  717  corresponds  to that after the EF -G-facilitated  transition to State H1 but before the transition of State  H1 to State HR, with the lifetime of  ≈ 2.1 s [5];  the period of low FRET efficiency corresponds  to that  after transition to State HR but before transition back  to State H1, with the lifetime of  ≈ 0.55 s [5]; and  the period of the last high FRET efficiency  corresponds  to that after the transition of State HR to  State H1 to State H2 and before the transition of State  H2 to State POST2, with the lifetime of  ≈ 6.4 s [5].",Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
13      http://www.ijbs.com  718  Model  VI   Another model for ribosome translation through  the mRNA duplex (called Model VI) is shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
"13      http://www.ijbs.com  719  In Model VI, the ribosome uses only one active  mechanism —the mechanical unwinding   mechanism —for its helicase activity [7], consistent  with the recent experimental evidence [12], and the  reduction of the translation rate arises from the  occurrence  of the futile translocation rather than the  reduction of the rate constant of the mRNA  translocation step.",Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
13      http://www.ijbs.com  720    Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
13      http://www.ijbs.com  721  VII are not consistent with the avail able smFRET or  smOT data.,Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
"13      http://www.ijbs.com  722  [23]  Nguyen K, Whitford PC.",Non-OADS,/arxiv_data1/oa_pdf/9c/ca/ijbsv13p0712.PMC5485627.pdf
"13      http://www.ijbs.com  723  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 723-734. doi: 10.7150/ ijbs.19642  Research Paper   Exosomes from Melatonin Treated  Hepatocellularcarcinoma Cells Alter the  Immunosupression Status through STAT3 P athway in  Macrophages    Liang Cheng1*, Jiatao Liu1, 2*, Qingqing Liu1, Yu Liu1, Lulu Fan1, Fang Wang1, Hanqing Yu1, Yuhuan Li1,  Lijia Bu1, Xiaoqiu Li1, Wei Wei3, Hua Wang1, 4, Guoping Sun1  1.",Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
"13      http://www.ijbs.com  724  Introduction   Hepatocellular carcinoma (HCC), one of the  malignant cancers  which mortality ranks as the fifth  in the  world, continues to have a great extent of drug  resistance and lack of effective treatment  [1].",Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  725  All cells were cultured at 37°C and with a humidified  atmosphere of 5% CO 2.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  726  from the National Institutes of Health for the care and  use of Laboratory Animals.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
"13      http://www.ijbs.com  727  Exosomes can be taken up by macrophages    To determine the effects of exosomes on the  function of macrophages, we examined whether  exosomes could enter macrophages .",OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  728    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  729  downregulated  in the Exo- MT group compared to the  Exo-con group.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  730    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
"13      http://www.ijbs.com  731  (IL-10), a negative factor in regulating the immune  system was found to be up -regulated in the Exo -con  group, which would play a crucial role in suppressing  the immune system for the tumor microenvironment   [40].",Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  732    Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  733    Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
13      http://www.ijbs.com  734  17.,Non-OADS,/arxiv_data1/oa_pdf/78/4d/ijbsv13p0723.PMC5485628.pdf
"13      http://www.ijbs.com  735  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 735-747. doi: 10.7150/ ijbs.18153  Research Paper   Genome -wide Identification  and Expression Analysis of  Amino Acid Transporters in the Whitefly, Bemisia tabaci  (Gennadius)    Jixing Xia1, 2, 3*, Zezhong Yang3, 4*, Cheng Gong3*, Wen Xie3, Huipeng Pan5, Zhaojiang Guo3, Huixin Zheng3,  4, Xin Yang3, Xiaodong Sun3, Shi Kang3, Fengshan Ya ng6, Qingjun Wu3, Shaoli Wang3, Bin Cong1, Xianfeng  Teng2, Youjun Zhang3  1.",Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC B Y-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  736  nutritional roles in insects [8 -18]: the amino  acid/polyamine/organocation (APC) family and the  amino acid/auxin permease (AAAP) family.,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  737  of seven other insect species were searched for APCs  and AAAPs based on the methods described above  for B. tabaci  B.,OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
Full- length amino acid sequences were  aligned with MUSCLE using MEGA 6  (http://www.megasoftware.net/).,OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  738  positive selection.,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
"13      http://www.ijbs.com  739  Results   Identification of APC and AAAP transporter  genes in the genome of B. tabaci B   Predicted APC and AAAP transporters in B.  tabaci  B were identified by searching for Pfam HMM  AA_permease (PF00324) and Aa_trans  (PF01490),  respectively.",OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  740    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  741  genome.,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
"13      http://www.ijbs.com  742  The studies of APC family showed that the  BtAPC4  and BtAPC12  were most highly expressed  throughout all of the developmental stages, whereas  the BtAPC5 , BtAPC13 , and BtAPC14  were lowly  expressed.",Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  743  Molecular evolutionary insights into the  evolution of AAAP transporter expansion in B.  tabaci B  We used AAAP expression profiles of different  stages to determine whether branches resting in  stage -based paralogs experienced accelerated  evolution rates.,OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
"13      http://www.ijbs.com  744  We were interested to determine whether the  accelerated evolution rates of BtAAAP16 , BtAAAP17   and BtAAAP20  resulted from positive selection or  relaxed selection.",Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
"13      http://www.ijbs.com  745  In our phylogenetic analysis of APC family  genes in insec ts, BtAPC3  clustered with AaAPC5   (AAEL009362), which plays a key role in nutritional  signaling during mosquito reproduction [10].",Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  746  not evolving at a significan tly higher rate than other  branches (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
13      http://www.ijbs.com  747  10.,Non-OADS,/arxiv_data1/oa_pdf/2a/19/ijbsv13p0735.PMC5485629.pdf
"13      http://www.ijbs.com  748  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 748-758. doi: 10.7150/ ijbs.18472  Research Paper   Oncogenic Protein Kinase D3 Regulating Networks in  Invasive Breast Cancer    Yan Liu1, 2*, Jian  Li1*, Jun Zhang1, 2*, Zhenghong Yu3*, Shiyi Yu1, 2*, Lele  Wu1, 2, Yuzhi  Wang1, 2, Xue Gong1, 2,  Chenxi Wu1, 2, Xiuxiu  Cai1, 2, Lin Mo3, Mingya Wang1, Jun Gu3, Liming Chen1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
"13      http://www.ijbs.com  749  angiogenesis, migration, and invasion via linking to a  diverse set of cancer  regulated signal transduction  pathways, such as the AKT, ERK1/2,  JNK, CREB,  HDAC and RAS/MAPK pathway [6-8].",Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  750  anti-mouse secondary antibody were purchased from  Kangchen.,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  751  normalization.,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  752    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
"13      http://www.ijbs.com  753  Other pathways are involved in various biological  events, including gene expression  (3 pathways),  programmed cell death (2 pathways), c hromatin  organization  (1 pathways) and signaling transduction   (1 pathways) (Figure 3A and Supplementary Table 4).",Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  754    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
"13      http://www.ijbs.com  755  A gene was regarded to be a PRKD3 regulated  gene, if its expression fold change between the sample  and control reached 1.5 fold with p<0.05 upon  silencing PRKD3 .",Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  756    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  757  indicates that PRKD3 is likely to play a role in energy  metabolism events in invasive breast cancer (Figure  5B).,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
13      http://www.ijbs.com  758  References   1.,Non-OADS,/arxiv_data1/oa_pdf/72/97/ijbsv13p0748.PMC5485630.pdf
"13      http://www.ijbs.com  759  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 759-771. doi: 10.7150/ ijbs.19820  Research Paper   Two Olfactory Pathways to Detect Aldehydes on  Locust Mouthpart  Liwei Zhang , Hongwei Li  and Long Zhang  Department of Entomology, China Agricultural University, Beijing 100193, PR China     Corresponding author : locust@cau.",Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  760  while the other is OR -independent and requires the  existence of IRs [12].,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
"13      http://www.ijbs.com  761  In order to relatively compare expression level,  20 µl of PCR pro duct was imaged on 1.5 % agarose  gel.",Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
"13      http://www.ijbs.com  762  palps contribute to behavior, either or both were  ablated.",Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  763    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  764  Next we performed additional experiments with  the goal of quantifying the response.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  765    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
"13      http://www.ijbs.com  766  Extracellular responses in mouthparts sensilla  basiconica tuned to two aldehydes   To further testify these two aldehydes are truly  detected via olfactory basiconica on the palp,  extracellular responses of basiconica ORNs to  E-2-Hexenal and Hexanal were recorded.",OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
"13      http://www.ijbs.com  767  Identification of IR8a and obp2a r equired for  detection of Hexanal   Dendritic localization of specific ORs requires  Orco, and mutation of Orco removes behavioral  responses toward many odorants [32] .",Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
"13      http://www.ijbs.com  768  co-receptor could continue signal trafficking on the  membrane to certain compounds, if not all.",Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  769  in similar spiking activity [45] .,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  770  Abbreviations   OR: Odorant receptor; IR: Ionotropic receptor;  OBP: Odorant binding protein; ORN: Olfactory  receptor neuron; GRN: Gustatory receptor neuron;  POR: Palp opening response; GLV: Green leaf  volatiles; iGlu Rs: Ionotropic glutamate receptors;  RNAi: RNA interference; FISH : Fluorescence in situ  hybridization .,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  771  36.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/ijbsv13p0759.PMC5485631.pdf
13      http://www.ijbs.com  772  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 772-781. doi: 10.7150/ ijbs.19603  Review  Angiomotin Family Members: Oncogenes or Tumor  Suppressors?,Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
This is an open access article distributed under the terms of the Creative Commo ns Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  773  Amot in cancers , with an emphasis  on the discovery,  structure, expression, location, and function of these  molecules.",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
13      http://www.ijbs.com  774  Table  1.,Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  775  Phosphorylated Amot -p130 proteins are not localized  to TJs and inhibit stress fiber and focal adhesion  formation, suggesting that the phosphorylation of  Amot inhi bits cell migration  [22].",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  776  In summary, distinct Amot isoforms play  specific  roles  in normal epithelial cells.",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  777  Hepatic carcinoma  and renal cell cancer   After liver injury, Amot deletion impedes the  proliferation of biliary epithelial cells and  tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  778  cell fate determination, including tumorigenesis  [53].",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  779  Other signaling pathways   In addition to the Hippo signaling pathway,  other pathways control Amot proteins.",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  780  the Hippo signaling pathway, Amot regulate the Wnt  and MAPK/ERK signaling pathwa y.",Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
13      http://www.ijbs.com  781  28.,Non-OADS,/arxiv_data1/oa_pdf/97/69/ijbsv13p0772.PMC5485632.pdf
"13      http://www.ijbs.com  782  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 782-793. doi: 10.7150/ ijbs.18732  Research Paper   Dioscin  Induces Gallbladder Cancer Apoptosis by  Inhibiting ROS -Mediated PI3K/AKT Signalling    Xiaoling Song1, 2*, Zheng Wang1, 2*, Haibin Liang1, 2*, Wenjie Zhang1*, Yuanyuan Ye1, 2, HuaiFeng Li1, 2,  Yunping Hu1, 2, Yijian Zhang1, 2, Hao Weng1, Jianhua Lu1, Xuefeng Wang1, Maolan Li1, 2, Yingbin Liu1, 2,  Jun Gu1  1.",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  783  generation of ROS through mitochondria dysfunction   [10].,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
"13      http://www.ijbs.com  784  Shanghai, China).",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  785      Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  786  profound effect on cell survival and drug sensitivity  by altering the ability of cells to detoxify ROS  [15].,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  787    Figure  3.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  788  transfected wild -type A KT (WT-AKT) and  constitutively active A KT (CA-AKT) into GBC cells.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  789    Figure  5.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  790    Figure  6.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  791    Figure  7.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
"13      http://www.ijbs.com  792  concluded  that DSN i nhibits ROS elimination and  then induces significant  ROS  accumulation in GBC  cells, leading to oxidative damage and cell death.",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
13      http://www.ijbs.com  793  9.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ijbsv13p0782.PMC5485633.pdf
"13      http://www.ijbs.com  794  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 794-803. doi: 10.7150/ ijbs.18969  Research Paper   Berberine Reverses Hypoxia -induced Chemoresistance  in Breast Cancer through the Inhibition of AMPK -  HIF-1α   Yue Pan1, Dan Shao1, Yawei Zhao1, Fan Zhang1, Xiao Zheng1, Yongfei Tan1, Kan He1, Jing Li1, Li Chen1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
"13      http://www.ijbs.com  795  extrusion by cell membrane pumps, drug -induced  apoptosis  inhibition an d drug target molecules   modification might play crucial roles on   hypoxia -induced chemotherapeutic resistance [4].",Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
"13      http://www.ijbs.com  796  different concentrations DOX and co- treated with 2.5,  5, 10 μM berberine separately were indicated with/or  6.25 μM IOX2 for 48  h. the cells were fixed with 10%  trichloroacetic acid, and 0.4% (w/v) SRB in 1% acetic  acid was  added to stain the cells.",Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
13      http://www.ijbs.com  797  MCF -7/hypoxia increase s about  8.4%～60.1% at the  D O X  d o s a g e  r a n g e  f r o m  0 .,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
13      http://www.ijbs.com  798    Figure  2.,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
"13      http://www.ijbs.com  799  Low-dose berberine resensitized  DOX  chemosensitivity of MCF -7/hypoxia cell s  To investigate whether low -dose berberine could  increase DOX chemosensitivity, we  treated  MCF -7/hypoxia cells with DOX (concentrations from  0.04 to 5 μg/mL) for 48 h and 72 h combi ned with low  concentrations  of berberine (2.5 μM, 5 μM and 10 μM).",Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
13      http://www.ijbs.com  800    Figure  4.,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
13      http://www.ijbs.com  801  High -dose berberine induces apoptosis  by  AMPK -HIF-1α downregulaton inducing p53  activation   It is showed that high -dose berberine ( 40 μM)  could directly induce apoptosis in MCF- 7/hypoxia   cells (Fig.2B) .,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
13      http://www.ijbs.com  802    Figure  7.,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
"13      http://www.ijbs.com  803  role on the DOX chemosensitivity of low -dose  berberine, while HIF -1α down- regulation inducing  p53 activation led to apoptosis in high -dose  berberine.",Non-OADS,/arxiv_data1/oa_pdf/a4/f4/ijbsv13p0794.PMC5485634.pdf
"13      http://www.ijbs.com  804  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2017; 13(6): 804-814. doi: 10.7150/ ijbs.19398  Research Paper   Stroma -derived Fibrinogen -like Protein 2  Activates  Cancer -associated Fibroblasts to Promote Tumor  Growth in Lung Cancer    Ying Zhu1, 2*, Longhui Zhang1, 2*, Haoran Zha1, 2, Fei Yang3, Chunyan Hu1, 2, Lin Chen4, Bo Guo3, Bo Zhu1, 2  1.",Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
See http://ivyspring.com/terms  for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
13      http://www.ijbs.com  805  and promotes tumorigenesis and metastasis in  immune -deficient mice  [10-12].,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
"13      http://www.ijbs.com  806  cell lysis and  blocking of Fc receptors, cells were  stained with anti -PDGFR α and anti -F4/80 antibodies  (Biolegend) at a 1:100 dilution for 30 min on ice.",Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
"To  investigate whether F gl2 w as widely produced  by  various cancer cells in addition to glioma  and  hepatoma cells , we analyzed  the mRNA levels of F gl2  in different type s of cancer cell lines using the Cancer  Cell Line Encyclopedia (CCLE) database  (http://www.broadinstitute.org/ccle/home).",OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
"13      http://www.ijbs.com  807  tumor cells directly, we assessed the effect of Fgl2 on  proliferation and apoptosis of LLC cells in vitro .",Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
13      http://www.ijbs.com  808    Figure  2.,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
"13      http://www.ijbs.com  809  In addition, the proportions of TAMs  (F4/80+CD206+) and Treg cells (CD4+Foxp3+) in WT  and Fgl2 -KO mice were also similar (Figure  2 C&E).",Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
13      http://www.ijbs.com  810      Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
13      http://www.ijbs.com  811    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
13      http://www.ijbs.com  812    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
"13      http://www.ijbs.com  813  mice, and the  studies focus ed on the functional  changes in tumor cells that  were intervened Fgl2  expression [10-12].",Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
13      http://www.ijbs.com  814  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/90/c1/ijbsv13p0804.PMC5485635.pdf
"We closely examined 16,202 SNPs in 295 candidate ADME genes from PharmaADME (http://www.pharmaadme.org/) and their surrounding regions ( 62 kb) for association with PRU or PRU >208 and the H4 concentration in 115 patients with CHD.",Non-OADS,/arxiv_data1/oa_pdf/a0/1f/CPT-101-791.PMC5485718.pdf
<http://www.fda.gov/ RegulatoryInformation/Guidances/default.htm >.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/CPT-101-745.PMC5485720.pdf
<http://sk.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/d8/bf/CPT-101-745.PMC5485720.pdf
<http://www.accessdata.fda.gov/ drugsatfda_docs/label/2015/207500Orig1s000lbl.pdf >(2015).,Non-OADS,/arxiv_data1/oa_pdf/cb/b5/CPT-101-782.PMC5485736.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jech-2016-208025).,Non-OADS,/arxiv_data1/oa_pdf/9f/b6/jech-2016-208025.PMC5485750.pdf
"Second, we inves-tigated the effects of replacing our postcode-speciﬁ c modelled pollution concentrations with daily mean pollution measure-ments from the London Bloomsbury monitoring station of theAutomatic Urban and Rural Network (AURN) of the UKDepartment for Environment, Food and Rural Affairs (http://uk-air.defra.gov.uk).",Non-OADS,/arxiv_data1/oa_pdf/9f/b6/jech-2016-208025.PMC5485750.pdf
[http://www.metof ﬁce.gov.uk/ public/weather/climate/gcpsvf37b] (accessed 5 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/9f/b6/jech-2016-208025.PMC5485750.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Lee JS, Joo EJ, Choi KS.",Non-OADS,/arxiv_data1/oa_pdf/1c/40/jech-2016-208283.PMC5485751.pdf
"http://www.mohw.gov.tw/EN/Ministry/Statistic.aspx?f_list_no=474 34 Pearlin LI, Mullan JT, Semple SJ, et al.",OADS,/arxiv_data1/oa_pdf/1c/40/jech-2016-208283.PMC5485751.pdf
http://cpms.chiba-u.jp/enquete/consent.php (15 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/e8/35/jech-2016-208088.PMC5485752.pdf
"Although data sharing agreements prohibit ICES from making the data set publicly available, access may be granted to those who meet the conditionsfor con ﬁdential access, available at http://www.ices.on.ca/Data-Services.",OADS,/arxiv_data1/oa_pdf/ef/20/jech-2016-208525.PMC5485756.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Immigration and ethnocultural diversity in Canada (99 –010-X).,Non-OADS,/arxiv_data1/oa_pdf/ef/20/jech-2016-208525.PMC5485756.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.05.012,Non-OADS,/arxiv_data1/oa_pdf/fe/c3/main.PMC5485758.pdf
"A total of 1038 high-quality se- quences (182 595 subreads) were obtained from the sequencing.The sequences were assembled using HGAP 3.0, and annotation was carried out with National Center for Biotechnology Infor- mation (NCBI) Prokaryotic Genome Annotation Pipeline [12] through the NCBI Genome submission portal (GenomeSubmit, http://ncbi.nlm.nih.gov ).",OADS,/arxiv_data1/oa_pdf/fe/c3/main.PMC5485758.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 4–37 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/fe/c3/main.PMC5485758.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 4–37 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/fe/c3/main.PMC5485758.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 4–37 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/fe/c3/main.PMC5485758.pdf
"Commentary In Silico Restriction Enzyme Digests to Minimize MappingBias in Genomic Sequencing Jason Roszik,1,2György Feny }ofalvi,3László Halász,3,4Zsolt Karányi,3 and Lóránt Székvölgyi3,4 http://dx.doi.org/10.1016/j.omtm.2017.06.003 A commonly used genome fragmentation method in next generation sequencing, re-striction endonuclease (RE) digestion, mayseverely compromise genomic mapping res-olution and prevent the functional annota-tion of certain chromosomal regions unlessREs are applied in correct combinations to sample all genomic regions with an equal probability.",Non-OADS,/arxiv_data1/oa_pdf/62/c7/main.PMC5485759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/c7/main.PMC5485759.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/a0/main.PMC5485760.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.06.008 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/a0/main.PMC5485760.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2017.06.008 .",OADS,/arxiv_data1/oa_pdf/12/a0/main.PMC5485760.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/7c/main.PMC5485761.pdf
"Thus,  to  conﬁrm  this  rare http://dx.doi.org/10.1016/j.ijscr.2017.06.013 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/3f/7c/main.PMC5485761.pdf
"Given that each cancer is different in terms of the molecularevents involved in its development, and if these oncogenes are thelong sought-after Achilles ’heel of cancer, exploiting this concept http://dx.doi.org/10.1016/j.omtn.2017.06.006 .",Non-OADS,/arxiv_data1/oa_pdf/bc/27/main.PMC5485762.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/27/main.PMC5485762.pdf
"Nature, Published online June 22, 2016. http://dx.doi.org/10.1038/nature.2016.20137 .",OADS,/arxiv_data1/oa_pdf/bc/27/main.PMC5485762.pdf
http://dx.doi.org/10.1016/j.omtn.2017.06.003 .,OADS,/arxiv_data1/oa_pdf/10/1a/main.PMC5485763.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/1a/main.PMC5485763.pdf
https://www.diabetes.org.uk/ Documents/AboutUs/Statistics/Diabetes-key-stats-guidelines-April2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/10/1a/main.PMC5485763.pdf
"London Department of Health, http://webarchive.nationalarchives.gov.uk/ 20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_088967.pdf .",Non-OADS,/arxiv_data1/oa_pdf/10/1a/main.PMC5485763.pdf
The PB system features transposons that can cutand paste transgenes into the genome where a TTAA sequence is Received 5 March 2017; accepted 10 June 2017; http://dx.doi.org/10.1016/j.omtn.2017.06.007 .,OADS,/arxiv_data1/oa_pdf/cf/e1/main.PMC5485764.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/e1/main.PMC5485764.pdf
"For each marker, the percentage of ﬂuores- cence protein-expressing cells or positively stained cells was calcu- lated from at least ten low-magni ﬁcation ﬁelds.SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/cf/e1/main.PMC5485764.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/5e/main.PMC5485858.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2017.02.007 2451-8654/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/5e/main.PMC5485858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 6 (2017) 22 e30,Non-OADS,/arxiv_data1/oa_pdf/a3/5e/main.PMC5485858.pdf
"Upon hospitalization, the patient was also submitted to biopsy of the skin lesion and lymph node of the anterior compartment http://dx.doi.org/10.1016/j.mmcr.2017.06.005 Received 3 May 2017; Received in revised form 14 June 2017; Accepted 18 June 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/94/fb/main.PMC5485862.pdf
This is an open access article under the CC  BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/fb/main.PMC5485862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/13/main.PMC5485864.pdf
"However, the absence of the suitable chelating agent that can form stable complex with anionic species http://dx.doi.org/10.1016/j.jare.2017.06.005 2090-1232/ /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/14/13/main.PMC5485864.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of Cairo University.,Non-OADS,/arxiv_data1/oa_pdf/14/13/main.PMC5485864.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/4b/ndt-13-1603.PMC5485890.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1603–1611Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1603OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12639 7 effects of subthalamic nucleus deep brain  stimulation on emotional working memory capacity  and mood in patients with Parkinson’s disease angela Merkl1,2 eva röck1 Tanja schmitz-hübsch1,3 gerd-helge schneider4 andrea a Kühn1,3,5 1Department of Neurology, charité –  University Medicine Berlin, campus  Virchow Klinikum, 2Department  of Psychiatry and Psychotherapy,   charité – University Medicine  Berlin, campus Benjamin Franklin,   3Neuro cure, charité – University  Medicine Berlin, 4Department of  Neurosurgery, charité – University  Medicine Berlin, campus Virchow  Klinikum, 5Berlin school of Mind and  Brain, charité – University Medicine  Berlin, Berlin, germanyBackground:  In Parkinson’s disease (PD), cognitive symptoms and mood changes may be  even more distressing for the patient than motor symptoms.",Non-OADS,/arxiv_data1/oa_pdf/44/4b/ndt-13-1603.PMC5485890.pdf
"There is  evidence that, in addition to the motor loop, other cortico-BG-thalamocortical loops that  are associated with cognitive (dorsolateral and lateral orbitofrontal loops) and emotional  function (anterior cingular loop) may be affected by DBS by current spread, leading to correspondence: angela Merkl Department of Neurology, charité –  University Medicine Berlin, campus  Virchow Klinikum, augustenburger  Platz 1, 13353 Berlin, germany Tel +49 30 450 560 123 Fax +49 30 450 560 932 email angela.merkl@charite.d e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Merkl et al Running head recto: Emotional working memory in patients with idiopathic PD after STN-DBS DOI: http://dx.doi.org/10.2147/NDT.S126397",Non-OADS,/arxiv_data1/oa_pdf/44/4b/ndt-13-1603.PMC5485890.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/44/4b/ndt-13-1603.PMC5485890.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/4b/ndt-13-1603.PMC5485890.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/77/copd-12-1837.PMC5485891.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1837–1845International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1837OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S129213 hospital admissions and mortality in patients  with COPD exacerbations and vertebral body  compression fractures sergi Pascual-guardia1–3 Diana Badenes-Bonet1,2 Clara Martin-Ontiyuelo1,2 Flavio Zuccarino4 Judith Marín-Corral5 alejandro rodríguez3,6 esther Barreiro1–3 Joaquim gea1–3 1Department of respiratory Medicine,   hospital del Mar-IMIM, Barcelona,   spain; 2Department CeXs, Universitat  Pompeu Fabra, Barcelona, spain;   3CIBeres, IsCiii.",Non-OADS,/arxiv_data1/oa_pdf/97/77/copd-12-1837.PMC5485891.pdf
"Both can  contribute to the development of ventilatory restriction.6,12,13Correspondence: Joaquim gea servicio de neumología, hospital  del Mar, Pg Marítim 27, 08003  Barcelona, spain Tel +34 93 248 3138 Fax +34 93 248 3425 email jgea@parcdesalutmar.ca t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Pascual-Guardia et al Running head recto: Vertebral fractures and COPD outcomes DOI: http://dx.doi.org/10.2147/COPD.S129213",Non-OADS,/arxiv_data1/oa_pdf/97/77/copd-12-1837.PMC5485891.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/97/77/copd-12-1837.PMC5485891.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/77/copd-12-1837.PMC5485891.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/d8/ijn-12-4541.PMC5485892.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4541–4551International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4541OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13932 6 regulation of apoptosis through bcl-2/bax proteins  expression and DN a damage by nano-sized  gadolinium oxide saud alarifi1 huma ali2 saad alkahtani1 Mohammed s alessia3 1Department of Zoology, college  of science, King saud University,   riyadh, saudi arabia; 2Department  of chemistry, Maulana azad National  Institute of T echnology Bhopal, MP ,   India; 3Department of Biology, Faculty  of science, al-Imam Muhammad  Ibn saud Islamic University,   riyadh, saudi arabiaAbstract:  Gadolinium oxide (Gd2O3) nanoparticles (GNPs) are applied in industrial products,  for example, additives, optical glass, and catalysis.",Non-OADS,/arxiv_data1/oa_pdf/f7/d8/ijn-12-4541.PMC5485892.pdf
"Gadolinium chelates induced potential toxicity such as nephrogenic fibrosis.7  In this regard, it is essential to develop effective in vivo nanoparticle toxicity assay to  avoid missing or having lower toxicity in vitro.8 Babic-Stojic et al9 have reported that correspondence: huma ali Department of chemistry, Maulana azad  National Institute of Technology, link  road Number 3, Near Kali Mata Mandir,  Bhopal, Madhya Pradesh 462003, India email humali.manit@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Alarifi et al Running head recto: Regulation of apoptosis DOI: http://dx.doi.org/10.2147/IJN.S139326",Non-OADS,/arxiv_data1/oa_pdf/f7/d8/ijn-12-4541.PMC5485892.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f7/d8/ijn-12-4541.PMC5485892.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/d8/ijn-12-4541.PMC5485892.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/a3/copd-12-1775.PMC5485893.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1775–1780International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1775OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S13265 2 serum levels of IgFBP7 are elevated during  acute exacerbation in COPD patients Wenjing ruan1 Minliang Wu2 liuhong shi1 Fengying li3 liangliang Dong1 Yuanhua Qiu1 Xiaohong Wu1 Kejing Ying1 1Department of respiratory Diseases,   sir run run shaw hospital, school  of Medicine, Zhejiang University,   2Department of laboratory, The  second affiliated hospital of Zhejiang  University, school of Medicine,   3Department of laboratory, sir  run run shaw hospital, school of  Medicine, hangzhou, ChinaObjective:  The purpose of this study was to explore the insulin-like growth factor binding  protein 7 (IGFBP7) level in the serum of chronic obstructive pulmonary disease (COPD) patients  during acute exacerbation (AE).",Non-OADS,/arxiv_data1/oa_pdf/e6/a3/copd-12-1775.PMC5485893.pdf
"Biomarkers may fluctuate in accordance with disease state, which may provide  important clues to the potential signaling pathways of the disease.7Correspondence: Kejing Ying Department of respiratory Diseases,  sir run run shaw hospital, school  of Medicine, Qingchun east road  3#, 310016 Zhejiang University,  hangzhou, China email rwj@zju.edu.c n Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ruan et al Running head recto: Serum levels of IGFBP7 are elevated during AE in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S132652",Non-OADS,/arxiv_data1/oa_pdf/e6/a3/copd-12-1775.PMC5485893.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e6/a3/copd-12-1775.PMC5485893.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/a3/copd-12-1775.PMC5485893.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/d7/ijn-12-4527.PMC5485894.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4527–4539International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4527OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12995 8 Preparation and antioxidant properties of selenium  nanoparticles-loaded chitosan microspheres Kaikai Bai1,2 Bihong hong1,2 Jianlin he1,2 Zhuan hong1,2 ran Tan1,2 1Third Institute of Oceanography,   2engineering research center  of Marine Biological resource,   comprehensive Utilization, state  Oceanic administration, Xiamen,   People’s republic of chinaAbstract:  Selenium nanoparticles (SeNPs), as a special form of selenium (Se) supplement,  have attracted worldwide attention due to their favorable properties and unique bioactivities.",Non-OADS,/arxiv_data1/oa_pdf/2c/d7/ijn-12-4527.PMC5485894.pdf
"Keywords:  selenium, nano, microsphere, chitosan, antioxidant Introduction As a dietary nutrient, Se is an indispensable trace element required for most of the liv - ing organisms including animals and human beings.1 Se is present in at least 25 human  selenoproteins and enzymes as selenocysteine, which plays an essential role in prevent - ing various diseases such as cardiovascular disease, hypercholesterolemia and certain  cancers.1,2 To meet the daily requirement of Se, extra Se supplementation is necessary,  especially for those having Se deficiency.1,2 Some Se compounds in both inorganic  and organic forms, such as selenite, selenomethionine and Se-methylselenocysteine,  have been used for decades to avoid Se deficiency in animals and human beings.2  However, these Se supplements, especially the inorganic ones, are usually toxic when  taken above their nutritional dosage.2 In the recent years, SeNP, a kind of elemental Se particle at a nano-size scale with  a bright red color, has aroused worldwide attention due to its unique properties and  excellent biological activities.2–5 It not only scavenges the free radicals in vitro6 but also  improves growth, serum oxidant status and Se concentration in vivo.3–5 Amazingly,  compared with Se compounds such as selenite,3,5 selenomethionine,4 Se-yeast5 and  Se-methylselenocysteine,7 SeNPs exhibit much lower acute toxicity while increasing correspondence: Kaikai Bai Third Institute of Oceanography, state  Oceanic administration, No 184, Daxue  road, siming District, Xiamen, Fujian  361005, People’s republic of china email kkbai@tio.org.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bai et al Running head recto: Preparation and antioxidant properties of SeNPs-M DOI: http://dx.doi.org/10.2147/IJN.S129958",Non-OADS,/arxiv_data1/oa_pdf/2c/d7/ijn-12-4527.PMC5485894.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2c/d7/ijn-12-4527.PMC5485894.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/d7/ijn-12-4527.PMC5485894.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1847–1856International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1847OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S13445 5 anti-p-benzoquinone antibody level as a  prospective biomarker to identify smokers at  risk for COPD santanu Banerjee1 Parthasarathi  Bhattacharyya2 subhra Mitra3 somenath Kundu4 samiran Panda5 Indu B Chatterjee1 1Department of Biotechnology and  Dr B C guha Centre for genetic  engineering and Biotechnology,   University College of science and  T echnology, University of Calcutta,   2Institute of Pulmocare and research,   3Department of Pulmonary Medicine,   Calcutta national Medical College,   4Department of Chest Medicine,   Institute of Post graduate Medical  education and research, 5national  Institute of Cholera and enteric  Diseases, Kolkata, IndiaBackground and objective:  Identification of smokers having predisposition to COPD  is important for early intervention to reduce the huge global burden of the disease.",Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
"Keywords:  COPD, cigarette smoke, biomarker, anti- p-benzoquinone antibody, enzyme-linked  immunosorbent assay (ELISA) Introduction COPD is currently the fourth leading cause of death worldwide.1 In 2015, about  3 million deaths were caused by this disease, and it was almost 5% of all deaths that  globally occurred in that year.2 It is predicted that COPD will cause 7.8% of global  deaths by 2030.3 Besides mortality, COPD results in morbidity and productivity loss,  in addition to presenting a great burden to both individual patients and the health care Correspondence: Indu B Chatterjee Department of Biotechnology and  Dr B C guha Centre for genetic  engineering and Biotechnology, University  College of science and Technology,  University of Calcutta, 35 Ballygunge  Circular road, Kolkata 700019, India Tel +91 983 049 3842 email ibchatterjee123@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Banerjee et al Running head recto: A biomarker for identification of smokers at risk for COPD DOI: http://dx.doi.org/10.2147/COPD.S134455",Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs310/en /.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
Available from: http://www.who.int/mediacentre/ factsheets /fs315/en /.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/copd-12-1847.PMC5485895.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1825–1836International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1825OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12900 7 a retrospective study to assess clinical  characteristics and time to initiation of open-triple  therapy among patients with chronic obstructive  pulmonary disease, newly established on long- acting mono- or combination therapy Douglas Mapel1 François laliberté2 Melissa h roberts1,3 susan r sama4 Devi sundaresan4 Dominic Pilon2 Patrick lefebvre2 Mei sheng Duh5 Jeetvan Patel6 1health services research Division,   lovelace Clinic Foundation,   albuquerque, nM, Usa; 2groupe  d’analyse, Montreal, QC, Canada;   3Department of Pharmacy Practice  and administrative sciences,   University of new Mexico, College  of Pharmacy, University of new  Mexico, albuquerque, nM, 4research  Department, reliant Medical group,   Worcester, M a, 5analysis group,   Boston, M a, 6Us health Outcomes,   glaxosmithKline, research Triangle  Park, nC, UsaIntroduction:  An incremental approach using open-triple therapy may improve outcomes in  patients with chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"Keywords:  COPD, open-triple therapy, long-acting muscarinic antagonists, inhaled corticos - teroids, long-acting β-agonists Introduction Treatment options for patients with chronic obstructive pulmonary disease (COPD)  such as inhaled bronchodilators (eg, long-acting muscarinic antagonists [LAMAs]  and long-acting β2-agonists [LABAs]) and inhaled corticosteroids (ICS) are central to Correspondence: Douglas Mapel health services research Division,  lovelace Clinic Foundation,  2309 renard Place se, suite 103,  albuquerque, nM 87106, Usa Tel +1 505 235 1434 email dmapel@comcast.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Mapel et al Running head recto: Open-triple therapy in patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S129007",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"Available from:  http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis- management.htm l. Accessed January 25, 2017.",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"Available from: https://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pd f. Accessed  March 16, 2017.",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"Available from: http://www.wma.net/ en/30publications/10policies/b3/index.htm l. Accessed March 16, 2017.",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/a6/copd-12-1825.PMC5485896.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/04/copd-12-1781.PMC5485897.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1781–1791International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1781OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10462 7 Dysregulation of microrna-214 and PTen  contributes to the pathogenesis of hypoxic  pulmonary hypertension haiTao liu Tao Yin Wenjun Yan rui si Bo Wang Mai Chen Fei li Qiong Wang ling Tao Department of Cardiology, Xijing  hospital, Fourth Military Medical  University, Xi’an, shaanxi, People’s  republic of ChinaAbstract:  Hypoxia-induced pulmonary hypertension, which is characterized by vascular  remodeling of blood vessels, is an important complication in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6e/04/copd-12-1781.PMC5485897.pdf
"The  mechanisms underlying the progression and development remain largely unknown,  and, if identified, it is possible that key therapeutic targets will be provided.3–5 Two mechanisms, vasoconstriction and the subsequent remodeling of medium- and  small-sized pulmonary arteries, serve as hallmarks of advanced and severe PH and  have been believed to contribute to PH.6 Abnormal proliferation and hypertrophy of Correspondence: ling Tao Department of Cardiology, Xijing  hospital, Fourth Military Medical  University, 15 Changlexi street,  Xi’an, shaanxi 710032, People’s  republic of China email phypertension@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liu et al Running head recto: miR-214 induces PH via targeting PTEN DOI: http://dx.doi.org/10.2147/COPD.S104627",Non-OADS,/arxiv_data1/oa_pdf/6e/04/copd-12-1781.PMC5485897.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6e/04/copd-12-1781.PMC5485897.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/04/copd-12-1781.PMC5485897.pdf
"https://doi.org/10.1177/1176935117711940 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Cancer Informatics Volume 16: 1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176935117711940 Introduction ClinicalTrials.gov is a database of clinical trials hosted by the  National Library of Medicine and the National Institutes of Health.",Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
"Therefore, the authors have released the grading software used to create the data classes to the public at http://cps-xena.cps.cmich.edu/ctdemo.",OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
https://clinicaltrials.gov/ct2/about-site/background.,Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
"Accessed August 11, 2015 (Archived by WebCite® http://www.webcitation.",Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
https://clinicaltrials.gov/ct2/show/ NCT01260415.,Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
http://cancer.sanger.ac.uk/cosmic.,Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
"Accessed August 3, 2015 (Archived by WebCite ® http://www.webcitation.org/6aW1CtNMd).",OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
https://clinicaltrials.gov/ct2/show/NCT02097810?term=ALK &recr=Open&rank=27.,Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
A Long-Term Safety Study of ALKS 5461. https://clinicaltrials.gov/ct2/show/ NCT02141399?term=ALK&recr=Open&rank=24.,Non-OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
"Accessed March 24, 2017  (Archived by WebCite http://www.webcitation.org/6pD77OhWO).",OADS,/arxiv_data1/oa_pdf/5e/ff/10.1177_1176935117711940.PMC5485907.pdf
"Published with license by Taylor & Francis Group, LLC © Claudia Penafuerte, Matthew Feldhammer, John R. Mills, Valerie Vinette, Kelly A. Pike, Anita H all, Eva Migon, Gerard Karsenty, Jerry Pelletier, George Zogopoulos, and Michel L. Tremblay.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
"6, e1321185 (14 pages)https://doi.org/10.1080/2162402X.2017.1321185",Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Immunol Rev 2014; 261:84-101;PMID:25123278; https://doi.org/10.1111/imr.12198 2.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Biol Chem 2001; 276:47771-4; PMID:11694501; https://doi.org/10.1074/jbc.M009472200 3.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Sci Signal 2014; 7:ra43; PMID:24803538; https://doi.org/ 10.1126/scisignal.2005020 5.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Curr Biol 2002; 12:446-53; PMID:11909529; https://doi.org/10.1016/S0960-9822(02)00697-8 6.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
FEBS J 2013; 280:432-44; PMID:22458809; https://doi.org/10.1111/j.1742- 4658.2012.08587.x 7.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
In ﬂamm Bowel Dis 2010; 16:2055-64; PMID:20848498; https://doi.org/10.1002/ibd.21325ONCOIMMUNOLOGY e1321185-13,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
JAKSTAT 2013; 2:e25112; PMID:24416644;https://doi.org/10.4161/jkst.25112 9.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Immune Netw 2016; 16:13-25; PMID:26937228; https://doi.org/10.4110/in.2016.16.1.13 10.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Blood 2007; 110:553-60;PMID:17395783; https://doi.or g/10.1182/blood-2006-11-059246 11.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Eur J Immunol2003; 33:2832-41; PMID:14515267; https://doi.org/10.1002/eji.200324073 12.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
PLoS One 2010; 5:e11491; PMID:20634889; https://doi.org/ 10.1371/journal.pone.0011491 13.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Mol Cell Biol 2015; 7:517-28; PMID:26063615; https://doi.org/10.1093/jmcb/mjv032 14.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Nat Rev Immunol 2004; 4:941-52; PMID:15573129; https://doi.org/10.1038/nri1498 15.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Expert Opin Biol Ther 2010; 10:1019-35; PMID:20415597; https://doi.org/10.1517/14712598.2010.482207 17.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Clin Dev Immunol 2011; 2011:267539; PMID:21922022; https://doi.org/10.1155/2011/267539 18.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Gastrointest Oncol 2012; 3:105-19; PMID:22811878; https://doi.org/10.3978/j.issn.2078-6891.2011.021 19.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Immunology2011; 133:221-38; PMID:21453419; https://doi.org/10.1111/j.1365- 2567.2011.03429.x 20.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Cancer Res 2008; 68:5439-49; PMID:18593947; https://doi.org/10.1158/0008-5472.CAN-07-6621 21.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Immunol 2007;178:7259-66; https://doi.org/10.4049/jimmunol.178.11.7259 2 2 .,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Immunol 2004; 172:1355-63; https://doi.org/10.4049/jimmunol.172.3.1355 23.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Bio- chem Pharmacol 2010; 80:2074-86; PMID:20709027; https://doi.org/10.1016/j.bcp.2010.07.040 24.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
"Yanagawa Y, Iwabuchi K, Onoe K. Co-operative action of interleukin- 10 and interferon-gamma to regulate dendritic cell functions.Immunology 2009; 127:345-53; PMID:19191915; https://doi.org/ 10.1111/j.1365-2567.2008.02986.x 25.",OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Cancer Cell 2009; 15:114- 23; PMID:19185846; https://doi.org/10.1016/j.ccr.2008.12.018 26.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Immunol 2004;172:464-74; https://doi.org/10.4049/jimmunol.172.1.464 27.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
"Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells.Immunity 2005; 23:491-502; PMID:16286017; https://doi.org/10.1016/j.immuni.2005.09.010 28.",OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Blood 2005;105:689-96; PMID:15251981; https://doi.org/10.1182/blood-2004-04-1309 29.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Eur J Immunol 2014; 44:3413-28; PMID:25100611; https://doi.org/10.1002/eji.201344417 30.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Mol Cell Biol 2012; 32:1080-8; PMID:22252315; https://doi.org/10.1128/ MCB.06279-11 31.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Biol Chem 2006; 281:5258- 66; PMID:16332678; https://doi.org/10.1074/jbc.M511546200 32.,OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Nat Genet 2007; 39:338-46;PMID:17259984; https://doi.org/10.1038/ng1963 33.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Cell MolLife Sci 2008; 65:3231-40; PMID:18668203; https://doi.org/10.1007/s00018-008-8228-6 34.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Cancer Res 2004; 64:8795-9; PMID:15604233; https://doi.org/10.1158/0008-5472.CAN-04-1776 35.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Nat Med 1999;5:444-7; PMID:10202937; https://doi.org/10.1038/7445 36.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
Blood Cells Mol Dis 2001; 27:206-16; https://doi.org/10.1006/bcmd.2000.0372 38.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Clin Invest 2000; 105:R9-R14; PMID:10727452; https://doi.org/10.1172/JCI9051 39.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
J Clin Invest 1999; 104:173-80; PMID:10411546; https://doi.org/10.1172/JCI6909 40.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/koni-06-06-1321185.PMC5486178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
"6, e1321187 (6 pages)https://doi.org/10.1080/2162402X.2017.1321187",Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
ORCID Alexandre Reuben http://orcid.org/0000-0003-4510-0382 Cara Haymaker http://orcid.org/0000-0002-1317-9287 Vancheswaran Gopalakrishnan http://orcid.org/0000-0002-8704-035X Sujan Reddy http://orcid.org/0000-0001-7454-114X Zachary A. Cooper http://orcid.org/0000-0003-1059-0940 Orenthial J. Fulbright http://orcid.org/0000-0003-3194-5376 Alexander J. Lazar http://orcid.org/0000-0002-6395-4499 Sapna P. Patel http://orcid.org/0000-0003-1339-1517 References 1.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Uveal mel-anoma: From diagnosis to treatment and the science in between.Cancer 2016; 122(15):2299-312; PMID:26991400; https://doi.org/ 10.1002/cncr.29727 2.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Cancer Biol Ther 2006; 5(2):225-7; PMID:16410717;https://doi.org/10.4161/cbt.5.2.2429 3 .,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.Nature 2009; 457(7229):599-602; PMID:19078957; https://doi.org/ 10.1038/nature07586 4.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
N Engl J Med 2010; 363(23):2191-9; PMID:21083380; https://doi.org/ 10.1056/NEJMoa1000584 5.,OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Jama 2014; 311(23):2397-405;PMID:24938562; https://doi.org/10.1001/jama.2014.6096 6.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Eur J Cancer 1992; 28A(12):2087;PMID:1419309; https://doi.org/10.1016/0959-8049(92)90266-5 7.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Cancer 2013; 119(20):3687-95; PMID:23913718; https://doi.org/10.1002/cncr.28282 8.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Cancer 2016; 122(21):3344-53; PMID:27533448; https://doi.org/10.1002/cncr.30258 9.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
"Cancers 2016; 8(1):pii: E17; PMID:26784231; https://doi.org/10.3390/cancers8010017 10. Cooper ZA, Reuben A, Spencer CN, Prieto PA, Austin-Breneman JL, Jiang H, Haymaker C, Gopalakrishnan V, Tetzlaff MT, Freder- ick DT et al.",Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Oncoimmunology 2016; 5(3):e1136044:00-00; PMID:27141370; https://doi.org/10.1080/2162402X.2015.1136044 11.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Clin Cancer Res 2012; 18(24):6758-70; PMID:23032743; https://doi.org/ 10.1158/1078-0432.CCR-12-1177 12.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Clin Laboratory Med 2011; 31(2):243-53; PMID:21549238; https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
J Clin Invest 2014; 124(5):2246-59; PMID:24667641; https://doi.org/10.1172/JCI73639 15.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
N Engl J Med 2012; 366(26):2455-65; PMID:22658128; https://doi.org/10.1056/NEJMoa1200694ONCOIMMUNOLOGY e1321187-5,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
N Engl J Med 2014; 371(23):2189-99; PMID:25409260; https://doi.org/10.1056/NEJMoa1406498 17.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Am J Hum Genet 2016; 99(5):1190-8; PMID:27745836; https://doi.org/10.1016/j.ajhg.2016.09.008 18.,OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
"Sci- ence (New York, NY) 2015; 348(6230):56-61; PMID:25838373; https://doi.org/10.1126/science.aaa8172 19.",Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
N Engl J Med 2010; 363(8):711-23; PMID:20525992; https://doi.org/10.1056/NEJMoa100346620.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
N Engl J Med 2012; 366(26):2443-54; PMID:22658127; https://doi.org/10.1056/NEJMoa1200690 21.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
N Engl J Med 2015; 373(1):23-34; PMID:26027431; https://doi.org/10.1056/NEJMoa1504030 22.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Nat Rev Immunol 2006; 6(11):836-48; PMID:17063185; https://doi.org/10.1038/nri1961 23.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
Clin Cancer Res 2016; 22(9):2237-49; PMID:26712692; https://doi.org/10.1158/1078-0432.CCR-15-2294e1321187-6 Y. QIN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/koni-06-06-1321187.PMC5486182.pdf
"Published with license by Taylor & Francis Group, LLC © Elisa Brandetti, Irene Veneziani, Ombretta Melaiu, Annalisa Pezzolo, Aurora Castellano, Ren ata Boldrini, Elisa Ferretti, Doriana Fruci, Lorenzo Moretta, Vito Pistoia, Franco Locatelli, and Loredana Cifaldi.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/89/37/koni-06-06-1316439.PMC5486189.pdf
